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Abstract
The interferon system functions as a first line of defense against viral infections.
The cellular recognition of viruses leads to the production of interferons (IFN) by
the infected cells. Secreted IFN stimulates an antiviral response in an autocrine and
paracrine manner: While autocrine IFN action inhibits virus production in infected
cells, paracrine IFN signaling induces an antiviral protective state in na¨ıve cells.
Although central molecular components of the IFN system have been characterized,
our quantitative understanding of its dynamics remains limited. In particular, it
is not precisely known which molecular processes are decisive for the outcome of
virus-host interactions.
Together with our experimental cooperation partners, we have studied virus-induced
IFN signaling at single-cell resolution in communicating cell populations after infec-
tion with a non-spreading and a spreading virus. On this basis, we established two
complementary mathematical models. First, we developed a stochastic multi-scale
model accounting for the intracellular dynamics in individual cells and the cell-to-
cell communication via secreted IFN. Second, we constructed a delay differential
equation model to analyze the competition between viral spread and IFN-induced
antiviral defense in a cell population. Both models were parameterized on the basis
of original experimental data and the numerical analyses of the models aimed at
deriving testable predictions for new experiments.
By live-cell imaging, we showed that key steps of the IFN pathway including virus-
induced signaling, IFN expression, and induction of IFN-stimulated genes are stochas-
tic events in individual cells. To relate the single-cell data after primary infection to
antiviral protection at the cell-population level, we established a stochastic model
which combines the heterogeneous IFN signaling in single cells with the intercellular
communication through released IFN. The parameters describing the virus-induced
activation of the transcription factors of the IFN gene were estimated from a distri-
bution of observed single-cell activation times using as objective function Neyman’s
chi-squares statistic. The minimization of this objective function by simulated an-
nealing revealed that virus-induced signaling is cooperative. Moreover, fitting of the
measured time delays between transcription factor activation and IFN gene induction
in individual cells with a gamma distribution by applying the maximum-likelihood
method implies that IFN gene induction downstream of transcription factor activa-
tion is a slow multi-step process. Notably, mathematical modeling and experimen-
tal validation indicate that reliable antiviral protection in the face of multi-layered
cellular stochasticity can be achieved by paracrine propagation of the IFN signal.
Therefore, a few IFN-producing cells are able to protect a large number of na¨ıve
cells (Rand, Rinas et al. 2012).
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To investigate the competition between viral spread and IFN-induced antiviral de-
fense, we examined virus-host interactions after infection with spreading Dengue
virus. For this purpose, our experimental partners generated data showing the
antiviral response dynamics of fluorescent reporter cells after infection with a fluo-
rescently labeled Dengue virus. Based on these kinetic data, we established a delay
differential equation model with time delays for virus replication, virus production
and IFN secretion. Using data-driven least-squares fitting and profile likelihood
analysis, we identified the model parameters within narrow confidence bounds and
found that the timing of virus production and IFN secretion after infection are al-
most identical. This direct competition together with the highly heterogeneous IFN
response in single cells fosters the coexistence of IFN-induced protection of na¨ıve
cells and viral spread in non-protected cells. To analyze which components of the
antiviral IFN system have the greatest influence on viral spread, we compared the
infection dynamics of the wild-type Dengue virus with the attenuated spread of
the vaccine candidate Dengue virus E217A mutant. We quantified the differences
between wild-type and mutant Dengue virus infections using data-driven parame-
ter optimization constrained by the determined wild-type virus related parameter
values. In this way, we identified two mutant virus specific parameters, which ex-
plain the attenuation of the mutant through a reduced virus production rate and
an accelerated IFN secretion taking place much earlier than virus production. By
mathematical modeling and validation experiments, we predict that rapid IFN ac-
tion curbing virus production in infected cells is critical for the attenuation of the
Dengue virus E217A mutant. Thus, a fast acting autocrine IFN signal could limit
viral spread in such a way that accelerated paracrine IFN response has only a minor
impact on the spread of Dengue virus (Schmid, Rinas et al. submitted).
In conclusion, our work demonstrates that mathematical modeling is an essential
tool to integrate data and mechanisms from the molecular to the cell-population
level. The research on understanding which molecular mechanisms shape virus-host
interactions might inform the development of new antiviral therapies and vaccines.
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Zusammenfassung
Das Interferon-System dient als eine der ersten Verteidigungslinien gegen virale In-
fektionen. Die zellula¨re Erkennung von Viren fu¨hrt dazu, dass infizierte Zellen Inter-
ferone (IFN) produzieren. Sezerniertes IFN stimuliert auf autokrine und parakrine
Weise eine antivirale Antwort: Wa¨hrend die autokrine Wirkung von IFN die Virus-
produktion in infizierten Zellen hemmt, induziert das parakrine IFN-Signal in naiven
Zellen einen antiviralen geschu¨tzten Zustand. Obwohl die zentralen molekularen
Komponenten des IFN-Systems charakterisiert sind, ist unser quantitatives Ver-
sta¨ndnis u¨ber die Dynamik dieses Systems nach wie vor begrenzt. Insbesondere ist
nicht genau bekannt, welche molekularen Prozesse fu¨r den Verlauf von Virus-Wirt-
Interaktionen entscheidend sind.
Zusammen mit unseren experimentellen Kooperationspartnern haben wir die durch
Virus induzierte IFN-Signalu¨bermittlung auf Einzelzellebene in kommunizierenden
Zellpopulationen nach Infektion mit einem sich nicht vermehrenden und einem sich
ausbreitenden Virus erforscht. Auf dieser Grundlage entwickelten wir zwei komple-
menta¨re mathematische Modelle. Zum einen erstellten wir ein stochastisches Mul-
tiskalenmodell, welches die intrazellula¨re Dynamik in Einzelzellen und die Zell-Zell-
Kommunikation mittels sezerniertem IFN beschreibt. Zum anderen konstruierten
wir ein zeitverzo¨gertes Differentialgleichungsmodell, um den Wettbewerb zwischen
Virusausbreitung und IFN-induzierter antiviraler Abwehr in einer Zellpopulation
zu analysieren. Beide Modelle wurden auf der Grundlage von neuartigen experi-
mentellen Daten parametrisiert, wobei die numerische Analyse der Modelle auf die
Erlangung von u¨berpru¨fbaren Vorhersagen fu¨r neue Experimente abzielte.
Mittels Lebendzell-Mikroskopie zeigten wir, dass zentrale Teilabschnitte des IFN-
Signalwegs - bestehend aus Virus-induzierter Signalu¨bertragung, Expression von
IFN und Induktion von IFN-stimulierten Genen - stochastische Ereignisse in einzel-
nen Zellen sind. Um die Einzelzelldaten nach prima¨rer Infektion mit dem antivi-
ralen Schutz der Zellpopulation in Beziehung zu setzen, haben wir ein stochastisches
Modell erstellt, welches die heterogene IFN-Signaltransduktion in einzelnen Zellen
mit der interzellula¨ren Kommunikation infolge des ausgeschu¨tteten IFN verbindet.
Die Parameter, welche die Virus-induzierte Aktivierung der Transkriptionsfaktoren
des IFN-Gens beschreiben, wurden anhand einer Verteilung von beobachteten In-
duktionszeiten in Einzelzellen gescha¨tzt, wobei Neymans Chi-Quadrat-Statistik als
Zielfunktion verwendet wurde. Die Minimierung dieser Zielfunktion mittels Simu-
lated Annealing hat ergeben, dass die Virus-induzierte Signalu¨bermittlung koopera-
tiv ist. Daru¨ber hinaus konnten die in Einzelzellen gemessenen Verzo¨gerungszeiten
zwischen der Aktivierung der Transkriptionsfaktoren und der IFN-Geninduktion
unter Anwendung der Maximum-Likelihood-Methode mit einer Gammaverteilung
beschrieben werden. Dies impliziert, dass die IFN-Geninduktion nach Aktivierung
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der Transkriptionsfaktoren einem langsamen, mehrstufigen Prozess entspricht. Ins-
besondere deuten mathematische Modellierung und experimentelle Validierung da-
rauf hin, dass ein verla¨sslicher antiviraler Schutz angesichts der vielschichtigen zel-
lula¨ren Stochastizita¨t durch parakrine Ausbreitung des IFN-Signals erzielt werden
kann. Demzufolge sind wenige IFN-produzierende Zellen dazu in der Lage, eine
große Anzahl naiver Zellen zu schu¨tzen (Rand, Rinas et al. 2012).
Um den Wettbewerb zwischen viraler Ausbreitung und IFN-induzierter antiviraler
Abwehr zu analysieren, untersuchten wir Virus-Wirt-Interaktionen nach Infektion
mit dem sich vermehrenden Dengue-Virus. Zu diesem Zweck generierten unsere ex-
perimentellen Kooperationspartner Daten u¨ber die Dynamik der antiviralen Antwort
von fluoreszierenden Reporterzellen nach Infektion mit einem fluoreszenzmarkierten
Dengue-Virus. Auf der Grundlage dieser kinetischen Daten entwickelten wir ein
zeitverzo¨gertes Differentialgleichungsmodell, welches die Zeitverzo¨gerungen der Vi-
rusreplikation, der Virusproduktion und der IFN-Ausschu¨ttung beru¨cksichtigt. Mit-
tels datenbasierter Parameteroptimierung unter Verwendung der Methode der kleins-
ten Quadrate und der Profile-Likelihood-Methode identifizierten wir die Modellpa-
rameter innerhalb enger Konfidenzintervalle und fanden dadurch heraus, dass die
Virusfreisetzung und die IFN-Sezernierung nach Infektion nahezu zeitgleich ein-
setzen. Dieser direkte Wettbewerb zusammen mit der a¨ußerst heterogenen IFN-
Antwort der Einzelzellen fu¨hrt dazu, dass der IFN-induzierte Schutz naiver Zellen
und die Virusausbreitung in nicht-geschu¨tzten Zellen nebeneinander bestehen. Um
zu ermitteln, welche Komponenten des antiviralen IFN-Systems den gro¨ßten Ein-
fluss auf die virale Verbreitung haben, verglichen wir die Infektionsdynamik des
Dengue-Virus-Wildtyps mit der eines sich kaum vermehrenden Impfstoffkandidaten,
der Dengue-Virus E217A Mutante. Wir quantifizierten die Unterschiede zwischen
Dengue-Virus Infektionen mit dem Wildtyp und der Mutante mittels datenbasierter
Parameteroptimierung, welche durch die ermittelten Parameterwerte des Wildtyps
beschra¨nkt wurde. Auf diese Weise identifizierten wir zwei Mutante-spezifische Pa-
rameter, welche die Abschwa¨chung der Dengue-Virus Mutante durch eine reduzierte
Virusproduktionsrate und eine beschleunigte, deutlich vor der Virusfreisetzung ein-
setzende IFN-Ausschu¨ttung erkla¨ren. Auf der Grundlage von mathematischer Mo-
dellierung und Validierungsexperimenten sagen wir voraus, dass eine rasche IFN-
Wirkung, welche die Virusproduktion in infizierten Zellen einda¨mmt, fu¨r die Ab-
schwa¨chung der Dengue-Virus E217A Mutante entscheidend ist. Daher ko¨nnte ein
schnelles autokrines IFN-Signal die virale Verbreitung derart einschra¨nken, dass eine
beschleunigte parakrine IFN-Antwort nur eine geringe Wirkung auf die Ausbreitung
des Dengue-Virus hat (Schmid, Rinas et al. eingereicht).
Zusammenfassend veranschaulicht unsere Arbeit, dass die mathematische Model-
lierung ein wichtiges Instrument ist, um Daten und Mechanismen von der moleku-
laren bis zur Ebene der Zellpopulation zusammenzufu¨hren. Ein besseres Versta¨ndnis
daru¨ber, welche molekularen Mechanismen die Virus-Wirt-Interaktionen beeinflus-
sen, ko¨nnte zur Entwicklung neuer antiviraler Therapien und Impfstoffe beitragen.
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1. Introduction
Viruses have been, and continue to be, one of the major causes of global public
health problems. Throughout history, viral diseases have claimed innumerable lives
due to epidemic spread of infections. It is no surprise that numerous researchers
from all fields of the natural sciences have for a long time contributed to the under-
standing and the battle against infectious diseases. This includes in particular the
mathematical modeling of viral infections, which continues to play an instrumental
role in improving our knowledge of virus-host interactions.
1.1. Mathematical methods applied in this thesis
In close collaboration with experimentalists, we perform data-driven mathematical
modeling to study the competition between virus infection and the antiviral immune
defense induced by secreted interferons (IFN) in communicating cell populations. In
general, mathematical models are tools to describe and analyze a system in mathe-
matical terms. In this study we use both deterministic and stochastic mathematical
modeling. While the output of a deterministic model is fully determined by the pa-
rameter values and the initial conditions, a stochastic model has at least one random
component causing variability, and thereby affecting the output of the model.
To account for various experimental conditions, we establish two complementary
mathematical models. First, in order to link heterogeneous single-cell data after
primary infection to antiviral protection at the cell-population level, we develop a
multi-scale stochastic model. Second, we construct a deterministic delay differential
equation model of viral spread and IFN-induced antiviral defense, which partitions
the cell population into different subpopulations according to their infection state.
1.1.1. Multi-scale stochastic modeling based on experimental data
Model structure
In section 2.2, we develop a multi-scale stochastic model, which combines the ob-
served heterogeneous intracellular dynamics of virus-induced signal transduction,
IFN gene induction and IFN response in single cells with the cell-to-cell commu-
nication mediated by secreted IFN in an infected cell population (see Figure 2.9).
The model is formulated as a continuous-time stochastic process in which the pos-
sible state changes of individual cells are determined through propensity functions
depending on the current state of the cell and the extracellular concentration of
1
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secreted IFN (see section 2.2.2). Our model is thus a Markov process (see sec-
tion 2.2.1). Given the high diffusion coefficient of IFN (Kreuz and Levy 1965:
DIFN = 3.42 × 105 µm2/h; Hu et al. 2011: DIFN = 1.08 × 105 µm2/h), the spread
of IFN on the relevant length scale of several cell diameters occurs within minutes,
which is fast compared to the hour-timescale of IFN expression and IFN response.
We therefore assume uniform distribution of released IFN and describe the kinetic
of extracellular IFN by an ordinary differential equation (ODE) depending on the
number of infected IFN-producing cells (see equation (2.11)). Corresponding to the
experimental system, we consider as initial conditions that a fraction of cells is in-
fected with virus, and that signal transduction and gene expression are inactive in
all cells at the starting time.
Model simulation
The stochastic state transitions of single cells are iterated using Gillespie’s stochastic
simulation algorithm, which is a Monte Carlo procedure for the numerical simulation
of stochastic kinetics (Gillespie 1976, Gillespie 1977) (see section 2.2.1 and 2.2.3). In
parallel to Gillespie’s direct method, we calculate the extracellular concentration of
IFN by utilizing the Euler method to integrate the corresponding differential equa-
tion numerically. Our multi-scale stochastic model is implemented and simulated in
Matlab (The Mathworks Inc., Natick, MA). All model related programs are freely
available as Supplementary Information for the open access paper Rand, Rinas et
al. 2012 at the Molecular Systems Biology website (www.nature.com/msb).
Parameter estimation
The Gillespie algorithm is a common and valuable method to simulate stochastic
processes, but generating a sufficient number of realizations of extensive models
with large time scale separation takes considerable time (Gillespie 2007, Cao and
Samuels 2009, Banks et al. 2011). Indeed, we find that the simulation time of our
model for a physiologically relevant number of cells (104 cells) with kinetics over
several hours is prohibitive of straightforward parameter optimization approaches
based on experimental data. To address this limitation, we divide the parameter
optimization problem into three parts with respect to the key steps of the IFN
signaling pathway: (1) estimation of parameters for the virus-induced activation of
the transcription factors of IFN (see section 2.3.1), (2) identification of parameters
corresponding to IFN gene induction (see section 2.3.2) and (3) determination of
parameters of the IFN response (see section 2.3.3).
The first two parts concern the induction of IFN expression in individual cells with-
out intercellular communication via secreted IFN. As the simulation of isolated
single-cell behavior is much less time-consuming than the full model, rigorous pa-
rameter estimation is feasible. The third part of the optimization problem regarding
the IFN response depends on cell-to-cell signaling and therefore requires the simu-
lation of a large number of communicating cells, which in turn causes impractically
long calculation times. However, it turns out that we can still infer quantitative
features of the IFN response from the experimental data (see section 2.3.3).
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1.1. Mathematical methods applied in this thesis
First, we estimate the parameters of the propensity function describing the virus-
induced activation of the transcription factors of IFN (see section 2.3.1). This
propensity function is formulated as a Hill function and its parameters are optimized
from a distribution of measured single-cell activation times using as objective func-
tion Neyman’s chi-squares statistic (Baker and Cousins 1984) (see equation (2.20)).
To minimize this objective function we apply the simulated annealing method (Kirk-
patrick et al. 1983, Schneider and Kirkpatrick 2006). From a biological point of view,
the most interesting estimate is the parameter value of the Hill coefficient, as a Hill
coefficient larger than 1 implies positive cooperativity (Murray 2002). To test the
goodness-of-fit with respect to the Hill coefficient, we apply the profile likelihood
method (Venzon and Moolgavkar 1988) (see section 2.3.1) and consider the degree
of freedom as an upper limit for good fits.
Second, we analyze if the histogram of the observed cell-to-cell variation of the time
delay between transcription factor activation and IFN gene induction is stochas-
tically compatible with a gamma distribution γ(m,z) (see section 2.3.2). For a
positive integer m, γ(m,z) describes the distribution of the sum of m independent
random variables, where each random variable is exponentially distributed with rate
z (Press et al. 2007). In biological terms, the gamma distribution characterizes a
multi-step process consisting of m consecutive single-rate steps. Based on the mea-
sured IFN induction times after transcription factor activation monitored in single
cells, we determine the parameters of the gamma distribution with the maximum-
likelihood method (Myung 2003). By calculating the root of the partial derivative
of the log-likelihood function L with respect to z, we obtain an explicit estimator
for z depending on m (see equation (2.30)). Utilizing this estimator, the parameter
m is determined independently from z by numerically computing the root of the
partial derivative of L with respect to m.
Third, we parameterize the IFN response by describing the measured dose-response
of IFN-responding cells versus external IFN with a Hill function (see section 2.3.3).
The parameters of the Hill function are fitted to the dose-response data set using
a least-squares method (see equation (2.35)). Restricted by the preceding param-
eterization, the IFN secretion rate and the IFN degradation rate are determined
to match the observed time course of extracellular IFN to the proportion of IFN
producing cells.
1.1.2. Data-driven delay differential equation model of population
dynamics
Model structure
In section 3.2, we establish a delay differential equation (DDE) model of viral spread
and IFN-induced antiviral protection in a cell population driven by experimental
data. The model classifies the cell population into several subpopulations according
to their infection state and is thus a modified version of the classical compartment-
based SIR model, which takes into account the temporal dynamics of susceptible S,
infected I and recovered R population classes (Kermack and McKendrick 1927) (see
section 1.3.1). Our DDE model describes how susceptible cells can become either
3
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infected by extracellular virus or protected by the antiviral effect of secreted IFN
(see Figure 3.16). The model is formulated as a system of 10 differential equations
with three constant time delays for virus replication, virus production and IFN
secretion, respectively (see system of equations (3.11)). At the starting time, only
the initial number of susceptible cells and the extracellular viral load are non-zero.
For variables with a delay argument, we use as history functions the constant zero
function, which is compatible with the experimental protocol.
Motivated by the experimental observation that stimulation of infected cells with
IFN in an early phase after infection resulted in reduced virus replication, we de-
velop an extended version of our model. This full DDE model additionally takes
into account that the recognition of secreted IFN in an early time window after viral
entry inhibits virus production in infected cells (see section 3.4). The full model is
described by a system of 13 differential equations with four constant time delays
(see system of equations (3.37)). At the starting time only the initial number of
susceptible cells as well as the extracellular viral load are non-zero. For those vari-
ables that have a delay argument, we consider as history functions the constant zero
function.
Model simulation
For the simulation of the basic DDE model (3.11) and the full DDE model (3.37) we
use Matlab as a programming environment. By means of a binary Matlab executable
(mex) subroutine, we set up an interface between Matlab and the freely available
RADAR5 solver written in ANSI Fortran-90 (Guglielmi and Hairer 2005). The
RADAR5 framework comprises an algorithm to calculate numerically the solution of
stiff delay differential equations based on an adapted 3-stage Radau IIA collocation
method (Hairer and Wanner 1999, Guglielmi and Hairer 2001, Guglielmi and Hairer
2008). In order to increase the accuracy of the numerical solution, we implement the
time-dependent standard Jacobian matrix and the Jacobian matrix with respect to
the delayed variables within the RADAR5 code. An explicit presentation of these
Jacobian matrices is given in the appendix.
Parameter estimation
In section 3.3, we perform data-driven optimization of the model parameters. For
parameter estimation and computation of confidence bounds using the profile like-
lihood method (Venzon and Moolgavkar 1988) (see equation (3.21) and (3.22)) we
employ a least-squares algorithm (see equation (3.19)). To speed up calculation, we
utilize Matlab’s parallel computing toolbox to run several optimization processes
simultaneously on a computer cluster.
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1.2. Biological background
1.2. Biological background
1.2.1. What is a virus?
Science has come a long way in understanding how infectious diseases are caused.
The idea that small, invisible particles might be responsible for infectious diseases
goes back to writings of Aristotle (384-322 BC). The first experimental evidences of
viruses has been provided by the work of Adolf Mayer and Dmitri Ivanowski (Mayer
1886, Ivanowski 1892, Artenstein 2010). Both researcher detected that the agent
of the tobacco mosaic disease remained infectious after passing through a bacteria-
stopping filter. Martinus Beijerinck extended the research on the tobacco mosaic
virus (TMV) and established the first concept of viruses as agents that can only
grow in living host cells (Beijerinck 1898).
The discovery of viruses is closely linked to the consistent progress in the area of
imaging technologies. In 1677, Antonie van Leeuwenhoek developed the first micro-
scope, which allowed him to identify microorganisms or “little animals” (Artenstein
2010). Also John Buist was not aware of his observation of “minute bodies” when
he monitored in 1887 for the first time the relatively large vaccinia virus using opti-
cal microscopy (Gordon 1937). Only the invention of electron microscopes achieved
through an international cooperation in the 1930s enabled the first visualization of a
virus, which was published by Helmut Ruska, Gustav Kausche, and Edgar Pfankuch
in 1940 (Ackermann 2011). The visual identification of viral and cellular structures
using electron microscopy was a scientific milestone.
The imaging advances revealed that, the general structure of these small infectious
agents is actually quite simple. A virus is made up of at least a genome and a protec-
tive capsid (Figure 1.1) (Gelderblom 1996). The genome consists of either a ribonu-
cleic acid (RNA) or deoxyribonucleic acid (DNA), which can be single-stranded (ss),
double-stranded (ds), linear or circular. Viruses with an ssRNA genome are further
classified according to the polarity of the ssRNA. A viral ssRNA genome is called
positive-sense, if it has the same polarity as the viral messenger RNA (mRNA) and
thus can serve directly as mRNA during the replication process. A negative-sense
ssRNA has the opposite polarity as the viral mRNA and must first be transcribed
into a complementary strand. The viral genome together with the capsid form the
nucleocapsid, which in some viruses is covered by an additional protective envelope.
Envelope 
(not present 
in all viruses) 
Genome 
Capsid Nucleocapsid 
Figure 1.1.: Scheme of the general structure of a virus. A virus comprises at least a
genome and a protective capsid. These two components form the nucleocapsid, which in
some viruses is surrounded by an envelope.
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Since viruses are not able to proliferate independently, the infectious agents enter
cells to utilize the cellular metabolic and biosynthetic machinery for replication.
1.2.2. Viruses studied in this thesis
In close collaboration with experimental partners, we investigate virus-host dynam-
ics at single-cell level in communicating cell populations after infection with two
different viruses. While we examine the dynamics of the Newcastle disease virus
(NDV) in chapter 2, our work in chapter 3 is based on Dengue virus (DENV) infec-
tions.
The avian Newcastle disease virus
The first reported outbreak of Newcastle disease occurred at a farm near Newcastle
upon Tyne in England in 1926 (Seal and King 2005). The Newcastle disease is a
contagious bird disease, whereby the severity of the illness can range from mild to
fatal (Capua and Alexander 2004). A transmission of NDV to humans is possible
through a close contact with the virus or with infected birds and may cause influenza-
like symptoms and even conjunctivitis.
The Newcastle disease is triggered by the avian paramyxovirus NDV, which is an
enveloped, negative-sense ssRNA virus. The viral genome encodes for a nucleopro-
tein, phosphoprotein, matrix protein, fusion protein, haemagglutinin-neuraminidase
(HN) protein and an RNA-directed RNA polymerase (Seal and King 2005). The
attachment of NDV to a cell is mediated by the HN protein. For successful viral
uptake into the cell during infection the HN protein interacts with the fusion pro-
tein. Subsequently, the nucleocapsid is released into the cytoplasm of the host cell,
where viral replication takes place. After the synthesis of the viral proteins, genomic
RNA replication starts with transcription of a positive-sense antigenome serving as
a template for the negative-sense genome synthesis. The NDV genomic RNA is
used for transcription as well as replication. The aggregation of viral proteins in
the infected cell enables the assembly and the release of the generated virus through
membrane budding. During the budding process, single copies of the NDV genome
are enclosed by an outer envelope that is made from the plasma membrane of the
host cell (Schirrmacher and Fournier 2009).
In experimental research, NDV is often used as a pathogen to analyze virus-host
interactions. Since the avian virus cannot generate new infectious virus particles
in most mammalian cell types (Rott 1979, Seal and King 2005), NDV is a suitable
model to investigate primary infection without viral spread.
The human Dengue virus
The Dengue virus (DENV) is a mosquito-transmitted human pathogen widely dis-
tributed throughout tropical and subtropical regions around the world (Murray et al.
2013). The flavivirus DENV is an enveloped, positive-sense, ssRNA virus (Fischl
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and Bartenschlager 2013) and includes five serotypes: DENV-1, DENV-2, DENV-3,
DENV-4 and a recently discovered DENV-5 (Normile 2013). Infection with any
serotype can lead to a broad spectrum of clinical manifestations, ranging from in-
apparent infection to flu-like Dengue fever, severe Dengue hemorrhagic fever and
life-threatening Dengue shock syndrome (Dı´az et al. 1988, Murphy and Whitehead
2011). The recovery from infection by one serotype can provide lifelong immunity
to this specific serotype. However, subsequent secondary infection with a different
serotype increases the risk of developing a serious disease. As primary infections
are often asymptomatic, Dengue fever is not diagnosed and disease surveillance is
inadequate, estimates of global DENV infections vary between 50 to 200 million
cases per year (Murray et al. 2013). An even worse situation of annually 96 million
apparent and additionally 294 million inapparent DENV infections is predicted by
a cartographic modeling approach (Bhatt et al. 2013). Since approximately 50% of
the world’s population lives in regions with a risk of DENV infection and neither
approved vaccines nor specific antiviral therapies are available, DENV is a major
global health problem (Wilder-Smith et al. 2012).
The infection of a host cell by DENV starts with the binding of the virus to a
cell surface receptor, which leads to the transportation of DENV into the cell via
endocytosis (Lindenbach et al. 2006, Bartenschlager and Miller 2008, Welsch et al.
2009, Kumar et al. 2013, Acosta et al. 2014). The fusion of the viral envelope with
the endosome membrane causes the release of the nucleocapsid into the cytoplasm.
The nucleocapsid detaches and the released RNA is translated into a single viral
polyprotein. This polyprotein is cleaved into 3 structural proteins, the capsid protein
(C), the premembrane protein (prM) as well as the envelope protein (E) and 7 non-
structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) by viral
and cellular proteases (Chambers and Rice 1987, Bartenschlager and Miller 2008,
Kumar et al. 2013, Acosta et al. 2014). Viral replication occurs in the cytoplasm
in close association with intracellular membranes (Welsch et al. 2009, Pen˜a and
Harris 2012). Newly generated viral RNA together with capsid proteins form a
nucleocapsid. The nucleocapsid associates with E and prM to form an immature
virus particle inside the endoplasmic reticulum. The immature virus attains its
maturity by passing through the trans-Golgi network and the mature infectious
virus particle is released into the extracellular milieu.
To study the replication dynamics of DENV, our cooperation partners have gener-
ated a fully viable, fluorescent DENV reporter construct (see section 3.1.1). This
DENV reporter enables us to detect both viral replication and viral spread in living
host cells.
1.2.3. The interferon response against viral infections
Viruses can enter cells within minutes to exploit the hosts for the production of new
virus particles, which are released some hours later to infect other cells. To prevent
pathogen replication and spread host organisms have evolved an elaborate immune
system that is able to respond in a fast, efficient and specific manner.
The immune system can be classified into an innate and an adaptive immunity.
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Figure 1.2.: Scheme of the antiviral interferon system. The cellular detection of repli-
cating (↻) RNA viruses by intracellular receptors activates a signaling cascade leading to
the expression of interferons (IFN) as well as antiviral interferon stimulated genes (ISGs)
(green background color). Secreted IFN induces the IFN response, which in turn triggers
an antiviral state in the cell (yellow background color).
The discovery of these two subsystems goes back to the work of Elie Metchnikoff
and Paul Ehrlich, who are considered the founders of the concepts of innate immu-
nity and adaptive immunity, respectively (Kaufmann 2008, Artenstein 2010). Elie
Metchnikoff carried out research on the innate immune response, the initial general
line of defense against invading foreign pathogens, and published in 1884 his the-
ory of cell-mediated immunity as a countermeasure against nonspecific pathogens.
Complementary to this area of immunity, Paul Ehrlich studied the principles of the
adaptive immune system, which comprises the defense against pathogens in the late
phase of disease progression and the formation of immunological memory against
specific disease agents. In the years of 1897–1901, Paul Ehrlich wrote several papers
on his side-chain theory of antibody formation, which through receptor-mediated
immune reactions generate a lasting infection memory (Ehrlich and Himmelweit
1956).
One central component of the innate immune response is the interferon system that
provides a powerful defense against viral infections (Kunzi and Pitha 2003, Sadler
and Williams 2008, Takeuchi and Akira 2009, West et al. 2011). After the infection
of a host cell, intracellular pattern-recognition receptors (PRRs) are able to detect
pathogen-associated molecular patterns (PAMPs) on the surface of the virus or
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Figure 1.3.: Scheme of the autocrine and paracrine effect of IFN. The cellular recognition
of viruses leads to the secretion of IFN (left, green background color). IFN activates in an
autocrine manner in infected cells (left) the expression of antiviral ISGs (yellow background
color). Moreover, the paracrine sensing of IFN by na¨ıve cells (right) induces an antiviral
protection against viral infection.
during the viral replication process. RNA viruses such as the Newcastle disease
virus (see chapter 2) and Dengue virus (see chapter 3) are recognized by the RIG-I-
like receptors (RLRs), including the retinoic acid-inducible gene I (RIG-I) and the
melanoma differentiation-associated gene 5 (MDA5) and, in addition, by Toll-like
receptors (TLRs) (Figure 1.2).
After viral sensing, RLRs associate with the mitochondrial antiviral-signaling pro-
tein (MAVS). MAVS interacts with several molecules that activate interferon reg-
ulatory factor (IRF) signaling such as the stimulator of interferon genes (STING,
also known as MITA). Activation of STING leads to phosphorylation of IRF-3 as
well as IRF-7. Furthermore, MAVS and different TLRs transmit the RNA virus
signal to the nuclear factor κB (NF-κB) consisting of the subunits p50 and p65.
The transcription factors (TFs) IRF-3, IRF-7 as well as NF-κB translocate from
the cytoplasm to the nucleus to induce the expression of type-I interferons (most
common IFN-α and IFN-β) (Roberts et al. 1998), type-III interferons (IFN-λ1-4)
(Wathelet et al. 1992, Takaoka and Yanai 2006, Prokunina-Olsson et al. 2013) and
also some interferon stimulated genes (ISGs) (Grandvaux et al. 2002, Diamond and
Farzan 2013, Chen et al. 2013). These ISGs can prevent further viral entry or inhibit
viral replication in the infected host cell (Jiang et al. 2010, Brass et al. 2009).
Moreover, secreted interferons (IFN) induce the Janus activated kinase / signal
transducer and activator of transcription (JAK/STAT) signaling pathway in an au-
tocrine and paracrine manner (Figure 1.3) (Hall and Rosen 2010). The term au-
tocrine IFN signaling stands for the action of IFN on already infected cells. Whereas
paracrine IFN signaling is a form of cell-to-cell communication and describes the ef-
fect of IFN on na¨ıve cells. While the IFN-α receptor recognizes secreted type-I IFN,
type-III IFN is sensed through the IFN-λ receptor (Takaoka and Yanai 2006, Sadler
and Williams 2008). Stimulation of the specific IFN receptors activates JAK1 as well
as tyrosine kinase 2 (TYK2) and these kinases phosphorylate STAT1 and STAT2.
Phosphorylated STAT1/STAT2 together with IRF-9 form the IFN-stimulated gene
factor 3 (ISGF3). The nuclear translocation of ISGF3 results in the expression of
ISGs, which in turn block viral activity in infected cells and trigger an antiviral
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protective state in na¨ıve cells.
While central molecular components of the IFN system have been characterized, it
is not precisely known which processes of the antiviral IFN defense are essential for
the outcome of viral infections. In the present work, we address this question by
means of data-driven mathematical modeling in an IFN-competent cell system after
primary infection with non-spreading NDV (see chapter 2) and, additionally, post
infection with spreading DENV (see chapter 3).
1.2.4. The development of vaccines
In addition to researching viruses and the antiviral immune response, scientists tried
intensively to develop a method for preventing infections. The first tool to protect
from viral infection was variolation, which has been initially carried out in China
around the 17th century in the fight against smallpox (Leung 2011). The idea of
this ancient attempt was to expose a healthy person with material taken from a
smallpox patient to trigger an attenuated but lifelong protective infection. In most
cases variolation was effective, but about 1 to 14 percent of the recipients contracted
severe smallpox and died (Gross and Sepkowitz 1998, Mishra 2012).
Based on the preparatory work of countless scientists, Edward Jenner achieved a
medical breakthrough in 1796 by demonstrating in a systematic clinical study that
preinoculation with cowpox virus protects humans against smallpox. This finding is
widely regarded as the beginning of the science of vaccinology (Jenner 1801, Hilleman
2000 Artenstein 2010). After a long lasting global vaccination campaign against
smallpox starting in the early 1800s, an international commission in 1979 certified
the global eradication of a human disease for the first time in history (Mishra 2012).
The principle of vaccination is to generate a specific immune memory that facili-
tates early viral recognition and a fast response upon infection with a certain virus.
Immune memory is achieved by challenging the host with a mimick of the virus that
induces a virus specific immune response without causing the disease. Nowadays,
there are three basic types of vaccines: subunit vaccines, inactivated vaccines, and
live-attenuated vaccines (Cann 2005, Artenstein 2010, Pulendran and Ahmed 2011).
Subunit vaccines contain only some components of the virus that are just sufficient
to trigger a protective immune response but not enough to initiate a dangerous
infection. Prominent examples for subunit vaccines are hepatitis B and human pa-
pillomavirus vaccines. The second group, the inactivated vaccines, are produced by
growing virus in cell culture and subsequently damaging the virus particles in such
a way that virus replication cannot occur, but the virus capsid proteins are recog-
nized by the immune system. Current examples include the inactivated hepatitis
A, polio and influenza vaccines. The third category, the live-attenuated vaccines,
are replication-competent viruses with reduced pathogenicity to elicit an immune
response without leading to disease. The used vaccine strain can originate from a
natural virus as was the case for smallpox vaccines or from an artificially attenuated
virus like the licensed vaccine YF-17D against yellow fever.
In the case of DENV, there are currently several vaccine candidates in clinical tri-
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als (Pierson and Diamond 2014). In addition, the DENV-E217A mutant, which
barely spreads, evokes strong immune responses and is therefore regarded as a novel
live-attenuated vaccine candidate (Zu¨st et al. 2013). Since the design of effective
vaccines depends on the understanding which antiviral factors are decisive to gener-
ate a strong immune response while limiting viral spread, we analyze the underlying
mechanisms responsible for the differences between DENV wild-type and attenuated
DENV-E217A mutant infections by means of a data-driven mathematical model in
chapter 3.
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1.3. Mathematical research on viral infections
1.3.1. The basic concepts of mathematical modeling of viral
infections
Early mathematical work on viral infections was mainly focused on better under-
standing the spread of the infection between hosts. William Heaton Hamer estab-
lished a discrete model concerning measles epidemics, in which he assumed that
the net rate of spread of infection is proportional to the product of the densities
of susceptible and infectious individuals (Hamer 1906). This notion is one of the
basic concepts in mathematical epidemiology and known as the “mass-action” prin-
ciple of transmission for directly transmitted infections (Anderson and May 1991).
Few years later, the scientists Anderson McKendrick as well as Ronald Ross derived
the law of mass-action for differential equations in a diverse and independent man-
ner. While Ronald Ross formulated mass-action from an original chemical perspec-
tive, Anderson McKendrick recognized the universal use of the mass-action principle
(Heesterbeek 2005).
The classical epidemic model known as SIR model developed by William Kermack
and Anderson McKendrick takes into account the temporal dynamics of susceptible
S, infected I and recovered R population classes (Kermack and McKendrick 1927).
This basic compartment model can be used to derive an epidemic threshold result,
which states that an epidemic outbreak occurs if the basic reproduction number
R0 is larger than 1 (Hethcote 2000). Since R0 is defined as the average number
of secondary infections caused by one infected individual in an entirely susceptible
population, a significant reduction of susceptible individuals through widespread
vaccination can prevent epidemics. Moreover, the threshold result allows to identify
viral diseases, which might be possible to eradicate. The data-based estimates of the
basic reproduction number for smallpox R0,smallpox = 5 and for measles R0,measles = 16
(Hethcote 1989, Anderson and May 1991) successfully demonstrate that it is easier
to eliminate smallpox through vaccination as achieved in 1979 than to combat the
still ongoing but declining transmission of measles (World Health Organization,
WHO 2014, Liu et al. 2014). Over time, the classical epidemic model has been
utilized as a basis for more complex and virus specific models. Such extended models
include additions like dividing the population into further compartments, integrating
additional biological factors, incorporating age structures and considering spatial
spread (Anderson and May 1991, Hethcote 2000, Getto et al. 2008, Labadie and
Marciniak-Czochra 2011).
1.3.2. Application and contribution of mathematical models in
medical research
Mathematical models have been recognized as essential tools for providing new in-
sights into the understanding of viral dynamics in human diseases (Moghadas 2006).
Prominent examples that mathematical modeling based on patient data can success-
fully guide the development of new antiviral therapies include research on acquired
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immunodeficiency syndrome (AIDS) and hepatitis C.
Since the first reported cases of AIDS around 1962–1972 (Gilbert et al. 2007), the
spread of its causative agent, the human immunodeficiency virus (HIV), triggered
a dreadful pandemic that cost the lives of more than 24 million people worldwide
(Feldmann et al. 2002). Each year the number of HIV-infected individuals rises
dramatically with around 2.3 million new HIV infections in 2012 (WHO 2014),
while the creation of a vaccine against AIDS is an ongoing challenge. To restrain
the propagation of HIV in the patient, in 1987 scientists started to generate specific
inhibitors of the viral enzymes (Montagnier 2010). Mathematical modeling based
on clinical data of patients treated with such an inhibitor, revealed that following an
initial exponential decline of HIV levels post treatment, HIV is sustained primarily
by a continuous and highly productive virus replication (Ho et al. 1995, Wei et al.
1995). Thus, Ho et al. assumed that treatment of HIV as early as possible after
infection could have a massive clinical impact. Based on the rapid HIV replication
rate, a large mutation rate of the HIV genome was computed (Coffin 1995, Perelson
et al. 1997). Importantly, mathematical modeling indicated that the high mutation
ability of HIV can result in a fast resistance to any single drug and especially to
those for which one mutation is sufficient to overcome the antiviral effects (Perelson
et al. 1997, Perelson 2002). By this means, mathematical analysis guided the design
of an immediate and prolonged combination therapy consisting of three and more
inhibitors also known as highly active antiretroviral therapy (HAART). In most
cases, the treatment of HIV patients with HAART prevents the onset of a lethal
infection (Zuniga et al. 2008), which in turn results in an higher number of people
living with HIV (∼ 35.3 million people were living with HIV in 2012, WHO 2014).
Another example of the interdisciplinary cooperation between mathematical model-
ing and medical science is the field of hepatitis C research. Hepatitis C is a severe
liver disease caused by the hepatitis C virus (HCV). The infection with HCV is ini-
tially asymptomatic, but becomes chronic in about 80% of the infected individuals
and can lead to serious liver diseases (Lauer and Walker 2001). With about 170
million chronically infected people worldwide and an annual number of 3–4 million
new infections, hepatitis C is a major global health problem (Rantala and Van de
Laar 2008). Apart from the challenge to generate a protective vaccine, scientists
work intensively on the improvement of the pharmacological treatment of HCV.
Mathematical modeling of viral kinetics under therapy has contributed to a better
understanding of the HCV pathogenesis and continuously supported the develop-
ment of antiviral drugs. A seminal model describing the dynamics of uninfected
target cells, infected cells and extracellular HCV could be parameterized with time
course data of patients treated with IFN and thus allowed to uncover the rapid
dynamics of HCV (Neumann et al. 1998). Moreover, the model indicated that the
major initial effect of IFN is to inhibit virus production or release rather than pre-
venting new infections. In consideration of new pharmaceuticals, this standard HCV
model has been extended over the years (Guedj and Neumann 2010, Rong et al. 2010,
Adiwijaya et al. 2010, Chatterjee et al. 2012). In particular, a multi-scale model of
HCV infection and treatment, which includes both intracellular and extracellular
HCV kinetics has proven to be an efficient tool to analyze the mode of action of
different antiviral drugs including IFN (Guedj et al. 2013). This multi-scale model
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demonstrated the antiviral effect of IFN in constraining HCV replication and to a
much lesser extent also HCV secretion. Furthermore, mathematical models com-
prising all relevant molecular processes of HCV replication have been established
using steady-state measurements (Dahari et al. 2007) and additionally based on
time course data (Binder et al. 2013). These comprehensive models provide a more
precise understanding of the determinants of HCV replication that could be targeted
by pharmacological therapies.
1.3.3. Mathematical modeling of the antiviral IFN system
Mathematical modeling of viral infections has a rich tradition. While much work
has focused on the adaptive immunity generating a specific and lasting response
(Anderson and May 1991, Nowak and May 2000), relatively few models described
the initial phase of infection.
The key elements of the IFN-induced defense against viral infections have been
examined using a mathematical model, which describes the temporal dynamics of
susceptible, infected and resistant cells along with extracellular virus and protective
IFN (Getto et al. 2008). Getto et al. have shown that in the case of a virus mortality
rate larger than zero the virus will become eventually extinct and uninfected cells
persist. If the virus mortality rate is zero, the kinetics may lead to the extinction of
susceptible cells. Getto et al. compared this basic model with an extended variant
in which the density of the infected cells is structured according to the infection age.
The infection-age structured model allows to study the impact of heterogeneous
intracellular processes like infection age dependent production of virus, secretion of
IFN as well as cell mortality. This model predicts that viral infection can be defeated
by both prolonging and shortening the time period of virus production. In addition,
the basic model was expanded to investigate the spatial effects of diffusing virus, IFN
and cells (Labadie and Marciniak-Czochra 2011). Labadie and Marciniak-Czochra
demonstrated that susceptible cells cannot coexist with extracellular virus in the
long run and that the spatial structure has a negative influence on the proliferation
of viruses that have a mortality rate larger than zero. Moreover, the comprehensive
mathematical analysis of the basic, infection-age structured and reaction diffusion
model revealed conclusions concerning existence, asymptotic behavior and stability
of the model solutions, which strongly depend on the initial conditions.
Systems biology approaches have also been successfully applied to explore the molec-
ular mechanisms shaping the antiviral immune response (Gottschalk et al. 2013). In
the case of the IFN system, mathematical models not only supported the character-
ization of virus-induced activation of IFN expression (Zou et al. 2010, Cheng et al.
2011) but also contributed to uncover the regulation of antiviral signaling mediated
by IFN (Smieja et al. 2008, Maiwald et al. 2010).
Given the central role of the IFN system in the antiviral immune defense, it is as-
tonishing that only a fraction of virus-infected cells express IFN (Zawatzky et al.
1985). Experimental studies suggested that the cell-to-cell variability of IFN ex-
pression is influenced by the cell-cycle state (Zawatzky et al. 1985), the limited
availability of transcription factors (Apostolou and Thanos 2008) or due to viral
14
1.3. Mathematical research on viral infections
countermeasures (Chen et al. 2010, Killip et al. 2011). Based on single-cell data,
Tay et al. (2010) established a hybrid stochastic-deterministic model to investigate
the observed heterogeneous activation of NF-κB, which is one essential transcription
factor of IFN. This model was able to reproduce both the measured digital activation
and the analogue information processing of single-cell NF-κB dynamics. Moreover,
the heterogeneous IFN induction was associated with the formation of the IFN-β
enhanceosome, a higher-order protein complex that initiates transcription from the
IFN-β promoter. Stochastic modeling and experimental validation showed that the
sequential assembly of the multicomponent IFN-β enhanceosome represents a major
source of the detected heterogeneous IFN expression (Hu et al. 2007).
1.3.4. Mathematical models of the antiviral IFN system in this
thesis
In order to study both the molecular key components of the IFN pathway in individ-
ual cells and the population dynamics after viral infection, we establish an integrative
stochastic model that links virus-induced heterogeneous single-cell behavior with the
cell-to-cell communication via secreted IFN (see chapter 2). The model is based on
measurements in which a murine cell line was infected with NDV. While replication
of NDV induces the expression of IFN in infected mouse cells (Kato et al. 2005,
Childs et al. 2007), NDV is unable to produce new infectious virus particles in the
murine NIH3T3 fibroblasts used in this study (Rott 1979). This system is thus a
suitable tool to examine IFN induction elicited by primary infection only without
influences by secondary infections. To adapt the mathematical model to the exper-
imental conditions, we neglect viral spread in the stochastic model. Mathematical
modeling and experimental validation indicate that few IFN-producing cells might
act as sentinels of viral infection to protect a large number of na¨ıve cells through
powerful propagation of the IFN signal (Rand, Rinas et al. 2012).
Driven by the question, which factors of the antiviral IFN system are essential for
limiting viral spread, we move to a system where viral spread is possible (see chapter
3). Based on time-resolved data of spreading DENV-infected cells, we establish
a mathematical model of viral spread and IFN-induced antiviral protection. The
model is a modified version of the classical SIR model (Kermack and McKendrick
1927). Apart from susceptible, infected and protected cells, our model also comprises
extracellular virus as well as secreted IFN. To study which antiviral factors of the
IFN system have the greatest influence on viral spread, we compare the infection
dynamics of DENV wild-type with the attenuated spread of a DENV mutant. Using
mathematical modeling and validation experiments, we find that the attenuation of
the mutant is mainly due to the effect of accelerated IFN secretion to inhibit virus
production during the early stages of viral replication, whereas faster protection of
na¨ıve cells by IFN has only a minor impact on spreading DENV (Schmid, Rinas et
al. submitted).
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1.4. Outline of this thesis
In this thesis we study the antiviral IFN system by means of data-driven math-
ematical modeling in intense collaboration with our experimental partners. Our
work focuses on the question, which components of the IFN system are decisive to
successfully combat viral infections.
In chapter 2, we investigate the relation between single-cell behavior and cell-to-cell
communication via secreted IFN after primary infection with the Newcastle disease
virus (NDV). By live-cell imaging, we show that the key steps of the IFN system
comprising virus-induced signal transduction, IFN expression and IFN response are
stochastic events in individual cells (see section 2.1).
To link the single-cell data to antiviral protection at the cell-population level, we
establish a stochastic model, which combines the virus-induced IFN signaling in
individual cells with the intercellular communication through released IFN (see sec-
tion 2.2). For the parameter estimation we utilize our extensive data regarding
high-dose infections (see section 2.3). Fitting of observed distributions of single-cell
switching-on times reveals two mechanistically relevant conclusions. First, the in-
duction of RIG-I-mediated signaling by virus is cooperative and, second, IFN gene
induction downstream of transcription factor activation is a slow multi-step process.
Mathematical modeling and experimental validation indicate that reliable antiviral
response in the face of multi-layered cellular stochasticity is achieved by paracrine
propagation of the IFN signal (see section 2.4) (Rand, Rinas et al. 2012).
To analyze which factors of the antiviral IFN pathway play a pivotal role in limiting
viral spread, we examine the dynamics of spreading Dengue virus (DENV) in an
IFN-competent cell system in chapter 3. Using fluorescent reporter cells and a fully
viable DENV wild-type (DENV-wt) reporter construct, we demonstrate that IFN
efficiently protects na¨ıve cells from productive DENV infection and, if given early
after infection, reduces viral replication in infected cells (see section 3.1.1 and 3.1.2).
However, since antiviral IFN response is highly heterogeneous in single cells, viral
spread and protection of cells by IFN occur in parallel - and compete - following
DENV infection (see section 3.1.3). To examine which antiviral factors are able
to control viral spread, we compare DENV-wt with the vaccine candidate DENV-
E217A mutant, which induces a stronger IFN response and barely spreads (see
section 3.1.4).
As the data concerning DENV infection suggest that the timing of IFN expression
and virus production play an important role, we study the competition between vi-
ral spread and IFN-induced antiviral defense by means of a population-based delay
differential equation model (see section 3.2). We first parameterize the model using
DENV-wt infection data exclusively (see section 3.3.1). Then, we utilize this DENV-
wt specific parameter set to discover DENV-E217A mutant specific parameters. The
parameter optimization based on DENV-E217A mutant data demonstrates that the
attenuation of the mutant can be explained by a reduced virus production rate and
an accelerated IFN secretion (see section 3.3.2). To identify the relative importance
of the two DENV-E217A mutant specific parameters on viral spread, we develop
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an extended version of our delay differential equation model, which in addition to
the paracrine effect of IFN on na¨ıve cells also explicitly describes the autocrine IFN
action on infected cells (see section 3.4). By analyses performed with this full model
and validation experiments, we find that the attenuation of the mutant can primar-
ily be attributed to accelerated IFN secretion triggered by DENV-E217A mutant
infection (see section 3.5). This rapid IFN signal limits virus production during
early phases of viral replication in infected cells, whereas accelerated protection of
na¨ıve cells by paracrine IFN action has only a low impact on the spread of DENV.
The outcome of infection is thus primarily determined by the relative dynamics of
DENV replication and the autocrine effect of IFN on infected cells (Schmid, Rinas
et al. submitted).
In chapter 4, we discuss our findings separately for each model system (see section 4.1
and 4.2) and subsequently in overall terms (see section 4.3). In this regard, we assess
our results, compare them with previous reports and draw biological conclusions.
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2. Stochastic modeling predicts
paracrine propagation of the IFN
response induced by individual
sentinels
The interferon system, as a first line of defense against viral infections, has a central
antiviral function (see section 1.2.3) (Kunzi and Pitha 2003, Sadler and Williams
2008, Takeuchi and Akira 2009, West et al. 2011). Since the expression of interferons
(IFN) is crucial to initiate an antiviral protective state, it is quite surprising that
only a fraction of cells in a virus-infected cell population induces IFN (Zawatzky
et al. 1985).
The literature suggests various reasons for the observed cell-to-cell heterogeneity in
IFN expression. Some studies have concluded that host cell-intrinsic causes, such as
a mechanism of IFN gene induction (Hu et al. 2007, Apostolou and Thanos 2008) or
cellular variance in expression of the viral sensor protein retinoic acid-inducible gene
I (RIG-I) (Hu et al. 2011) lead to heterogeneous IFN production. Alternatively, the
stochasticity in IFN induction has been linked to the infecting virus due to its ability
to antagonize the IFN system (Chen et al. 2010, Killip et al. 2011). According to
the involved cell type or virus it could be that multiple factors contribute to the
heterogeneity in IFN induction.
To study cell-to-cell variability of the IFN system, our experimental cooperation
partners Ulfert Rand, Mario Ko¨ster and Hansjo¨rg Hauser from the Department of
Gene Regulation and Differentiation at the Helmholtz Centre for Infection Research
(HZI) in Braunschweig generated a set of reporter constructs to monitor successive
steps of IFN induction and IFN response in individual cells (see section 2.1.1, Rand
2010). The live-cell imaging data demonstrate that all key steps of the IFN system
- the virus-induced signal transduction, the IFN expression (see section 2.1.2), and
the induction of IFN-stimulated genes (ISGs) (see section 2.1.3) - are stochastic
events in single cells. Additional experiments reveal that cell-intrinsic variability
largely contributes to the detected heterogeneity in IFN induction (see section 2.1.2).
Moreover, the examination of the response to IFN shows a dose-dependent binary
pattern of two distinct subpopulations (see section 2.1.3). While the IFN-responding
subpopulation is protected against viral infection, virus can still replicate in the non-
responding cell fraction.
Based on the observed stochastic dynamics of the IFN network we establish a multi-
scale mathematical model accounting for the stochastic intracellular dynamics in
individual cells and the cell-to-cell communication via released IFN (see section
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2.2). The model is formulated as a continuous-time stochastic process in which the
possible state changes of individual cells are specified through propensity functions
depending on the current state of the cell and the extracellular concentration of
secreted IFN. The kinetic of extracellular IFN is described by an ordinary differential
equation and depends on the number of infected IFN-producing cells. The stochastic
state transitions of individual cells with respect to virus replication, expression of
IFN and induction of ISGs are simulated using Gillespie’s stochastic simulation
algorithm, while the intercellular communication via IFN is calculated in parallel
with a deterministic Euler method.
To determine the model parameters from the experimental data, we utilize our ex-
tensive measurements for high-dose infections (see section 2.3). The parameters
describing the virus-induced activation of the transcription factors of IFN are esti-
mated from a distribution of observed single-cell activation times using as objective
function Neyman’s chi-squares statistic (Baker and Cousins 1984) (see section 2.3.1).
For the minimization of this objective function we apply the simulated annealing
algorithm (Kirkpatrick et al. 1983, Schneider and Kirkpatrick 2006). The result-
ing parameter estimates indicate that the initiation of RIG-I-mediated signaling by
virus is cooperative.
Moreover, we find that the measured histogram of the time delay between transcrip-
tion factor activation and IFN gene induction in individual cells can be fitted with
a gamma distribution by using the maximum-likelihood method (Myung 2003) (see
section 2.3.2). The parameter optimization reveals that IFN gene induction down-
stream of transcription factor activation corresponds to a slow multi-step process
consisting of six consecutive and exponentially distributed steps.
Importantly, mathematical modeling and validation experiments predict that a small
fraction of IFN-producing cells are sufficient to induce IFN target genes in the other,
non-producing cells of the population (see section 2.4). Thus, we expect that stochas-
tic sensing of viral infections by the innate immune system together with paracrine
signal propagation provide an efficient and viral load-sensitive mechanism to achieve
a reliable antiviral protection of the cell population (Rand, Rinas et al. 2012).
2.1. Experimental study of the IFN system reveals
multi-layered stochasticity in individual cells
2.1.1. Monitoring virus-triggered IFN induction and response in
single cells
The finding that only a fraction of infected cells induces IFN (Zawatzky et al. 1985,
Hu et al. 2007) demonstrates the necessity to investigate the IFN system at single-
cell level. A valuable method to monitor the dynamics and variability of individual
cells in real time is provided by live-cell imaging (Spiller et al. 2010). The first
live-cell analysis for the IFN system was realized by our experimental collaboration
partners Ulfert Rand, Mario Ko¨ster and Hansjo¨rg Hauser (Rand 2010, Rand et al.
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Figure 2.1.: Visualization of the key steps of the IFN pathway with fluorescent reporter
cells. (A) Scheme of the established intracellular reporters. Virus recognition by RIG-
I causes the nuclear translocation of the fusion proteins IRF-7-CFP (cyan cytoplasm →
cyan nucleus) and NF-κB/p65-YFP (yellow cytoplasm → yellow nucleus). Subsequent IFN-
β expression becomes visible through the BAC reporter IFN-β-tGFP (green cytoplasm)
and induces the expression of ISGs illustrated by the BAC construct IRF-7-mCherry (red
cytoplasm). (B) Fluorescence picture of the generated intracellular reporters. The virus-
induced activation of the latent transcription factor IRF-7 (cyan cytoplasm) lead to its
nuclear translocation (cyan nucleus). The following expression of IFN (green cytoplasm)
results in the induction of the ISG IRF-7 (red cytoplasm). (Experiments by U. Rand, M.
Ko¨ster and H. Hauser)
2012).
Hauser and colleagues developed fluorescent reporter cells to visualize successive key
steps of the IFN system consisting of (i) virus-induced signal transduction, (ii) IFN
expression and (iii) IFN response (Figure 2.1, Table 2.1). The signal transduction
after the recognition of viruses by intracellular receptors like RIG-I results in the nu-
clear translocation of the nuclear factor κB (NF-κB) and the IFN regulatory factors
(IRFs) 3 as well as 7 (Brennan and Bowie 2010). To observe the nuclear transloca-
tion of the transcription factors, the scientists at the HZI designed dual reporter cells
which were labeled with the fluorescent markers NF-κB/p65-YFP (yellow fluorescent
protein) and IRF-7-CFP (cyan fluorescent protein), respectively. The presence of
the transcription factors IRF-3/7 and NF-κB in the nucleus induces the expression
of IFN including IFN-β (Theofilopoulos et al. 2005). The induction of IFN-β was
monitored by transfecting murine fibroblasts with a bacterial artificial chromosome
(BAC) encoded reporter expressing TurboGFP (green fluorescent protein) under the
control of the IFN-β promoter (IFN-β-tGFP). In addition, a dual reporter cell line
expressing both IRF-7-CFP and IFN-β-tGFP was generated. Another BAC-based
reporter construct in which the mCherry gene is linked to the C-terminal end of the
genomic IRF-7 sequence (IRF-7-mCherry, monomeric cherry red fluorescent protein)
enables the investigation of the prototypical ISG IRF-7 in response to secreted IFN
(Honda et al. 2005).
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Reporter cell line Visualization Color
IRF-7-CFP - NF-κB/p65-YFP Activation of IRF-7 and NF-κB cyan/yellow
IRF-7-CFP - IFN-β-tGFP IRF-7 activation, IFN expression cyan/green
IFN-β-tGFP IFN expression green
IRF-7-mCherry IFN response red
Table 2.1.: Overview of the used fluorescent reporter cell lines in chapter 2. Our collab-
oration partners developed 4 fluorescent reporter cell lines to monitor (1) the activation of
the transcription factors IRF-7 and NF-κB in a given cell, (2) the relation between IRF-7
activation and IFN-β expression in a certain cell, (3) single-cell IFN-β expression as well as
(4) IFN-induced IRF-7 response in individual cells.
All reporter constructs were transfected into murine NIH3T3 fibroblasts and rep-
resentative stable cell clones were utilized for the studies (Rand, Rinas et al. 2012:
Supplementary Figure S2 and Supplementary Figure S8, Rand 2010).
2.1.2. Cell-to-cell variability in IFN induction
In order to examine the properties of the virus-induced IFN system, we use the New-
castle Disease Virus (NDV), which is an enveloped, negative-sense single-stranded
(ss) RNA virus (cf. section 1.2.2). After infection, NDV replicates and induces IFN
expression in the murine NIH3T3 fibroblasts via the viral RNA sensor RIG-I (Kato
et al. 2005, Kato et al. 2006, Childs et al. 2007), but the avian NDV virus cannot
generate new infectious virus particles in the mouse cells (Rott 1979). Therefore the
experimental setup allows us to examine the properties of the IFN pathway after
primary infection.
As we are primarily interested in the single-cell behavior of IFN expression, we first
monitored IFN-β-tGFP reporter cells by time-lapse microscopy (cf. section 2.1.1)
after infection with different doses of NDV given in haemagglutinating unit per
milliliter (HAU/ml) (Figure 2.2A left and Rand, Rinas et al. 2012: Supplementary
Movie S1). The IFN-β-producing cells started at various times to express IFN-
β with cell-to-cell differences of up to 20 h. Although we detected earlier onset of
IFN-β-tGFP induction after infection with higher viral loads, the relative variability
or “noise” (Swain et al. 2002, Elowitz et al. 2002, Kærn et al. 2005) which can be
quantified with the coefficient of variation (CV ; standard deviation divided by mean)
varied only slightly (Figure 2.2A top left).
Moreover, we analyzed if the temporal heterogeneity in IFN-β expression is deter-
mined by varying times of infection or due to intrinsic features of the host cell. For
this purpose, viral infection was bypassed by using the polyinosinic-polycytidylic
acid (poly I:C) stimuli. Poly I:C is a synthetic double-stranded RNA mimicking vi-
ral infections. This viral-surrogate serves as a non-replicating inducer control as it is
recognized by the intracellular virus sensors RIG-I, MDA5 and TLR3 (Alexopoulou
et al. 2001, Yoneyama et al. 2004, Kato et al. 2006). Poly I:C was introduced into
IFN-β-tGFP reporter cells through liposome-mediated transfection, which allows a
synchronization of the viral stimuli (Figure 2.2A right, B and C). Also after transfec-
22
2.1. Experimental study of the IFN system reveals multi-layered stochasticity
A
80 
NDV (HAU/ml) 
16 400 
0
10 
20 
30 
CV = 0.3 0.24 0.25 0.39 0.39 0.45 
2.5 
Poly I:C (µg/ml) 
1.25 5
0
10 
20 
30 
IF
N
-β
-tG
FP
 o
ns
et
 (h
) 
B
Time (h) 
1.0 
0.8 
0.6 
0.4 
0.2 
0.0 
22.5 20.0 17.5 15.0 12.5 10.0 7.5 5.0 2.5 0.0 
Relative 
intensity of 
IFN-β-tGFP 
Time (h) 
1.  
0.  
0.  
0.  
0.  
0.  
.5 01 .5 51 .5 07.   2  0  R
el
at
iv
e 
in
te
ns
ity
 o
f 
IF
N
-β
-tG
FP
 
C
 1.5 h  4.5 h  7.5 h 10.5 h 
13.5 h 16.5 h 19.5 h 22.5 h 
Figure 2.2.: Cell-to-cell heterogeneity in onset of IFN-β expression. (A) Single-cell vari-
ability in IFN-β induction is not caused by varying infection times. IFN-β-tGFP reporter
cells were infected for 1 h with different doses of NDV (left, x-axis) or transfected with
varying concentrations of poly I:C (right, x-axis). Onset of IFN-β-tGFP expression (y-
axis) was detected by time-lapse microscopy at 15 min intervals. The scatter plots show
the distribution of 456 NDV-infected cells or 140 poly I:C transfected cells, respectively.
Experiment-related coefficient of variation (CV ) is given at the top. (B, C) Live imaging il-
lustrates heterogeneous IFN-β induction in individual cells. IFN-β-tGFP reporter cells were
stimulated with 32 µg/ml poly I:C and subsequently monitored via time-lapse microscopy
every 20 min. Selected single-cell kinetics in (B) and fluorescence pictures at indicated time
post stimulation in (C) are presented. (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
tion with different poly I:C concentrations we observed an extremely heterogeneous
onset of IFN-β expression in individual cells, which was quantitatively compara-
ble to viral infection as seen by the same order of magnitude of the CV s (Figure
2.2A top right). These data reveal that the cell-to-cell variance in IFN-β expression
originates not from variable infection times.
To quantitatively determine viral replication and IFN induction in single cells, IFN-
β-tGFP reporter cells were infected with NDV and subjected to flow cytometry.
At several time points post infection (p.i.) we measured simultaneously the viral
hemagglutinin-neuraminidase (HN) protein and the IFN-β-tGFP intensity (Figure
2.3A and B). The increasing fraction of virus replicating cells over time was fol-
lowed by an about 12 h delayed rising number of IFN-β-tGFP positive cells. As in
other studies (Kumagai et al. 2009, Rehwinkel et al. 2010), we detected IFN-β-tGFP
expression only in cells with replicating virus. However, a remarkable number of in-
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fected cells did not express IFN. To analyze this phenomenon further, we divided
the amount of infected cells into cells with low or high viral load, respectively (Rand,
Rinas et al. 2012: Supplementary Figure S3). Since both subpopulations contained
nearly the same fraction of IFN-β-tGFP positive cells, we found no correlation be-
tween the level of viral replication and the expression of IFN-β-tGFP.
In the literature it was discussed that the absence of IFN-inducing viral RNA may
be responsible for the heterogeneity in IFN expression (Killip et al. 2011). Thus,
we infected IFN-β-tGFP reporter cells with NDV and subsequently transfected in-
tracellular RNA of IFN-producing and non-producing cells into na¨ıve IFN-β-tGFP
reporter cells (Rand, Rinas et al. 2012: Figure 2C and Supplementary Figure S4).
As both RNA transfections activated a comparable fraction of IFN-β-tGFP positive
cells, heterogeneous IFN induction appears despite the presence of IFN-inducing
viral RNA. These results demonstrate that viral replication is necessary to induce
IFN but not sufficient.
Furthermore, we investigated the properties of IFN-β-tGFP expression after infec-
tion with different virus doses (Figure 2.3C). The fraction of IFN-β-tGFP positive
cells increased almost linearly with higher virus concentrations and a multiplicity of
infection (MOI; number of infectious virus particles divided by the number of po-
tential host cells) of 1 induced IFN expression in less than half of the IFN-β-tGFP
reporter cells. In contrast, the mean fluorescence intensity (MFI) of the IFN-β ex-
pressing subpopulation reached ∼ 70% of its maximum already at very low virus
titer (5 HAU/ml NDV). Therefore, virus-induced IFN-β production is dominated
by the fraction of IFN-β expressing cells.
Taken together, we observed stochastic IFN-β expression after infection with NDV
and after transfection with the viral-surrogate poly I:C. The data show strong cell-to-
cell heterogeneity in IFN-β induction, which is not caused by varying infection times,
the level of viral replication or the absence of IFN-inducing viral RNA. Therefore
we conclude that the stochasticity in IFN-β expression is predominantly of cellular
origin.
To examine mechanistically how cell-to-cell variability in IFN expression arises, we
had a closer lock on the IFN induction pathway. We analyzed the virus-induced
activation of the key transcription factors NF-κB and IRF-7 by utilizing the dual
reporter cells expressing NF-κB/p65-YFP and IRF-7-CFP (cf. section 2.1.1). After
infection with NDV, latent transcription factors NF-κB and IRF-7 located initially
in the cytoplasm, translocated into the nucleus (Figure 2.4A). The nuclear translo-
cation of both transcription factors happened simultaneously in a single cell, but
this joint translocation time varied strongly between different cells from 7 to 20 h
post infection (Figure 2.4B). We also observed a simultaneous translocation of the
transcription factors NF-κB/p65 and IRF-3 in individual cells by antibody staining
of endogenous NF-κB/p65 as well as IRF-3 after infection with NDV or transfection
with poly I:C (Rand, Rinas et al. 2012: Supplementary Figure S6). The discovery
of a single cell specific but at population level varying translocation time of the
key transcription factors of IFN demonstrates that strong cell-to-cell heterogeneity
in IFN induction originates already in the shared upstream activation pathway of
NF-κB and IRF-7.
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A
differences in cell-cycle stage or cellular environment (Elowitz
et al, 2002; Maheshri and O’Shea, 2007; Paixa˜o et al, 2007; Raj
and van Oudenaarden, 2008; Snijder and Pelkmans, 2011). To
minimize extrinsic cell-to-cell differences, we analysed sister
cells after division (Spencer et al, 2009). Cells that divided after
the 1 h period of infection were followed. IRF-7 activation in
sister cells occurred mainly asynchronously, differing by42 h
in B50% of cell pairs (Figure 4A). The time between IRF-7–
CFPactivation and IFN-b–tGFP expression correlated even less
in sister cells (Figure 4B), consistent with the previously
described stochastic transcription of the Ifnb gene (Apostolou
and Thanos, 2008). The coefficient of determination r2 was 0.6
for Tsig and 0.34 for Tgen, indicating that 40% of the variability
in signalling and 66% of the variability in Ifnb gene expression
are uncorrelated between sister cells and thus provide an
estimate for the cell-intrinsic stochasticity. To examine
whether different viral replication kinetics in sister-cell pairs
are a source of variability, we subjected cells to poly I:C
stimulation. Also, under these conditions cells displayed
largely uncorrelated IRF-7 signalling and IFN-b gene expres-
sion (Figure 4E and F), with similar coefficients of determina-
tion (r2¼ 0.54 for Tsig and 0.11 for Tgen) as with viral infection.
Taken together, these findings show that cell-intrinsic
stochasticity is a strong source of cell-to-cell heterogeneity in
IFN-b expression.
We checked whether the observed differences between
sister cells relate to their time of division. For this purpose, we
plotted the time differences between sister cells (DTsig and
DTgen) versus the time elapsed since cell division. The very
weak correlations argue against strong control of heterogene-
ity by the cell cycle (Figure 4C and D for NDV infection and
Figure 4G and H for poly I:C stimulation).
Taken together, the sister-cell analysis indicates a role for
both ‘extrinsic’ variability between cells and cell-intrinsic
stochasticity. The cell-intrinsic component is strong, account-
ing for approximately half of the variability in the kinetics of
antiviral signalling and IFN-b induction in individual cells.
This intrinsic stochasticity provides a rationale for the lack of
correlation of IFN-b expression with the extent of viral
replication (cf. Figure 2A).
Antiviral protection is an IFN concentration-
dependent switch in individual cells
The intrinsic stochasticity indicates that the responsiveness
of IFN-b induction towards virus is not maximized (i.e.,
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Figure 2 Viral replication is necessary but not sufficient to induce IFN-b expression. (A) Fractional IFN-b expression among productively infected cells. Reporter cells
were infected with 40 HAU/ml NDV for 1 h. IFN-b–tGFP reporter expression and intracellular NDV HN protein was measured by flow cytometry at indicated time post-
infection. Dot plots show IFN-b–tGFP expression among productively infected (NDV HNþ ) cells at indicated time post-infection. (B) Separate kinetics of viral replication
and IFN-b expression. Frequency of IFN-b–tGFP (black circles) and NDV HN expression (grey squares) over time. (C) Unresponsiveness is not caused by the absence
of inducing viral RNA. NDV-infected (80 HAU/ml) IFN-b–tGFP reporter cells were separated into GFPþ and GFP# fractions. Total RNA was isolated and transfected
into naive IFN-b–tGFP reporter cells (lower graphs). RNA from non-infected cells served as a control (upper graph). The frequency of IFN-b–tGFP-expressing cells 20 h
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Figure 2.3.: Quantitative and temporal heterogeneity in IFN-β expression. (A, B) Viral
replication is necessary but not sufficient to activate IFN-β expression. IFN-β-tGFP re-
porter cells infected with 40 HAU/ml NDV for 1 h were subjected to flow cytometry at
the indicated time points post infection (p.i.). R presentative dot plots in (A) illustrate
the jointly measured viral HN rotein (x-axis) as well as IFN-β-tGFP (y-axis) of individual
cells. The corresponding kinetics of virus replicating cells (HN+, orange color) and IFN-β
expressing cells (IFN-β-tGFP+, green color) are shown in B). (C) Secreted IFN is deter-
mined by the fraction of IFN-producing cells. IFN-β-tGFP reporter cells were infected with
1, 2, 5, 10, 20, 40, 80 or 100 HAU/ml NDV and analyzed by flow cytometry 24 h after in-
fection. Illustrated are the fraction of IFN-β positive cells (IFN-β- GFP+, green co or) and
the respective geometric me n f he fluorescence intensity (MFI) of the IFN-β expressing
subpopulation (gray color, mean of triplicate measurements and error bars). (Experiments
by U. Rand, M. Ko¨ster and H. Hauser)
Additionally, we studied the relation between transcription factor activation and IFN
induction using dual reporter cells expressing IRF-7-CFP oge er with IFN-β-tGFP
(Figure 2.4C as well as Rand, Rinas et al. 2012: Supplementary Figure S7). Most of
the cells (91% at 80 HAU/ml NDV) with activated transcription factor IRF-7 also
expressed IFN afterwards (Figure 2.4D). The few cells (9% at 80 HAU/ml NDV)
which exhibited no IFN-β expression after tran cription factor activation showed
similar distributed IRF-7 nuclear translocation times as the IFN-β producing cells
(Figure 2.4D bottom part). Since we found no IFN-β-tGFP induction without
prior nuclear translocation of IRF-7, activation of IRF-7 is necessary for IFN-β
production. It is also almost (in 91% of the cells) sufficient. Thus, we suggest
that the decision to express IFN is pri arily taken upstream of transcription factor
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activation.
The signaling delay from viral infection to IRF-7 nuclear translocation T sig (mean
value T sig = 11.7 ± 4.0 h) was comparably broadly distributed among individual cells
as already detected with the dual reporter cells expressing the fusion proteins NF-
κB/p65-YFP and IRF-7-CFP (Figure 2.4B; T sig = 11.9 ± 3.4 h). Furthermore, also
the time delay between nuclear translocation of IRF-7 and onset of IFN-β-tGFP
expression T gen (mean value T gen = 3.4 ± 1.5 h) varied remarkably from cell-to-
cell. The similar CV s of T sig (CV sig = 0.34) and T gen (CV gen = 0.44) indicate a
comparable variability of virus-induced signal transduction and subsequent IFN-β-
tGFP gene expression. These quantitative data thus reveal that both transcription
factor activation and IFN-β expression are sources of heterogeneity in single cells.
The phenomenon of cellular variability is widely studied in many different research
areas. Cellular noise is classified into intrinsic noise arising from inherent stochastic
biochemical reactions observed in equal elements and extrinsic noise, which results
from extrinsic factors varying from one cell to another like differences in cell-cycle
stage or cellular environment (Elowitz et al. 2002, Swain et al. 2002, Raser and
O’Shea 2005, Maheshri and O’Shea 2007, Raj and van Oudenaarden 2008, Snijder
and Pelkmans 2011). To analyze the origin of the single-cell heterogeneity more
closely, we reduced extrinsic cell-to-cell differences through examining sister cells
which divided during the first hour post infection (Spencer et al. 2009). The experi-
ments show that the virus-induced nuclear translocation of IRF-7 happened mainly
asynchronously in sister cells with a temporal difference larger than 2 h in ∼ 50% of
the cell pairs (Figure 2.5A). An even weaker relation between sister cells was found
for the time of IFN-β-tGFP expression after transcription factor activation (Figure
2.5B), which agrees with the previously described stochastic transcription of the
IFN-β gene (Apostolou and Thanos 2008). To quantify the relation of sister cells
we used the correlation coefficient r and the coefficient of determination r2. The
value of the coefficient of determination can be interpreted as the percentage of the
variation that is explained through the correlation between the sister cells (Taylor
1990). The corresponding coefficient of determination was 0.6 for T sig and 0.34 for
T gen, which in turn means that 40% of the variability in signaling and 66% of the
variability in IFN-β-tGFP expression are uncorrelated between sister cells and thus
provide an estimate for the cell-intrinsic heterogeneity.
In order to verify whether different viral replication kinetics in sister-cell pairs are a
source of stochasticity, we repeated the sister cell analysis with poly I:C stimulated
reporter cells. Even after transfection with poly I:C the sister cells showed a largely
uncorrelated behavior in IRF-7 activation as well as IFN-β-tGFP expression (Figure
2.5E and F), with similar coefficients of determination (r2 = 0.54 for T sig and r2 =
0.11 for T gen) as after viral infection. In addition, we tested if the time of cell
division T div influences the variation between sister cells in terms of transcription
factor activation or IFN-β induction. For this purpose, we determined the time
elapsed since cell division versus the time difference between sister cells regarding
IRF-7 signaling ∆T sig and IFN-β-tGFP expression ∆T gen (Figure 2.5C and D for
NDV infection; Figure 2.5G and H for poly I:C stimulation). The consideration of
cell division yielded very weak correlations which argues against strong impact of
the cell cycle on the stochasticity in IFN induction.
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Figure 2.4.: Both virus-induced signal transduction and IFN expression are sources of
heterogeneity. (A, B) Synchronous translocation time of transcription factors in single
cells varies at cell population level. Dual reporter cells expressing the fusion proteins NF-
κB/p65-YFP and IRF-7-CFP were infected with 80 HAU/ml NDV for 1 h and monitored by
time-lapse microscopy every 20 min. (A) Fluorescence images of subcellular localization of
IRF-7-CFP (left column) and p65-YFP (right column) at denoted time post infection. The
kinetics show relative nuclear fluorescence for IRF-7-CFP (cyan) and p65-YFP (yellow)
of two different cells. (B) Initial nuclear translocation of p65-YFP and IRF-7-CFP were
determined in 65 individual cells and plotted against each other. Colored dots represent
the frequency of data points. (C, D) Heterogeneous transcription factor activation and IFN
expression in single cells. Dual reporter cells expressing IRF-7-CFP together with IFN-
β-tGFP were infected with 80 HAU/ml NDV and monitored by time-lapse microscopy at
20 min intervals. (C) Fluorescence images of subcellular localization of IRF-7-CFP (left
column) and IFN-β-tGFP (right column) at given time post infection. The kinetics show
relative fluorescence intensity for nuclear IRF-7-CFP (cyan) as well as tGFP (green) of one
cell. T sig indicates the signaling delay from viral infection to IRF-7 nuclear translocation
and T gen defines the period of time between nuclear translocation of IRF-7 and onset of
IFN-β-tGFP expression. (D) Initial nuclear translocation of IRF-7-CFP (T sig) and IFN-β-
tGFP expression (T sig + T gen) were determined in 315 individual cells and plotted against
each other. Colored dots represent the frequency of data points. (Experiments by U. Rand,
M. Ko¨ster and H. Hauser)
In summary, the data revealed two sources of cell-to-cell heterogeneity in IFN induc-
tion, namely the virus-induced signal transduction and the subsequent IFN expres-
sion (cf. Figure 2.4). According to the sister-cell analysis, approximately half of the
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Figure 2.5.: Heterogeneous IFN induction in sister cells. (A-H) Dual reporter cells express-
ing IRF-7-CFP or IRF-7-TagRFP (red fluorescent protein tag) together with IFN-β-tGFP
were infected with 80 HAU/ml NDV for 1 h (A-D, 38 sister-cell pairs) or transfected with 5
mg/ml poly I:C (E-H, 36 sister-cell pairs) and monitored by time-lapse microscopy every 20
min. Colored dots represent the frequency of data points. Experiment-related correlation
coefficient r and the coefficient of determination r2 are given at the top. (A, E) Delay from
viral infection to IRF-7 nuclear translocation T sig of sister cell A versus sister cell B. (B,
F) Time interval between IRF-7 nuclear translocation and IFN-β-tGFP expression T gen
of sister-cell pairs. (C, G) Time elapsed from cell division T div to IRF-7 nuclear translo-
cation (T sig − T div) of one sister cell versus time difference between sister cells regarding
IRF-7 signaling ∆T sig. (D, H) Time elapsed from cell division to IFN-β-tGFP expression
(T sig + T gen − T div) of one sister cell versus time difference between sister cells regarding
IFN-β-tGFP expression ∆T gen. (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
stochasticity in both sources can be attributed to cell-intrinsic variability (cf. Figure
2.5). This intrinsic stochasticity provides a rationale for the lack of correlation of
viral replication and IFN-β expression (cf. Figure 2.3A).
2.1.3. IFN target gene induction is an all-or-nothing switch
The observation that many cells with replicating virus do not express IFN-β or do
so only very late after infection demonstrates that virus-induced IFN-β expression
is incomplete (cf. Figure 2.3). To understand the functional consequences of this
stochastic and occasional IFN induction, the cellular antiviral response to IFN in
terms of ISG expression should also be considered. Thus, we stimulated the IRF-
7-mCherry reporter cells (cf. section 2.1.1) with IFN-β (given in units per milliliter
(U/ml)) and monitored IRF-7 expression by time-lapse microscopy (Figure 2.6 and
Rand, Rinas et al. 2012: Supplementary Movie S2). Individual cells responded very
heterogeneously at various time points to IFN-β stimulation. So, not only IFN
induction but also IFN response is a stochastic event in single cells.
To quantify the observed heterogeneous response to IFN, IRF-7-mCherry reporter
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Figure 2.6.: Single-cell heterogeneity of IRF-7 expression in response to IFN-β. IRF-
7-mCherry reporter cells were stimulated with 500 U/ml IFN-β and detected by time-
lapse microscopy at 30 min intervals. Selected fluorescence pictures at indicated time post
stimulation are presented. (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
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Figure 2.7.: Binary time- and dose-dependent IRF-7-mCherry response towards IFN-β.
IRF-7-mCherry reporter cells were stimulated with increasing concentrations of IFN-β in-
dicated at the top of each panel. The intensity of IRF-7-mCherry expression was measured
by flow cytometry at multiple time points after stimulation, which is represented through
different colors. Normalized distributions are shown to enable the comparison of individual
measurements with each other. (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
cells were stimulated with different concentrations of IFN-β and analyzed by flow
cytometry at several times after stimulation (Figure 2.7). The distributions of IRF-
7-mCherry levels from individual cells showed a bimodal pattern with distinct IRF-7
expressing and non-expressing subpopulations. The IRF-7 expressing subpopulation
increased with the passage of time and with higher amounts of extracellular IFN-β,
which implies a time- and dose-dependent response to IFN. We also measured the
IFN response in several IRF-7-mCherry clones and detected consistently a binary
IRF-7 expression (Rand, Rinas et al. 2012: Supplementary Figure S8). Moreover,
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Figure 2.8.: Bimodality of IRF-7 expression is reflected in ISG transcription and antiviral
protection. (A) IRF-7 expression represents production of ISGs. IRF-7-mCherry reporter
cells were stimulated with 500 U/ml IFN-β for 16 h and subjected to FACS. IRF-7-mCherry
negative (1, black) as well as positive (2, red) cells illustrated by the shaded areas were
separated. RNA was isolated from both subpopulations and analyzed by qPCR for the
expression of indicated ISGs and Rps9 as a control. The bar charts show the fold RNA
increase in relation to untreated reporter cells after normalization to β-actin mRNA. (B)
IRF-7 expression correlates with antiviral protection. IRF-7-mCherry reporter cells were
left untreated (upper row), pre-treated for 8 h (middle row) or 24 h (lower row) with 500
U/ml IFN-β and subsequently infected with 80 HAU/ml NDV. After an infection period
of 20 h, we measured simultaneously in each single cell the NDV HN intracellular antibody
level and IRF-7-mCherry fluorescence intensity by flow cytometry. The NDV HN positive
(colored in blue) as well as negative cells (colored in red) were identified (left column) and
examined for their respective IRF-7-mCherry expression (right column). (Experiments by
U. Rand, M. Ko¨ster and H. Hauser)
the unresponsiveness was not influenced by competition of cells for available IFN-β,
since IFN-β was still detectable in the supernatant for more than 30 h (Rand, Rinas
et al. 2012: Supplementary Figure S9).
To test whether induction of IRF-7-mCherry correlates with the expression of en-
dogenous ISGs, we separated IRF-7-mCherry negative and positive cells by fluores-
cence-activated cell sorting (FACS) and analyzed isolated RNA from these cells by
quantitative polymerase chain reaction (qPCR) for the expression of common ISGs
(Figure 2.8A). All tested ISGs showed enhanced mRNA levels in IRF-7-mCherry ex-
pressing cells (Figure 2.8A red bars, whereby the 40S ribosomal protein S9 (RPS9)
serves as control). These measurements suggest that a distinct subpopulation of
cells which can be identified by IRF-7-mCherry expression coordinately activates
an antiviral gene program. To examine this further, we pre-treated IRF-7-mCherry
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reporter cells with IFN-β for 8 or 24 h to allow induction of ISGs and subsequently
infected the cells with NDV (Figure 2.8B). Virus replicated in IRF-7-mCherry neg-
ative cells (Figure 2.8B in blue color) but not in the IRF-7-mCherry positive cells
(Figure 2.8B in red color). Thus, only IRF-7-mCherry expressing cells have been
protected by IFN-induced antiviral ISG expression.
Taken together, the data demonstrate that IFN response is a stochastic, IFN-β
concentration-dependent, switch in individual cells. This switch is characterized by
an all-or-nothing principle, in which virus can replicate in the non-responding sub-
population and the responding subpopulation is protected against viral replication.
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2.2. Stochastic model of the IFN response against viral
infection
The experimental study of the IFN system revealed a remarkably strong cell-to-cell
heterogeneity of both IFN induction (cf. section 2.1.2) and antiviral IFN response (cf.
section 2.1.3). To understand the stochastic dynamics of the IFN network we develop
a multi-scale mathematical model that combines the virus-induced IFN signaling in
individual cells with the extracellular cell-to-cell communication via secreted IFN
in an infected cell population (Figure 2.9). The stochastic state transitions of indi-
vidual cells with respect to virus replication, IFN induction and IFN response are
iterated using Gillespie’s algorithm, while the intercellular communication via IFN
is calculated in parallel with a deterministic Euler method.
2.2.1. Stochastic simulation based on Gillespie’s algorithm
The stochastic simulation algorithm (SSA) by Daniel T. Gillespie is a Monte Carlo
procedure to simulate numerically stochastic kinetics (Gillespie 1976, Gillespie 1977).
It has been proven that the SSA is fully equivalent to the master equation approach,
which in turn is the fundamental description of stochastic processes (McQuarrie
1967, Matheson et al. 1975). Using Gillespie’s algorithm enables the realization of a
continuous-time Markov process (Gillespie 1976, Banks et al. 2011, Gillespie 2007).
A continuous-time stochastic process {X(t), t ≥ 0} is a set of random variables X at
time t on a countable state space Q, where X can be in a state s ∈ Q. The process{X(t), t ≥ 0} is called a Markov process, if the Markov property
P(X(tn+1) = sn+1 ∣X(t0) = s0,X(t1) = s1, . . . ,X(tn) = sn)= P(X(tn+1) = sn+1 ∣X(tn) = sn) (2.1)
is fulfilled for all n ∈ N0, successive times t0 ⩽ t1 ⩽ . . . ⩽ tn ⩽ tn+1 and states
s0, s1, . . . , sn+1 ∈ Q (Waldmann and Stocker 2004). The notation P(A ∣ B) desig-
nates the conditional probability of A under the condition B. The Markov property
therefore requires a memoryless system in which a state change depends only on the
current state and not on the past history.
In our model, the Gillespie algorithm is applied to simulate the dynamic process of
a heterogeneous cell population comprising N cells. A single cell i with i = 1, . . . ,N
can be in K different states Sk,i, k ∈ {1, . . . ,K}. The transitions between these states
of an individual cell are specified through M state dependent propensity functions{W1, . . . ,WM}. The whole system is characterized by the state vector of the cell
population
X(t) = (Sk,1(t), . . . , Sk,N(t)) = x, (2.2)
at time t ∈ R≥0. The full system with respect of the K different subpopulations is
given by
Y (t) = (Y1(t), . . . , YK(t)) = y, (2.3)
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where Yk(t) denotes the number of individuals in the state Sk. The goal is to
determine the dynamic of X(t), given that the system was in state X(t0) = x0 at
the starting time t0.
In the following section 2.2.2, we establish a stochastic model that describes key
steps of the IFN system at single-cell level along with intercellular communication
through expressed IFN. To simulate a time step X(t)→X(t+dt) of the population
dynamic, we consider at time t all possible state changes of the individual cells of
the population and compute the time interval dt and the state change to be realized
in accordance with Gillespie’s direct method (see section 2.2.3) (Gillespie 2007, Cao
and Samuels 2009).
2.2.2. Model of virus-induced IFN signaling in single cells along
with cell-to-cell communication through secreted IFN
To analyze the heterogeneous single-cell dynamics of the antiviral IFN network, we
develop a stochastic model for an ensemble of N individual cells communicating via
released IFN.
Since the experimentally used virus cannot spread (cf. section 2.1.2 page 22), we
restrict the viral activity in our model to the initial infection with subsequent virus
replication and neglect reinfection. Depending on the initial infection dose, we set
a fraction of cells as infected. A certain percentage of these infected cells will even-
tually express IFN-β corresponding to the measured number of IFN-β-tGFP+ cells
(cf. Figure 2.3). Since the MOIs used in the experiments are approximately unity
or below, the number of infecting virus particles per cell is low. At the starting time
t0 = 0, we therefore randomly assign each cell i = 1, . . . ,N a number of intracellular
virus particles Vi according to
Vi(0) = { 0 , if cell i is uninfected;1,2 or 3 , if cell i is infected. (2.4)
The state Sk,i(t) of a cell i at time t ∈ R≥0 is defined by the intracellular viral load
Vi(t) and the phenomenological state Zl,i(t) representing the signal transduction in
single cells after viral infection. To count the number of all possible single-cell states
K, we utilize the index k = 1, . . . ,K.
The initial condition of the model is given by the states of the individual cells at
time zero Sk,i(0) = (Zl,i(0), Vi(0)), whereby only the following two phenomenological
states are possible at time t0 = 0:
(Z0) Z0,i =̂ cell i is uninfected
(Z1) Z1,i =̂ cell i is infected and virus replication is recognizable by receptors.
After the initial infection, the cells change their current states Sk,i(t) = (Zl,i(t), Vi(t))
and the number of cells in a state Sk at time t ∈ R≥0, denoted as Yk(t), varies over
time. For a compact computational description of the system that can be compared
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with the live-cell imaging data (cf. section 2.1.2 and 2.1.3), we choose additional phe-
nomenological states Zl,i as illustrated in Figure 2.9 and outlined under (Z2)–(Z9)
below.
Experiments of the virus-induced IFN expression revealed two sources of single-
cell variability, first, the activation of latent transcription factors NF-κB and IRF-7
downstream of viral sensing by RIG-I (cf. Figure 2.4A and B) and, second, induction
of the IFN-β gene by intranuclear NF-κB and IRF-7 (cf. Figure 2.4C and D). Based
on the sister-cell analysis, both of these sources arise substantially from cell-intrinsic
noise (cf. Figure 2.5). In the model, we thus attributed the cell-to-cell variability in
IFN induction and IFN response to intrinsic stochasticity. On the one hand, both the
onset of transcription factor activation and IFN-β expression are broadly distributed
among the cell population (cf. Figure 2.4D). On the other hand, the examination
of single-cell kinetics in terms of nuclear fluorescence intensity of the transcription
factors NF-κB as well as IRF-7 (cf. sample trajectories in Figure 2.4A) and IFN-β
fluorescence (cf. sample kinetics in Figure 2.4C) show a quantitatively steep rise
once nuclear translocation and gene induction, respectively, have been triggered. To
account for the switch-like activation of the transcription factors and subsequent
IFN-β expression, we describe the dynamics of these events in an individual cell
i = 1, . . . ,N as stochastic transitions between the following discrete states (Z1)–(Z3)
shown along the first column in Figure 2.9 (Mariani et al. 2010):
(Z1) Z1,i =̂ cell i is infected and virus replication is recognizable by receptors
(Z2) Z2,i =̂ NF-κB/IRF is activated in cell i
(Z3) Z3,i =̂ cell i secretes IFN-β.
Furthermore, our studies expose the IFN response as an IFN-β concentration de-
pendent all-or-nothing switch in individual cells (cf. Figure 2.7 and Figure 2.8). To
model the switch-like induction of antiviral ISGs, we simulate the IFN response as
two stochastic transitions between discrete states consisting of the IFN-dependent
nuclear translocation of STAT1/2 (Lillemeier et al. 2001, Vinkemeier 2004) and the
subsequent expression of ISGs, such as IRF-7. With regard to the possible combi-
nations of the cell properties we consider the states (Z4)–(Z9) as follows (cf. middle
and last column in Figure 2.9):
(Z4) Z4,i =̂ STAT1/2 is activated in cell i
(Z5) Z5,i =̂ NF-κB/IRF and STAT1/2 are activated in cell i
(Z6) Z6,i =̂ cell i secretes IFN-β and STAT1/2 is activated
(Z7) Z7,i =̂ cell i expresses ISGs
(Z8) Z8,i =̂ cell i expresses ISGs and NF-κB/IRF is activated
(Z9) Z9,i =̂ cell i expresses IFN-β and ISGs.
The transitions between the states Sk,i(t) = (Zl,i(t), Vi(t)) with k ∈ {1, . . . ,K}
and l ∈ {0, . . . ,9} are defined by state-dependent propensity functions Wm for
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Figure 2.9.: A multi-scale mathematical model of IFN induction and response. The model
describes an infected cell population with state transitions of individual cells according to (i)
virus replication (⤾), (ii) virus-induced nuclear translocation of the transcription factors
IRFs/NF-κB (cyan nucleus), (iii) IFN-β gene induction (green cytoplasm), (iv) nuclear
translocation of STAT1/2 induced by extracellular IFN and (v) expression of antiviral ISGs
including IRF-7 (red cytoplasm), in combination with the cell-to-cell communication via
secreted IFN. Possible state changes of an individual cell i ∈ {1, . . . ,N} between the discrete
states (Z1)–(Z9) depend on the propensity functions w±s,i with s ∈ {V, TF, I, STAT, ISG}.
The color code corresponds to the experimentally used fluorescent reporter cells (cf. section
2.1.1). Induction of IFN-β (dashed arrow) is explicitly modeled as a multi-step process to fit
the available experimental data (cf. section 2.3.2); all other state transitions are described
as single steps (solid arrows).
m = 1, . . . ,M . In order to make a reference to the occurring state transition, we
specify the propensity functions of an individual cell i as w±⋅,i, which in turn depend
on the current state of the cell Sk,i(t). For the description of our system, we choose
the following propensity functions (cf. Figure 2.9):
(1) After the initial infection the virus starts to replicate in the host cells. We
simulate the replication of virus particles in the model as a birth-death process
(Kendall 1949) with the rate constant of virus replication rV and the rate
constant of virus decay dV (Figure 2.10). The associated propensity function
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Figure 2.10.: Scheme of the used birth-death process to simulate virus replication. Intra-
cellular virus particles Vi replicate in an infected cell i ∈ {1, . . . ,N} with the rate constant of
virus replication rV. The maximal number of virus particles which an intact cell can harbor
is defined by Vmax. The antiviral effect of ISG expression inhibits further viral replication
and decreases the intracellular viral load with the rate constant of virus decay dV.
of virus replication is specified through
w+V,i = rVVi(t)H(Vmax − Vi(t)), (2.5)
where the Heaviside step function
H(Vmax − Vi(t)) = { 0 , if Vi(t) ≥ Vmax;1 , if Vi(t) < Vmax (2.6)
is taken into account for the limited capacity of an intact cell to harbor maximal
Vmax virus particles.
(2) The presence of virus induces the activation of the transcription factors NF-κB
as well as IRF-7. In dependence of the intracellular viral load Vi, we describe
the propensity function of transcription factor (TF) activation by the Hill
function
w+TF,i = kRIG-I Vi(t)hV
KhVV + Vi(t)hV , (2.7)
with the half-saturation constant KV, the Hill coefficient hV and the rate kRIG-I
of RIG-I pathway activation by virus (Alon 2006). This formulation enables a
threshold response of the RIG-I pathway with saturation regarding the number
of intracellular virus particle Vi. Since some reporter cells demonstrated that
IRF-7 accumulated in the nucleus also returns to the cytoplasm (cf. left column
in Figure 2.4A, Rand 2010), we allow in our model the inactivation of the RIG-I
pathway with propensity
w−TF,i = lRIG-I. (2.8)
(3) The nuclear translocation of the transcription factors NF-κB as well as IRF-7
leads to IFN-β gene induction according to the propensity
w+I,i = kIFN, (2.9)
whereby IFN-β expression can also terminate with propensity
w−I,i = lIFN. (2.10)
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(4) The experimental data show that the fraction of IFN-β expressing cells de-
termines the extracellular concentration of IFN-β (cf. Figure 2.3C). Although
extracellular IFN-β decreases through the cellular uptake and degradation in
the medium, IFN-β was always detectable in the supernatant (cf. Rand, Ri-
nas et al. 2012: Supplementary Figure S9) indicating the presence of a large
number of IFN-β molecules in the cell culture. Regarding the high diffusion co-
efficient of IFN (Kreuz and Levy 1965: DIFN = 3.42×105 µm2/h; Hu et al. 2011:
DIFN = 1.08 × 105 µm2/h), diffusion on the relevant length scale of several cell
diameters occurs fast (within minutes) compared to the hour-timescale of IFN
and ISG expression. For these reasons, we consider an uniform distribution
of secreted IFN in our model and calculate the instantaneously equilibrating
extracellular concentration of IFN-β in parallel with the Gillespie algorithm.
We assume that IFN-β producing cells secrete IFN-β with the rate constant
kS and take into account a degradation of extracellular IFN-β according to the
rate constant dIFN. The corresponding differential equation of the extracellular
concentration of IFN-β I over time is given by
I˙(t) = kSNIFN(t) − dIFNI(t), (2.11)
where NIFN(t) stands for the number of IFN-β expressing cells at time t.
(5) The activation of STAT1/2 by autocrine or paracrine recognition of extracel-
lular IFN-β I (cf. Figure 1.3) is formulated with the propensity function
w+STAT,i = kSTAT IhIFN
KhIFNIFN + IhIFN , (2.12)
where kSTAT, KIFN and hIFN denote the rate, the half-saturation constant and
the Hill coefficient of STAT1/2 pathway activation by IFN, respectively.
(6) Activated STAT1/2 in turn cause the expression of ISGs, including IRF-7,
with propensity
w+ISG,i = kISG. (2.13)
As the observed number of IRF-7 expressing cells remained high within the
observation period of 48 h post infection (cf. Figure 2.11B (4)), we ignore both
a termination of ISG expression and an inactivation of STAT1/2.
(7) To characterize the induction of an antiviral state through IFN response, we
assume that in an ISG expressing cell i ∈ {1, . . . ,N} viral replication is inhib-
ited and the intracellular viral load Vi declines according to the propensity
function
w−V,i = dVVi(t), (2.14)
where dV denotes the rate constant of virus decay (cf. Figure 2.10).
An additional overall decline of viral load can be attributed to the death of virus-
infected cells (cf. decrease of HN+ cells in Figure 2.3A and B, orange color). To
keep the model as simple as possible we have neglected cell death and also cell
proliferation by simulating a constant cell population. The consideration of a non-
growing cell population is justified since we did not detect obvious differences in
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heterogeneous IFN-β induction between the cell fraction dividing during the time of
observation (cf. Figure 2.5A and B) and the whole cell population which contains a
sizable proportion of non-dividing cells (cf. Figure 2.4B and D).
2.2.3. Model simulations using Gillespie’s algorithm
Our cell population model, which couples the stochastic state changes of individual
cells according to the propensity functions w±⋅,i with the intercellular communication
via secreted IFN-β (cf. section 2.2.2), is implemented and simulated in Matlab (The
Mathworks Inc., Natick, MA) using Gillespie’s direct method (Gillespie 2007, Cao
and Samuels 2009).
To execute a time step of the dynamics, we consider at time t ∈ R≥0 all possible state
changes of each cell i = 1, . . . ,N and calculate the time interval dt after which the
next stochastic switching event takes place by
dt = − ln(u1)
w0
, (2.15)
where u1 denotes a random number drawn from the unit-interval uniform distribu-
tion. The denominator in (2.15) is defined as
w0 = ∑
s∈S+
N∑
i=1w+s,i + ∑s∈S−
N∑
i=1w−s,i =
M∑
m=1Wm (2.16)
with S+ = {V, TF, I, STAT, ISG} as well as S− = {V, TF, I}. The term w0 rep-
resents the sum of all propensity functions Wm for m = 1, . . . ,M that “lead away”
from the current state of the system.
The propensity function Wj of the actually occurring state transition at time t + dt
has to fulfill the condition
j−1∑
m=1Wm < u2 w0 ⩽
j∑
m=1Wm, (2.17)
where u2 denotes a second random number drawn from the uniform distribution in
the unit-interval.
In parallel to the Gillespie algorithm, we compute the extracellular IFN-β concen-
tration I by utilizing the Euler discretization of the differential equation (2.11):
I˙(t) = kSNIFN(t) − dIFNI(t)⇐⇒ I(t + dt) − I(t)
dt
= kSNIFN(t) − dIFNI(t)⇐⇒ I(t + dt) = I(t) + dt[kSNIFN(t) − dIFNI(t)]. (2.18)
The application of the Euler method requires a sufficiently small time step dt that
satisfies dt≪ d−1IFN. We found the latter condition to be guaranteed with the param-
eter choices for our model (cf. Table 2.2). After every Gillespie step, we update the
system in accordance with the current states of the individual cells. To compare the
model simulations with the experimental data (Figure 2.11), we take into account
the following readouts (ROs):
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(RO1) The total viral load of the cell population computed by
V (t) = N∑
i=1Vi(t) (2.19)
is compared with the measured mean fluorescence intensity of the viral hem-
agglutinin-neuraminidase (HN) protein staining by using a scaling factor (cf.
Figure 2.3A and Figure 2.11B (1)).
(RO2) During simulation, we extract the modeled initial nuclear translocation times
of the transcription factors NF-κB and IRF-7 after infection Tsig,i, i = 1, . . . ,N
through storing the time point a cell i changes for the first time its state from
Z1,i to Z2,i, from Z4,i to Z5,i or from Z7,i to Z8,i (cf. Figure 2.9 upper and
middle row). These simulated times Tsig,i are used to fit the distribution of
the imaged activation times of the transcription factors Tsig (cf. Figure 2.4D
and Figure 2.11A upper panel).
(RO3) The simulated time delays between transcription factor activation and onset
of IFN-β expression Tgen,i, i = 1, . . . ,N are calculated by storing the time point
a cell i with activated transcription factor starts to express IFN-β (cf. Figure
2.9 middle and last row). The modeled times Tgen,i are utilized for the estima-
tion of the observed time spans Tgen of IFN-β-tGFP switching-on times after
activation of the transcription factors (cf. Figure 2.4D and Figure 2.11A lower
panel).
(RO4) The simulated number of IFN-β expressing cells at time t NIFN(t) is related to
the monitored IFN-β-tGFP+ reporter cells (cf. Figure 2.3B and Figure 2.11B
(2)).
(RO5) The computed extracellular IFN-β concentration over time I(t) is compared
with the experimentally quantified amount of released IFN-β (Figure 2.11B
(3)).
(RO6) The modeled number of ISG expressing cells at time t NISG(t) represents the
investigated IRF-7-mCherry+ reporter cells (cf. Figure 2.7 and Figure 2.11B
(4)).
The determination of the model parameters is explained briefly in the following and
described in more detail in the next section 2.3. The resulting parameter values are
listed in Table 2.2 and lead to the simulations shown in Figure 2.11.
For the parameterization of our model, we focus on the extensive data for high-dose
infections with 40 and 80 HAU/ml NDV (Figure 2.11). Fitting of the observed
distributions regarding the NF-κB/IRF-7 nuclear translocation times (Tsig) and the
IFN-β-tGFP switching-on times (Tsig +Tgen) results in a good approximation of the
data (Figure 2.11A) and enables the description of the measured kinetic of IFN-
β-tGFP+ cells (Figure 2.11B (2)). The fits require that (i) the activation of the
RIG-I-mediated signaling by virus is cooperative (cf. section 2.3.1) and (ii) IFN-β
gene induction is modeled as a multi-step process (cf. section 2.3.2). These two
conclusions drawn from the parameter estimation correspond well with previously
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Figure 2.11.: Simulating the multi-layered cell-to-cell heterogeneity of the IFN system
results in predictable populations dynamics. (A) Model simulations of NF-κB/IRF nuclear
translocation time points and IFN-β-tGFP onset times versus experimental data. With the
stochastic model computed distributions (black lines) match the data of IRF-7-CFP nuclear
translocation times (Tsig, cyan histogram) and IFN-β-tGFP expression onset (Tsig + Tgen,
green histogram) monitored in single cells after infection with 80 HAU/ml NDV (cf. Figure
2.4D for a representation of individual time points). (B) Comparison between simulated
and measured cell population dynamics. The stochastic model (solid lines) reproduces the
observed kinetics (dots) of (1) viral load (as measured by HN expression), (2) IFN-β-tGFP
induction, (3) extracellular IFN titre and (4) IRF-7-mCherry expression after infection with
40 HAU/ml NDV. The smooth model curves in (A) and (B) are mean values obtained
by simulating 104 cells. Time course data in (B)(2)–(4) represent the mean and standard
deviation of triplicate measurements. (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
described findings (Hu et al. 2007, Ford and Thanos 2010, Onoguchi et al. 2010,
Binder et al. 2011).
To estimate the parameters of the IFN response, we initially scale our model to the
measuring unit of IFN by fitting the dose-response curve of IRF-7-expressing cells
depending on external IFN-β (cf. Figure 2.14). Restricted through this calibration
and the already specified dynamics of IFN-β producing cells (cf. Figure 2.11B (2),
green curve), we determine the IFN-β secretion rate per cell to match the observed
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Model parameter Value
Intracellular virus dynamics
Maximum viral load per cell Vmax 130
Rate constant of virus replication rV 0.34/h
Rate constant of virus decay dV 0.1/h
IFN induction
Rate of RIG-I pathway activation by virus kRIG-I 0.48/h
Half-saturation constant of RIG-I pathway activa-
tion by virus
KV 43
Hill coefficient of RIG-I pathway activation by virus hV 3
Rate of RIG-I pathway inactivation lRIG-I 0.4/h
Rate constant of IFN-β gene induction kIFN 1.79/h
Rate of termination of IFN-β expression lIFN 0.08/h
IFN response
Half-saturation constant of STAT1/2 pathway acti-
vation by IFN-β
KIFN 100 U/ml
Hill coefficient of STAT1/2 pathway activation by
IFN-β
hIFN 1
Rate of STAT1/2 pathway activation kSTAT 0.1/h
Rate constant of ISG (IRF-7) induction by STAT1/2
pathway
kISG 0.1/h
Rate constant of IFN-β secretion kS 0.13 U/h/ml/cell
Rate constant of IFN-β degradation dIFN 0.15/h
Table 2.2.: Model parameters of the stochastic model. Based on the biological meaning of
the model parameters (cf. section 2.2.2), we determined the parameter values as depicted
in section 2.3. All model simulations in section 2.2.3 and 2.4 refer to this parameter set.
time course of extracellular IFN (cf. Figure 2.11B (3)). With these parameters (cf.
Table 2.2), the simulated kinetic of IRF-7-expressing cells agrees with the data (cf.
Figure 2.11B (4)).
Importantly, the model simulations demonstrate that the single-cell heterogeneity
of transcription factor activation, IFN-β gene induction as well as ISG expression
translates into predictable dynamics of IFN-secreting and protected cell fractions at
the population level.
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2.3. Estimation of the model parameters of the
stochastic model
The Gillespie algorithm is a prevalent and valuable method to simulate stochastic
processes. Nevertheless, the long computation time of this algorithm for extensive
models with large time scale separation is a serious disadvantage (Gillespie 2007,
Cao and Samuels 2009, Banks et al. 2011). Also the simulation of our full model for
a sufficient number of cells (N = 104 cells) with dynamics over several hours is very
time consuming and practically excludes straightforward optimization approaches
for parameter estimation. Therefore we divide the parameter estimation problem
into three parts: (1) determination of parameters for the virus-induced activation
of the transcription factors IRFs/NF-κB (cf. section 2.3.1), (2) identification of pa-
rameters with respect to IFN-β expression (cf. section 2.3.2) and (3) estimation of
parameters concerning the IFN response (cf. section 2.3.3).
The first two parts consider the induction of IFN in individual cells without cell-
to-cell communication via secreted IFN-β. As the simulation of isolated single-cell
behavior is much faster than the complete model, rigorous parameter estimation is
applicable and several mechanistically relevant conclusions will be drawn from the
parameter optimization.
The third part regarding ISG induction depends on the intercellular signaling be-
tween cells, which implies the need for simulating large numbers of cells and thus
having impractically long calculation times. However, it turns out that we can still
derive quantitative features of ISG expression from the experimental data.
An overview of the determined parameter values in this section is provided in Table
2.2 and serves as a reference for the used parameter set of all model simulations in
section 2.2.3 and 2.4.
2.3.1. Parameter determination for the virus-induced activation of
the transcription factors of IFN
In our model, we describe the activation of the transcription factors of IFN in an
infected cell i ∈ {1, . . . ,N} as a state change from virus-infected to NF-κB/IRF-
activated according to the propensity function (2.7) given by
w+TF,i = kRIG-I Vi(t)hV
KhVV + Vi(t)hV ,
with the rate constant kRIG-I, the half-saturation constant KV, the Hill coefficient hV
of RIG-I pathway activation and the intracellular viral load Vi(t) at time t ∈ R≥0 (cf.
Figure 2.9). A perfectly suited experiment to determine the parameters of w+TF,i
is the single-cell analysis of the nuclear translocation time of NF-κB and IRF-7
after infection Tsig monitored by live-cell imaging (cf. Figure 2.4D explicit for IRF-7
and also for NF-κB, since both transcription factors synchronously translocate into
the nucleus as illustrated in Figure 2.4B). To describe this measured histogram of
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nuclear translocation times of the transcription factors (Figure 2.12A), we utilize a
submodel comprising viral replication and subsequent NF-κB/IRF-7 activation.
For the simulation of the submodel we initially characterize viral reproduction by
comparing the model with the measured time course of viral replication after high-
dose infection (cf. Figure 2.11B (1)). By setting the rate constant of virus replication
rV = 0.34/h, the maximum viral load per cell Vmax = 130 and the rate constant of
virus termination dV = 0.1/h, we receive a satisfactory match of the model with the
data.
Next, we compute the distribution of NF-κB/IRF translocation times by simulating
the submodel consisting of viral replication and subsequent NF-κB/IRF-7 activation
sufficiently often using Gillespie’s algorithm. To adjust this computed distribution
to the experimentally measured histogram, we allow the parameters of the RIG-I
pathway activation by virus (kRIG-I, KV and hV) to vary while keeping the previ-
ously determined viral replication parameters (rV, Vmax and dV) fixed. As objective
function we use Neyman’s chi-squares statistic (Baker and Cousins 1984), which
considers the squared difference between the binned observed and simulated events
weighted by the inverse binned experimental data as a measure for the sample vari-
ance:
χ2Neyman = B∑
b=1
(Db −Eb)2
Db
, (2.20)
where B denotes the number of bins of the histogram, Db stands for the number of
observed events in the bth bin and Eb represents the number of simulated events in
the bth bin for b ∈ {1, . . . ,B}, under the condition
B∑
b=1Db =
B∑
b=1Eb. (2.21)
In order to satisfy the condition (2.21) and to ensure accuracy by simulating many
more events (5 × 104 runs) than experimentally measured (315 cells), we utilize the
the cumulative distribution function (CDF) for normalization. We calculate Eb
using the cumulative distribution function of the simulations for transcription factor
activation at time t ∈ R≥0 given by
CDF TF(t) = 1
Ns
Ns∑
i=11[0;t](Tsig,i), (2.22)
with the number of simulated events Ns, the simulated nuclear translocation times
of the transcription factors Tsig,i, i = 1, . . . ,Ns and the characteristic function 1 of
the interval [0; t]
1[0;t](Tsig,i) = { 1 , for Tsig,i ∈ [0; t];0 , for Tsig,i ∉ [0; t]. (2.23)
After simulating the submodel Ns times, we compute the number of simulated events
in the bth bin according to
Eb = Ndata(CDF TF(tj+1b ) −CDF TF(tjb)), (2.24)
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where Ndata defines the number of observed data points, while t
j
b and t
j+1
b designate
the left and the right bin edge of the bth bin for j ∈ {1, . . . ,B}, respectively.
For the minimization of the objective function (2.20) we apply the simulated an-
nealing method, which is a heuristic optimization technique (Kirkpatrick et al. 1983,
Schneider and Kirkpatrick 2006). The idea of simulated annealing is based on the
thermodynamic concept that slow cooling of a system allows to find the minimum
energy state (Press et al. 2007). In the initial phase of the algorithm (high temper-
ature), it is more likely that large changes in the objective function occur and that
slightly worse solutions are permitted. With increasing computation time (falling
temperatures), changes in the objective function become progressively smaller and
the temperature-dependent probability to accept a worse solution tends to zero. The
opportunity to enable slightly worse solutions, i.e. controlled uphill steps, prevents
to get stuck in a local optimum and therefore makes it possible to find the global
minimum. To minimize our objective function (2.20), we use the simulated annealing
algorithm implemented by Joachim Vandekerckhove, which is freely available at the
Mathworks File Exchange library. The resulting parameter values (kRIG-I = 0.48/h,
KV = 43 and hV = 3.0) yield a good match of computed and measured distributions
of nuclear translocation times of the transcription factors (cf. Figure 2.12A).
From a biological point of view, the most interesting feature of this parameter set
is the high Hill coefficient hV, since a Hill coefficient larger than 1 implies positive
cooperativity (Murray 2002). To analyze how robust the estimation of the Hill
coefficient hV is, we utilize the profile likelihood method (Venzon and Moolgavkar
1988). Thus, we fix hV systematically to different values around the estimated
optimum of hV = 3.0 and refit kRIG-I as well as KV by simulated annealing. To
ensure that the obtained values of the objective function (2.20) are unaffected by
the inherent stochasticity of the submodel, we repeat the calculation for each fixed
value of hV 10
4 times. The profile likelihood (Figure 2.12B) shows the corresponding
mean values of Neyman’s chi-squares statistic for each fixed hV. A measure for the
goodness of the fit is the degree of freedom (DF ), which defines an upper limit for
good fits (Press et al. 2007). In the present case, the degree of freedom is calculated
by
DF = B − normalization constraint − number of fit parameters= 12 − 1 − 3= 8. (2.25)
A non-cooperative activation of the RIG-I pathway (hV = 1) far exceeds the degree of
freedom, whereby a Hill coefficient hV ≥ 3 leads to a very good fit of the translocation-
time distribution. Based on these findings we conclude that the activation of the
RIG-I pathway by virus is cooperative, while the available data are insufficient to
estimate the precise degree of cooperativity.
After the nuclear translocation of the transcription factor IRF-7 we monitored in
some reporter cells a relocation of IRF-7 back to the cytoplasm and after a while
again an accumulation in the cytoplasm (cf. left column in Figure 2.4A, Rand 2010).
To account for this nucleocytoplasmic transport of IRF-7 we allow in our model the
inactivation of the RIG-I pathway with the rate lRIG-I, which consequently prevents
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Figure 2.12.: Parameter determination demonstrates a cooperative induction of RIG-I
mediated signaling by virus. (A) Parameter estimation of virus-induced transcription factor
activation. As basis for the parameter determination serves the initial nuclear translocation
time of IRF-7 monitored by live-cell imaging in 315 IRF-7-CFP reporter cells after infection
with 80 HAU/ml NDV (cyan histogram, cf. Figure 2.4D for a representation of individual
time points). The computed distribution (black line) is obtained by simulating 5× 104 runs
of the mathematical submodel comprising viral replication and subsequent NF-κB/IRF-7
activation. A match of the computed with the measured distribution is achieved by applying
the simulated annealing algorithm. (B) Profile likelihood with respect to the Hill coefficient
of virus-induced RIG-I signaling hV. The profile likelihood calculation is repeated 10
4 times
for each fixed value of hV. Shown are the resulting mean values and standard deviations of
Neyman’s chi-squares statistic. The upper limit for a good fit is defined by the degree of
freedom (DF = 8, cf. (2.25)). (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
or at least delays a subsequent IFN-β gene induction. For the adaptation of the
parameter lRIG-I, it is therefore necessary to simulate the whole IFN induction path-
way with the determined parameter values for viral replication and RIG-I pathway
activation discussed in this section and the results from the parameter estimation
of IFN-β gene induction outlined in the following section 2.3.2. After simulation of
the IFN induction, we compare the arising distribution of IFN-β switching-on times
with the measured histogram (cf. Figure 2.11A, lower graph) and find an improved
match by setting lRIG-I = 0.4/h.
2.3.2. Parameter determination of the IFN expression
After the virus-induced nuclear translocation of the transcription factors NF-κB
and IRF-7 we detected that the majority of the cells (91% at 80 HAU/ml NDV)
also induces the IFN-β gene (cf. Figure 2.4D). The time delay between nuclear
translocation of IRF-7 and onset of IFN-β-tGFP expression Tgen varied considerably
in individual cells and resulted in a broad distribution (Figure 2.13). To simulate the
heterogeneous onset of IFN-β expression after transcription factor activation using
Gillespie’s algorithm, we have to formulate this state transition as a Markov process
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(cf. section 2.2 page 32). The only continuous distribution fulfilling the Markov
property (2.1) is the memoryless exponential distribution (cf. Waldmann and Stocker
2004). However, according to the shape of the experimentally measured histogram
of Tgen (cf. Figure 2.13) a single exponentially distributed rate cannot generate the
distinct time delay between transcription factor activation and IFN-β gene induction.
In this context it should be noted that the distribution of the transcription factor
translocation times Tsig (cf. Figure 2.12A) can neither be modeled with a single
exponential rate (cf. section 2.3.1). In the case of transcription factor activation,
the time delay between infection and virus-induced signaling is explained by the
viral replication process (cf. Figure 2.10).
A possible explanation for the observed time delay between the nuclear translocation
of the transcription factors NF-κB/IRF-7 and IFN-β expression is the multi-step
assembly of the IFN-β enhanceosome that activates transcription from the IFN-β
promoter (Hu et al. 2007, Ford and Thanos 2010). Therefore we analyze if the
measured histogram of Tgen can be fitted with a gamma distribution γ(m,z). For a
positive integer m, γ(m,z) describes the distribution of the sum of m independent
random variables, where each random variable is exponentially distributed with
rate z (Press et al. 2007). Based on the measured onset times of IFN-β-tGFP
expression after transcription factor activation Tgen,i for i = 1, . . . ,Ndata monitored
in Ndata = 315 individual cells (cf. Figure 2.13), we estimate the parameters of the
gamma distribution m and z with the maximum-likelihood method (Myung 2003).
For this purpose, we have to maximize the likelihood function L of the sample Tgen,i,
i = 1, . . . ,Ndata, which is described as
L(p1, . . . , pNp ∣ Tgen,1; . . . ;Tgen,Ndata) = f(Tgen,1; . . . ;Tgen,Ndata ∣ p1, . . . , pNp) (2.26)
using the assumed common density function f(t ∣ p1, . . . , pNp) with the parameters
p1, . . . , pNp and t ∈ R. The density function of the considered gamma distribution
fγ is given ∀m,z > 0 by
fγ(t ∣m,z) = ⎧⎪⎪⎪⎨⎪⎪⎪⎩
zm
Γ(m) tm−1e−z t , for t > 0;
0 , for t ≤ 0, (2.27)
with the gamma function Γ(m). According to Euler’s integral representation, the
gamma function is defined for m > 0 as
Γ(m) = ∞∫
0
tm−1e−tdt. (2.28)
Instead of maximizing L, we prefer to maximize the log-likelihood function L of the
independent and identically distributed (i.i.d.) sample Tgen,i, i = 1, . . . ,Ndata:
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Figure 2.13.: Parameter estimation characterizes IFN-β gene induction as a multi-step
process. The parameter determination of IFN-β gene induction is based on the time delay
between IRF-7-CFP nuclear translocation and IFN-β-tGFP expression (Tgen) monitored by
live-cell imaging in 315 dual reporter cells after infection with 80 HAU/ml NDV (green
histogram, cf. Figure 2.4D for a representation of individual time points). The observed
histogram can be approximated by the gamma distribution γ(6,1.79) (black line), which
represents a stochastic process consisting of 6 consecutive and with rate 1.79/h exponentially
distributed steps. (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
L (m,z ∣ Tgen,1; . . . ;Tgen,Ndata)= ln(L(m,z ∣ Tgen,1; . . . ;Tgen,Ndata))(2.26)= ln(fγ(Tgen,1; . . . ;Tgen,Ndata ∣m,z))
Tgen,i i.i.d.= ln⎛⎝Ndata∏i=1 fγ(Tgen,i ∣m,z)⎞⎠
(2.27)= ln⎛⎝Ndata∏i=1 [ z
m
Γ(m)Tm−1gen,ie−z Tgen,i]⎞⎠
= Ndata ln( zm
Γ(m)) + Ndata∑i=1 ln (Tm−1gen,ie−z Tgen,i)= Ndatam ln(z) −Ndata ln(Γ(m))+(m − 1)Ndata∑
i=1 ln(Tgen,i) − z
Ndata∑
i=1 Tgen,i.
(2.29)
To find a maximum of the likelihood function, we first calculate the root of the
partial derivative of L with respect to z
∂
∂z
L (m,z ∣ Tgen,1; . . . ;Tgen,Ndata) = 0
(2.29)⇐⇒ Ndatam 1
z∗ − Ndata∑i=1 Tgen,i = 0
⇐⇒ z∗ = ⎛⎝ 1Ndatam Ndata∑i=1 Tgen,i⎞⎠
−1
, (2.30)
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which results in an explicit estimator for z depending on m and allows to reformulate
L as follows:
L (m,z ∣ Tgen,1; . . . ;Tgen,Ndata)∣z = z∗
(2.30)= −Ndatam ln⎛⎝ 1Ndatam Ndata∑i=1 Tgen,i⎞⎠ −Ndata ln(Γ(m))+(m − 1)Ndata∑
i=1 ln(Tgen,i) −mNdata= Ndata ⎡⎢⎢⎢⎢⎣m ln(Ndatam) −m ln
⎛⎝Ndata∑i=1 Tgen,i⎞⎠ − ln(Γ(m)) −m
⎤⎥⎥⎥⎥⎦+(m − 1)Ndata∑
i=1 ln(Tgen,i).
(2.31)
Utilizing this new formulation (2.31), the partial derivative of L with respect to m
is given by
∂
∂m
L (m,z ∣ Tgen,1; . . . ;Tgen,Ndata)∣z = z∗
(2.31)= Ndata ⎡⎢⎢⎢⎢⎣ln(Ndatam) + 1 − ln
⎛⎝Ndata∑i=1 Tgen,i⎞⎠ − Γ
′(m)
Γ(m) − 1
⎤⎥⎥⎥⎥⎦ +
Ndata∑
i=1 ln(Tgen,i)
= Ndata ⎡⎢⎢⎢⎢⎣ln(Ndatam) − ln
⎛⎝Ndata∑i=1 Tgen,i⎞⎠ − Γ
′(m)
Γ(m)
⎤⎥⎥⎥⎥⎦ +
Ndata∑
i=1 ln(Tgen,i)
=∶ M (m ∣ Tgen,1; . . . ;Tgen,Ndata).
(2.32)
Fulfilling the necessary condition for a maximum of the likelihood function concern-
ing the partial derivative of L with respect to m supplies an implicit estimate of
m:
∂
∂m
L (m,z ∣ Tgen,1; . . . ;Tgen,Ndata) = 0(2.32)⇐⇒ M (m ∣ Tgen,1; . . . ;Tgen,Ndata) = 0. (2.33)
We determine m independently from z through solving the nonlinear equation (2.33)
with the trust-region-dogleg algorithm of Matlab’s optimization toolbox (Coleman
and Zhang 2003). Using the measured data points Tgen,i we obtain m = 6.4. Since
in the present case m is interpreted as the number of exponentially distributed
steps in a stochastic process, we round m to the nearest integer. Inserting m = 6
in (2.30) yields directly z = 1.79/h. The resulting gamma distribution γ(6,1.79)
provides a good approximation of the measured histogram of Tgen (cf. Figure 2.13).
Therefore we conclude that IFN-β expression after transcription factor activation
can be described through 6 consecutive and exponentially distributed steps with
rate kIFN = 1.79/h. Consequently, each of these first-order processes has a half-life
of ln(2)/kIFN = 23 min. The estimated number of steps and the half-life correspond
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well with the mechanistic knowledge about the multi-step formation of the IFN-β
enhanceosome (Hu et al. 2007, Ford and Thanos 2010), although transcription and
translation might also contribute relevant steps.
In addition, we have observed that the activated transcription factors NF-κB and
IRF-7 stay in average for ∼ 13 h in the nucleus (Rand 2010). This mean duration
provides an upper limit for the average time span of IFN production, since IFN
expression requires the presence of transcription factors in the nucleus. Accordingly,
we fix the rate of termination of IFN-β expression to lIFN = 0.08/h.
2.3.3. Parameter determination of the IFN response
With the intention to obtain quantitative insight into IFN-induced ISG regulation,
we have a closer look on the IRF-7 response experiment, in which the IRF-7-mCherry
reporter cells were stimulated with increasing units of IFN-β and subjected to flow
cytometry at different times after stimulation (cf. Figure 2.7). On the basis of this
experiment, we derive a dose-response data set by recording the maximal fraction
of IRF-7-mCherry+ cells for each applied IFN-β concentration (Figure 2.14). The
hyperbolic shape of the derived data set indicates that the dose-response to the
extracellular concentration of IFN-β I can be characterized by a Hill function
R(I) = IhIFN
KhIFNIFN + IhIFN , (2.34)
where KIFN and hIFN denote the half-saturation constant and the Hill coefficient of
STAT1/2 pathway activation by IFN-β, respectively.
To fit the parameters of the Hill function to the dose-response data set, we utilize
the trust-region-reflective least-squares algorithm of Matlab’s optimization toolbox
(Coleman and Zhang 2003). The least-squares method is based on the chi-squares
statistic
χ2 = Ndata∑
i=1 (di − y(xi ∣ p1, . . . , pM)σi )
2
, (2.35)
with the number of observed data points Ndata, the measured data set (xi, di), the
corresponding measurement error σi for i = 1, . . . ,Ndata and the objective function
y(xi ∣ p1, . . . , pM) at xi with M adjustable parameters pj for j = 1, . . . ,M (Press
et al. 2007). In order to find the best fit parameter values, the chi-squares statistic
χ2 has to be minimized.
In the present optimization problem, we consider (2.34) as objective function to
describe the derived dose-response data set by assuming a measurement error of
10%. The resulting parameter values KIFN = 100.8 U/ml and hIFN = 1.08 yield a
satisfying fit to the data (cf. Figure 2.14, black curve). For simulations of the full
model we use non-negative integer numbers and set KIFN = 100 U/ml as well as
hIFN = 1 (cf. Figure 2.14, red curve). The description of the IFN-induced response
data by a Hill coefficient with value 1 implies a non-cooperative IRF-7 induction
through extracellular IFN-β (Murray 2002).
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Figure 2.14.: Parameter estimation reveals a non-cooperative induction of IRF-7 by ex-
tracellular IFN-β. Based on the IRF-7 response measurement (cf. Figure 2.7), we derive a
dose-response data set (red dots) by considering the maximal fraction of IRF-7-mCherry+
cells (y-axis) for each applied IFN-β concentration (x-axis). The data set was fitted with a
Hill function (black curve) by applying a trust-region-reflective least-squares algorithm and
assuming the indicated 10% measurement error (black error bars). For further simulations
we round the fitted parameter values to the nearest integers KIFN = 100 U/ml and hIFN = 1
(red curve). (Experiments by U. Rand, M. Ko¨ster and H. Hauser)
In contrast to the dose-response parameters KIFN and hIFN, the rate constants for
STAT1/2 activation kSTAT and ISG induction kISG cannot be rigorously fitted from
the available data. By comparing the simulated kinetic of ISG expression to the
experimentally measured one at high viral load (cf. Figure 2.11B (4)), we detect
that kSTAT = kISG = 0.1/h leads to a good match between model and data.
For the determination of the IFN-β secretion rate kS and the IFN-β degradation
rate dIFN, we use the measured kinetics of IFN-β-tGFP expressing cells and the
amount of released IFN after high-dose infection (cf. Figure 2.11B (2) and (3)).
Using the preceding parameterization of the IFN-β induction (cf. section 2.3.1 and
2.3.2) enables the description of the IFN-β-tGFP+ cell fraction over time. Restricted
by the kinetic of the IFN-β-producing cells and the already adjusted measurement
unit of IFN through fitting KIFN = 100 U/ml, we find that kS = 0.13 U/(h ml cell)
and dIFN = 0.15/h lead to a good agreement between the measured and simulated
dynamic of extracellular IFN (cf. Figure 2.11B (3)).
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2.4. Stochastic modeling exposes individual IFN
producers as sentinels of viral infection
The temporal dynamics of IFN-β-tGFP expressing cells and IRF-7-mCherry re-
sponding cells after infection with high viral load (cf. Figure 2.11 (2) and (4)) sug-
gest that IFN-β secreted by a single cell can induce antiviral ISG production in
several cells. To analyze this presumption more closely, we simulate the stochastic
model for a range of low-dose infections, where IFN-β-producing cells are rare. The
subsequent comparison of the predicted kinetics of IFN-responding cells with the
measured fraction of ISG-expressing cells shows a good match with the associated
data (Figure 2.15A).
In addition, we consider the proportion of IFN responding cells to IFN producing
cells after infection with different virus titers (Figure 2.15B). For low-dose infections,
the model predicts a strong paracrine propagation of antiviral protection through
secreted IFN, with up to 40 times as many ISG-expressing cells than IFN-secreting
cells. This model prediction proved remarkably accurate when tested experimentally,
given that the model is calibrated only for high dose infections (cf. Figure 2.15B blue
square and Figure 2.11).
To further examine the relation between IFN expressing and IFN responding cells,
we cultivated IFN-β-tGFP reporter cells together with IRF-7-mCherry cells (Fig-
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Figure 2.15.: Paracrine propagation of the IFN response is predicted by the model and
verified experimentally. (A, B) After the model parameterization based on experimental
data concerning high dose infections, we simulate the model for low dose infections by taking
into account a population of 104 cells. (A) The model predicts IFN response dynamics after
low-dose infections. The simulated kinetics of ISG expressing cells (solid curves) can be
confirmed by the measured dynamics of IRF-7-mCherry+ cells (dots) for sparse infections
with 1, 2 and 5 HAU/ml NDV. (B) Predicted paracrine propagation of the IFN response
induced by individual sentinels. Shown is the proportion of IFN responding cells to IFN
producing cells (y-axis) after infection with different viral doses (x-axis) for an infection
period of 48 h. The blue square denotes the model calibration (cf. Figure 2.11), while
the red squares represent the predictions of the model regarding low-dose infections. The
subsequent verification of the model predictions by experimental data is marked by the black
dots. The data correspond to the mean and standard deviation of triplicate measurements.
(Experiments by U. Rand, M. Ko¨ster and H. Hauser)
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Figure 2.16.: Illustrations of the predicted paracrine response communication based on our
analysis of the antiviral IFN system with respect to primary infections. (A) Co-culturing of
IFN-β-tGFP and IRF-7-mCherry reporter cells illustrates paracrine communication. IFN-
β-tGFP reporter cells (green cells) were infected with 40 HAU/ml NDV for 1 h. After
this infection period IRF-7-mCherry cells (red cells) were added at same density and cells
were subjected to time-lapse microscopy. Merged fluorescence pictures for IFN-β-tGFP and
IRF-7-mCherry at indicated time points post infection (p.i.) are shown. (B) Scheme of the
assumed protective function of IFN-producing cells. In consideration of our study of the IFN
network, we speculate that few IFN-β expressing cells (green cells) can induce an antiviral
gene program in a large number of cells (red cells) to curb viral infection. (Experiments by
U. Rand, M. Ko¨ster and H. Hauser)
ure 2.16A). Indeed, we detected that few IFN-β-tGFP expressing cells can induce
ISG expression in many IRF-7-mCherry cells. This observation corroborates the
predicted paracrine amplification of the IFN signal (Figure 2.16B).
Based on our study of the antiviral IFN system regarding primary infections we
suggest that the paracrine propagation of the IFN response transforms stochastic
single-cell behavior into efficient and predictable antiviral protection of the cell pop-
ulation. If this is the case, a few IFN-producing cells might suffice as sentinels of
viral infection to protect a large number of na¨ıve cells (Rand, Rinas et al. 2012).
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3. Population-based modeling reveals
that viral spread is mainly
controlled by the autocrine effect of
rapidly produced IFN
Driven by the question, which components of the antiviral IFN system play a de-
cisive role in limiting viral spread, we move to a system where viral spread is pos-
sible. Together with our experimental collaboration partners Bianca Schmid and
Ralf Bartenschlager from the Department of Infectious Diseases at the University
of Heidelberg, we study the dynamics of spreading Dengue virus (DENV) in an
IFN-competent cell system.
DENV elicits a strong IFN response in host cells and, at the same time, counteracts
both IFN induction and IFN response (Figure 3.1). Several studies (Aguirre et al.
2012, Yu et al. 2012) demonstrate that DENV restrains IFN expression by cleaving
the stimulator of IFN genes (STING, also known as MITA), which in turn mediates
the activation of the transcription factors IRF-3 as well as IRF-7 (cf. Figure 1.2)
(Zhong et al. 2008, Ishikawa and Barber 2008, West et al. 2011, Acosta et al. 2014).
Further findings from the literature illustrate a DENV-induced inhibition of STAT1
(Mun˜oz-Jorda´n et al. 2003, Mun˜oz-Jorda´n et al. 2005) and degradation of STAT2
(Jones et al. 2005, Ashour et al. 2009, Mazzon et al. 2009, Morrison et al. 2013) re-
sulting in an disruption of the antiviral IFN response. In addition, DENV can modify
its RNA genome by 2’-O-methylation (Egloff et al. 2002, Ray et al. 2006, Dong et al.
2014). It is reported that 2’-O methylation of the viral genome prevents the viral
recognition by the intracellular receptor melanoma differentiation-associated gene 5
(MDA5) (Zu¨st et al. 2011) and supports evasion from the antiviral response (Daffis
et al. 2010, Zu¨st et al. 2011, Szretter et al. 2012, Kimura et al. 2013).
Despite the countermeasures taken by DENV to disturb the antiviral IFN pathway,
DENV strongly induces the expression of IFN and antiviral ISGs (Kurane and Ennis
1987, Jiang et al. 2010, Schoggins et al. 2012, Pan et al. 2012). It was shown that pre-
stimulation with IFN protects cells against DENV (Diamond et al. 2000, Diamond
and Harris 2001) and some ISGs inhibit viral entry or impede the early replication
of DENV (Jiang et al. 2010, Chan et al. 2012).
Quantitative approaches to analyze this competition between DENV and the an-
tiviral IFN system have been lacking and it remains poorly understood why DENV
is at all able to spread in an IFN-competent cell systems. To investigate the direct
interactions between DENV infection and the antiviral IFN response in living cells,
our cooperation partners have generated a fully viable DENV wild-type (DENV-wt)
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Figure 3.1.: Scheme of the competition between spreading DENV and the antiviral IFN
system. After infection of a host cell, DENV can on the one hand interfere the induc-
tion of IFN by cleaving the transcription factor (TF) activator STING and, on the other
hand, suppress the IFN response through inhibition of STAT1 and degradation of STAT2
(red inhibition links). In addition, DENV modifies its RNA genome by 2’-O-methylation
(indicated by the red frame), which further negatively impacts the IFN network. Despite
these impairments of the IFN pathway, the recognition of DENV replication (↺) through
intracellular receptors strongly induces the expression of IFN and also some ISGs. Secreted
IFN activates in an autocrine manner in infected cells (left) the expression of antiviral ISGs,
which in turn inhibit the early replication of DENV. Moreover, the paracrine sensing of IFN
by na¨ıve cells (right) results in an antiviral protection against DENV infection.
reporter construct and fluorescent reporter cells to monitor viral replication, virus-
induced signal transduction and ISG expression (see section 3.1.1, Schmid 2014).
The data indicate that IFN efficiently protects na¨ıve cells against productive DENV
infection and, if given early after infection, reduces viral replication in infected cells
(see section 3.1.2). In agreement with the results regarding primary infection with
NDV (see section 2.1.2 and 2.1.3), we also detected strong cell-to-cell heterogeneity
in IFN induction as well as IFN response after DENV infection (see section 3.1.3).
Importantly, this implies that protection of na¨ıve cells by secreted IFN and viral
spread in unprotected cells occur simultaneously. To examine which antiviral fac-
tors have the greatest influence on viral spread, we compare DENV-wt with the
vaccine candidate DENV-E217A mutant, which lacks 2’-O-methylation of the vi-
ral RNA genome, induces a stronger IFN response and barely spreads (see section
3.1.4).
In consideration of the experimental findings, we establish a delay differential equa-
tion model of viral spread and IFN-induced antiviral protection in a cell population
(see section 3.2). At first, we parameterize the model from measurements concerning
DENV-wt infection (see section 3.3.1). By utilizing this DENV-wt specific parame-
ter set, we are able to identify two DENV-E217A mutant specific parameters, which
explain the attenuation of the mutant through a reduced virus production rate and
an accelerated IFN expression (see section 3.3.2). To determine the relative im-
portance of the two DENV-E217A mutant specific parameters on viral spread, we
develop an extended version of the model, which in addition to the paracrine effect
of IFN on na¨ıve cells also explicitly considers the autocrine effect of IFN on infected
cells (see section 3.4). By analyses performed with this full model and validation
experiments, we demonstrate that the attenuation of the DENV-E217A mutant is
mainly due to the effect of a rapid IFN signal to limit virus production in infected
cells during the early stages of viral replication, whereby faster paracrine protection
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of na¨ıve cells by IFN has only a weak impact on spreading DENV (see section 3.5).
Our results thus indicate that the outcome of infection is primarily determined by
the relative dynamics of DENV replication and autocrine IFN action on already
infected cells (Schmid, Rinas et al. submitted).
3.1. Studying the dynamics of IFN-induced antiviral
defense against spreading DENV in living cells
3.1.1. Detection of the immediate interactions between DENV
infection and the antiviral IFN response at single-cell level
Previous studies on DENV have described the viral replication process (Linden-
bach et al. 2006, Bartenschlager and Miller 2008, Welsch et al. 2009, Kumar et al.
2013), the propagation properties under the influence of IFN stimulation (Diamond
et al. 2000, Diamond and Harris 2001, Jones et al. 2005) and the antiviral effect of
IFN target genes against DENV (Chan et al. 2012, Schoggins et al. 2012) primarily
under steady-state conditions. However, a kinetic analysis of the direct interac-
tions between DENV infection and the antiviral IFN response in individual cells has
been missing. To address the lack of a single-cell system enabling such investiga-
tion, our experimental cooperation partners Bianca Schmid and Ralf Bartenschlager
have established both a fully viable DENV wild-type (DENV-wt) reporter and IFN-
competent fluorescent reporter cells (Schmid 2014).
For the visualization of DENV replication and spread our collaboration partners
constructed a genetically modified DENV reporter virus expressing the far red fluo-
rescent protein TurboFP635 “faR” (Figure 3.2A). This DENV-faR-wt reporter con-
struct is based on the DENV serotype 2 (isolate 16681), which is an enveloped,
positive-sense, single-stranded (ss) RNA virus (Fischl and Bartenschlager 2013).
The DENV genome encodes 3 structural proteins, the capsid protein (C), the pre-
membrane protein (prM) as well as the envelope protein (E) and 7 non-structural
(NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) (Chambers and
Rice 1987, Bartenschlager and Miller 2008, Kumar et al. 2013, Acosta et al. 2014).
While the structural proteins and the RNA genome form the infectious virus parti-
cle, the non-structural proteins are required for RNA replication, which takes place
in the cytoplasm in close association with intracellular membranes (cf. section 1.2.2)
(Welsch et al. 2009, Pen˜a and Harris 2012). During the replication process of the
DENV-faR-wt construct, the integrated faR fluorescent protein accumulates in the
nucleus as the capsid sequence contains a nuclear localization signal (NLS) (Figure
3.2B and C).
In order to study the interplay of DENV infection with the IFN system in real time
at single-cell level, the biologists generated IFN-competent fluorescent reporter cell
lines to monitor the virus-triggered signal transduction and the induction of distinct
ISGs (Figure 3.2B and C, Table 3.1). After infection, the sensing of the RNA virus
by the intracellular receptors RIG-I, the melanoma differentiation-associated gene
5 (MDA5) and the Toll-like receptor 3 (TLR3) leads to the nuclear translocation
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Reporter cell line Visualization Color
IRF-3-eGFP Activation of IRF-3 green, plotted in cyan
IFIT1-deGFP IFIT1 expression green
Mx1-deGFP Mx1 expression green, plotted in yellow
Table 3.1.: Overview of the used fluorescent reporter cell lines in chapter 3. Our cooperation
partners developed 3 fluorescent reporter cell lines to monitor at single-cell level (1) the
activation of the transcription factor IRF-3, (2) the induction of IFIT1 and (3) the expression
of Mx1.
of the transcription factors NF-κB, IRF-3 as well as IRF-7 (Bustos-Arriaga et al.
2011, Nasirudeen et al. 2011, da Conceic¸a˜o et al. 2013, Acosta et al. 2014). For
the detection of transcription factor activation, reporter cells were tagged with the
fluorescent marker IRF-3-eGFP using the enhanced green fluorescent protein (eGFP)
(cf. Figure 3.2B and C, in cyan color to clearly distinguish IRF-3-eGFP from other
GFP markers). Transcription factors located in the nucleus result in the expression
of IFN-α, IFN-β as well as IFN-λ (Wathelet et al. 1992, Pichlmair and Reis e
Sousa 2007, Thompson and Locarnini 2007, Thompson et al. 2011, Prokunina-Olsson
et al. 2013) and some ISGs including the IFN-induced protein with tetratricopeptide
repeats 1 (IFIT1, also known as ISG56) (Grandvaux et al. 2002, Diamond and
Farzan 2013, Chen et al. 2013). The recognition of extracellular IFN causes the
phosphorylation of STAT1 and STAT2, which in turn induce the expression of ISGs
such as IFIT1 as well as MX dynamin-like GTPase 1 (Mx1) (Darnell et al. 1994,
Onoguchi et al. 2007, Stark and Darnell Jr. 2012). To visualize the expression of the
subset of ISGs that are expressed together with IFN as well as in response to IFN, the
virologists transfected cells with a bacterial artificial chromosome (BAC) encoding
for a fusion protein composed of IFIT1 and a destabilized version of the enhanced
green fluorescent protein (deGFP) (cf. Figure 3.2B and C, green color). Another
BAC-based reporter construct Mx1-deGFP was created to detect the expression of
Mx1 which exclusively occurs in response to extracellular IFN (Bandyopadhyay et al.
1995) (cf. Figure 3.2B and C, in yellow color for a better comparison of Mx1-deGFP
with other GFP markers).
All reporter constructs were stably transfected into carcinomic human alveolar ep-
ithelial cells (A549), since A549 cells are permissive for DENV, able to produce IFN
and capable to induce an IFN-stimulated antiviral gene program (Schmid 2014).
While IFIT1 as well as Mx1 proteins are very stable, e.g. mouse MxA has a half-
life of ∼ 2.3 days (Ronni et al. 1993) and human IFIT1 has a half-life of > 24 h
(Andreas Pichlmair, personal communication), we observed for the deGFP reporter
cells short half-lives of ∼ 2 h for IFIT1-deGFP and ∼ 4 h for Mx1-deGFP (Schmid
2014). The reduction of the half-lives due to destabilized reporter proteins enables
a more precise characterization of the dynamics of the IFN response. Therefore,
infection of the reporter cell lines IFIT1-deGFP or Mx1-deGFP with the generated
DENV-faR-wt is an ideal model system for live-cell dual-color imaging of virus repli-
cation indicated by the red nucleus and IFIT1 or Mx1 expression appearing in the
cytoplasm of individual cells over time.
To examine how accurate the constructed DENV reporter reflects viral replica-
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Figure 3.2.: The immediate interactions between DENV infection and the antiviral IFN
response can be monitored in real time with generated fluorescent reporter constructs. (A)
Scheme of the established DENV-faR-wt reporter virus genome. The first 103 nucleotides
of the capsid coding sequence of DENV-wt contain the circularization sequence 1 (CS1),
which is essential for DENV RNA replication. The virologists duplicated the first 103 nu-
cleotides of the capsid sequence and inserted them at the 5’ end of the reporter gene. The
far red reporter is fused N-terminally with amino acid residues of the capsid protein con-
taining a NLS, and C-terminally with the sequence encoding for the 2A cleavage factor
of the Thosea asigna virus (PCS) to generate the authentic N-terminus of the capsid pro-
tein. The adjacent polyprotein can be cleaved into 3 structural proteins (capsid protein
(C), premembrane protein (prM) as well as envelope protein (E)) and 7 non-structural (NS)
proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) by viral and cellular proteases
during the viral replication process. (B, C) Scheme and fluorescence pictures of the cre-
ated intracellular reporter constructs. Infection with DENV-faR becomes visible through
the nuclear accumulation of the faR fluorescent protein in virus replicating cells (⤾, red
nucleus). Subsequent viral sensing through the receptors RIG-I, MDA5 and TLR3 causes
the translocation of the latent fusion protein IRF-3-eGFP (plotted in cyan) into the nucleus
(cyan nucleus). Activated transcription factors induce the expression of IFN and some ISGs
including IFIT1. The recognition of extracellular IFN stimulates the production of further
ISGs such as IFIT1 and Mx1. ISG expression is illustrated by the BAC constructs IFIT1-
deGFP (green cytoplasm) and Mx1-deGFP (plotted in yellow). (Experiments by B. Schmid
and R. Bartenschlager)
tion, we directly compared the faR protein marker with the well-established DENV
double-stranded (ds) RNA indicator for active virus replication in the same cell
after infection with a high dose of DENV-faR-wt (Figure 3.3). The subsequent im-
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Figure 3.3.: The generated DENV-faR-wt reporter is a reliable marker to detect DENV
replication dynamics in individual cells. (A, B) A549 cells were infected with DENV-faR-wt
at a MOI of 10 and analyzed by immunofluorescence assay using the faR fluorescent protein
or dsRNA-specific antibodies. (A) Strong correlation between faR fluorescent protein and
dsRNA in a given host cell. Selected immunofluorescence pictures of DENV-dsRNA (top left
in green color) and DENV-faR (bottom left in red color) individually or combined (right)
at 14 h post infection demonstrate correlated presence of both markers in a given host cell.
(B) Similar dynamics of faR protein and dsRNA expression. The fraction of dsRNA (gray
color) or faR protein (red color) positive cells was determined after infection via ImageJ
cell counter plugin. Shown are the mean values and standard deviations of two independent
measurements. (Experiments by B. Schmid and R. Bartenschlager)
munofluorescence analysis showed a strong correlation between the appearance of
the faR fluorescent protein and the production of dsRNA in a given host cell (cf.
Figure 3.3A). Following the heavily infected cell population over time resulted in
similar kinetics of faR protein and dsRNA expression with only a slightly delayed
detection of the faR protein marker (cf. Figure 3.3B). These data demonstrate that
the DENV reporter is a reliable marker to study the dynamics of DENV replication
at single-cell level.
Apart from verifying the reliability of the created DENV-faR-wt reporter to monitor
viral replication we also characterized the propagation properties of the DENV re-
porter construct. First we investigated whether DENV-faR-wt infected cells produce
a comparable amount of infectious virus particles as DENV-wt infected cells. The
release of infectious virus particles was quantified by performing a limiting dilution
assay to determine the tissue culture infectious dose 50 (TCID50) per milliliter (ml),
where TCID50 is the dilution which infects 50% of replicate cell cultures (Linden-
bach et al. 2005). The corresponding TCID50 titers were calculated by applying
the widely used method of Spearman and Ka¨rber (Hierholzer and Killington 1996).
The resulting extracellular virus titers over time after infection with DENV-faR-wt
were only marginally lower as compared to DENV-wt (Figure 3.4A). DENV-faR-wt
is thus well suited to analyze the release of new viral particles.
Moreover, we examined if the DENV reporter efficiently spreads in IFN-competent
human A549 cells by comparing DENV-faR-wt with DENV-faR trans-complementa-
tion particle (TCP) infection. TCPs are particles which contain no genetic informa-
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Figure 3.4.: The established DENV-faR reporter efficiently spreads in IFN-competent
cells. (A) Virus production of DENV-faR-wt complies with the viral release of DENV-wt.
A549 cells were infected with DENV-wt (black color) or DENV-faR-wt (red color) at a
MOI of 1. At the indicated time points after infection we measured the virus titers in the
supernatant by performing a limiting dilution assay to determine the tissue culture infectious
dose 50 (TCID50) per milliliter (ml). (B) DENV-faR-wt propagates successfully in an IFN-
competent cell system. A549 cells were infected with virus producing DENV-faR-wt (red
color; virus production shown in (A)) or with non-spreading DENV-faR TCP (dark red color;
cf. TCP system in (C)) at a MOI of 0.1. The fraction of faR positive cells was detected
at three time points after infection by flow cytometry. (C) Scheme of the TCP system.
(1) Infectious DENV-faR TCPs were produced by transfecting cells that stably express
the structural proteins C, prM as well as E with a subgenomic DENV-faR reporter replicon
RNA. This replicon contains the faR reporter gene and lacks C, prM and E that are provided
in trans in the engineered helper cell line. DENV-faR TCPs (dark red circles) released into
the cell culture supernatant were harvested 24 h after transfection. (2) DENV-faR TCPs
are unable to spread in cell cultures that do not express the structural proteins C, prM and
E, as DENV-faR TCPs cannot encode the required structural proteins by themselves. Thus,
infection of na¨ıve target cells with DENV-faR TCPs only leads to infection and replication,
but not to virus particle production and viral spread. (Experiments by B. Schmid and R.
Bartenschlager)
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tion to encode the structural proteins C, prM and E. While TCPs are able to enter
host cells and replicate the viral genome, they cannot spread as the missing structural
proteins are necessary to form infectious virus particles (Lai et al. 2008). To produce
infectious DENV-faR TCPs the biologists transfected a helper cell line stably ex-
pressing the structural proteins C, prM as well as E with a subgenomic DENV-faR
reporter replicon RNA that contains the faR reporter gene and lacks the structural
proteins (Figure 3.4C (1)). The subsequent infection of non-complementing target
cells with the non-spreading DENV-faR TCPs enables the investigation of a sin-
gle round of infection (Figure 3.4C (2)). The comparison of DENV-faR TCP and
DENV-faR-wt infected cells showed an almost constant fraction of DENV-faR TCP
positive cells over time, whereby the number of DENV-faR-wt positive cells grew
steadily (Figure 3.4B). These data demonstrate that the DENV-faR-wt reporter
efficiently spreads in an IFN-competent cell system.
Taken together, the established DENV-faR-wt reporter is a reliable tool to observe
the dynamics of viral replication, virus production and viral spread. Additionally,
the infection of the reporter cell lines IRF-3-eGFP, IFIT1-deGFP or Mx1-deGFP
with DENV-faR-wt allows us to investigate the immediate interactions between
DENV infection and the antiviral IFN response at single-cell level.
3.1.2. The competition between spreading DENV and IFN-induced
antiviral protection
The competition between DENV and the antiviral IFN system is characterized, on
the one hand, by the virus-induced IFN expression followed by strong antiviral IFN
response. But on the other hand, DENV is able to proliferate, to spread and to
counteract IFN production as well as IFN-induced signaling (cf. Figure 3.1). To
analyze the strength of the IFN-induced antiviral protection, we stimulated IFN-
competent human A549 cells prior, at or post DENV infection with IFN. We used a
high viral dose to ensure a large number of primary infected cells and measured the
fraction of DENV-wt positive cells 24 h post infection (Figure 3.5A and B). IFN pre-
treatment enables initiation of the antiviral IFN response in advance and resulted in
a remarkable decrease of infected cells compared to the control experiment without
IFN stimulation (cf. Figure 3.5B black horizontal line). The IFN pre-stimulation
experiments demonstrate a protective effect of IFN against DENV infection. In
comparison with no IFN treatment, IFN stimulation at or post infection still yielded
a significantly reduced number of infected cells for delays up to 6 h after infection.
As we expect that secondary infections are rare at the used viral titer, the IFN post-
treatment measurements indicate a reduction of viral replication and, consequently,
virus production in infected cells through recognition of IFN in a certain time window
post infection.
Findings from the literature describe that DENV is able to disturb IFN-induced
signaling by STAT2 degradation (Jones et al. 2005, Ashour et al. 2009, Mazzon
et al. 2009. Morrison et al. 2013). To examine this proposed countermeasure of
DENV in our system, we related the dynamics of DENV replication directly with
STAT2 expression. For this purpose, we infected human A549 cells with DENV-wt
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Figure 3.5.: IFN can protect na¨ıve cells against DENV infection and, if given early after
infection, reduces viral replication in infected cells. (A, B) IFN-competent A549 cells were
left untreated (no IFN) or treated with 100 international units per milliliter (IU/ml) IFN-
α prior (-4 h, -2 h), at (0 h) or post (2 h, 4 h, 6 h, 8 h) infection with DENV-wt at a
MOI of 10. (A) After an infection period of 24 h we performed an immunofluorescence
assay to highlight nuclear DNA by 4’,6-diamidino-2-phenylindole (DAPI) staining (upper
row, cyan color) and simultaneously visualized DENV-wt using a NS5-specific antiserum
(middle row, red color). Merged images of DAPI and DENV-wt staining are shown in the
last row. (B) Quantification of DENV-wt positive cells in (A) by analyzing 500-1000 cells
in two view fields for each column in (A). The error bar diagram illustrates the mean values
and standard deviations for treated cells, while the mean value and standard deviation for
the measurement without treatment is specified by the black line and the shaded gray area,
respectively. The dashed vertical line indicates the experiment in which cells were stimulated
and infected at the same time. Mock-treated cells served as control. (Experiments by B.
Schmid and R. Bartenschlager)
and quantified simultaneously the DENV envelope and STAT2 protein levels over
time by Western blot analysis (Figure 3.6). In agreement with other reports (Jones
et al. 2005), the Western blot analysis showed already after 6 h post infection a
rapid decrease of the ISG STAT2. From 26 h after infection onwards, STAT2 levels
increased again, which might be due to STAT2 expression in response to secreted
IFN, continued growth of some uninfected cells or limitation of viral spread by IFN-
induced protection of some remaining na¨ıve cells in the meantime. In any case, the
dynamic of STAT2 expression after infection illustrates the impairment of the IFN
response by DENV replication.
In order to obtain more insight in the properties of DENV with respect to viral
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Figure 3.6.: DENV counteracts the IFN response by STAT2 degradation. IFN-competent
A549 cells were infected with DENV-wt at a MOI of 10. At the given time points post
infection (p.i.), STAT2 (upper strip), DENV envelope (middle strip) and β-actin (last strip,
as loading control) protein levels were detected simultaneously by Western blot analyze
using the respective specific antibodies. Mock-infected cells (last two columns) serves as
reference. Numbers at the right refer to the positions of molecular weight standards in
kilodalton (kDa). A representative immunoblot out of three independent experiments is
shown. (Experiments by B. Schmid and R. Bartenschlager)
replication, virus production and immune activation, we utilized the classical method
for the determination of single-step growth curves (Ellis and Delbru¨ck 1939, Gong
et al. 1996). Therefore, we infected A549 cells with the DENV-faR reporter (cf.
Figure 3.2) at a high viral dose and measured in short time intervals viral RNA,
virus release, IFIT1 mRNA expression and IFN-λ production (Figure 3.7). The
initial high level of detected viral RNA and extracellular virus is due to added
DENV particles which stick to the cell surface and remained in spite of thoroughly
performed multiple washing steps. Disregarding the residual DENV particles bound
on the cells, the first RNA replication occurred roughly 8 h post infection (p.i.) and
increasing viral RNA levels saturated 48 h p.i. New infectious virus particles were
released approximately between 14-36 h after infection. The subsequent decrease of
extracellular virus can probably be attributed to exhausted or dying infected cells
and virus degradation in the medium. In agreement with the dynamics of viral
replication and virus production, we found an increase of IFIT1 mRNA (coding for
IFIT1) starting 12 h p.i. followed by an delayed release of IFN-λ from 18 h p.i.
onwards.
Furthermore, the data in Figure 3.7 demonstrate that DENV replication leads to
IFN production in A549 cells. To investigate the antiviral effect of secreted IFN
to induce ISG expression in our system, we treated the IFIT1-deGFP and Mx1-
deGFP reporter cells (cf. Figure 3.2) with IFN-α and measured for several ISGs the
mRNA expression levels in deGFP positive as well as negative cells (Figure 3.8A for
IFIT1-deGFP reporter cells; similar results for Mx1-deGFP reporter cells, Schmid
2014). IFN-treated and deGFP positive cells expressed a higher amount of ISG mR-
NAs than IFN-stimulated deGFP negative cells. We also monitored the induction
kinetics of the IFIT1-deGFP and Mx1-deGFP reporter cells after stimulation with
biologically equipotent concentrations (Bauhofer et al. 2012) of IFN-α or IFN-λ (Fig-
ure 3.8B for IFN-λ treatment; similar results after IFN-α stimulation, Schmid 2014).
The fraction of IFIT1-deGFP+ and Mx1-deGFP+ was almost identical over time for
both types of IFN. In addition, we studied the dose response of IFIT1-deGFP and
Mx1-deGFP reporter cells to IFN-α and IFN-λ (Figure 3.8C and D for IFN-λ; simi-
lar results for IFN-α, Schmid 2014). The mean fluorescence intensity (MFI) (Figure
3.8C) as well as the number of IFN-responding cells (Figure 3.8D) increased with
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Figure 3.7.: Temporally resolved dynamics of viral replication, virus production and im-
mune activation after DENV infection. IFN-competent A549 cells were infected with DENV-
faR-wt at a MOI of 10 and analyzed at the indicated time points post infection. Upper panel:
Viral RNA (orange color) was evaluated by quantitative real time reverse polymerase chain
reaction (qRT-PCR). In addition, we measured extracellular virus (blue color) by perform-
ing a limiting dilution assay to determine the tissue culture infectious dose 50 (TCID50)
per milliliter (ml). Lower panel: IFIT1 mRNA (light green color) was quantified using
qRT-PCR. Moreover, we detected the amount of extracellular IFN-λ (dark green color) by
enzyme-linked immunosorbent assay (ELISA). Viral RNA and IFIT1 mRNA were normal-
ized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH) mRNA (Schmid 2014). The
virus release data is a representative result out of three independent experiments. All other
values correspond to the mean and standard deviation of independent triplicate measure-
ments. (Experiments by B. Schmid and R. Bartenschlager)
higher IFN concentrations. With the exception of the MFI values after stimulation
with 104 ng/ml IFN-λ, we detected a substantial agreement of the dose-dependent
IFN response between IFIT1 and Mx1 reporter cells. These data show that the
IFIT1 and Mx1 reporter cells are comparable to each other and respond in a time
and dose-dependent way to IFN-α as well as IFN-λ with the expression of different
ISGs.
In summary, DENV efficiently spreads in IFN-competent cells, but at the same
time also elicits a strong IFN response. Our data revealed that extracellular IFN
efficiently protects na¨ıve cells against DENV infection and, if given early after in-
fection, inhibits viral replication in infected cells.
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Figure 3.8.: Comparable time and dose-dependent IFN response of IFIT1 and Mx1 reporter
cells. (A) Expression of different ISGs in IFIT1 positive cells. A549 IFIT1-deGFP reporter
cells were stimulated with 10 IU/ml IFN-α for 24 h and subsequently sorted according
to deGFP expression by flow cytometry. Immediately after sorting IFIT1-deGFP+ (green
color) and IFIT1-deGFP− (gray color) were lysed and total RNA was extracted. Amounts of
different ISG mRNAs (x-axis) were quantified using qRT-PCR and normalized to GAPDH
mRNA levels (y-axis). (B) Similar induction kinetics of IFIT1 and Mx1 reporter cells after
IFN stimulation. A549 IFIT1-deGFP and Mx1-deGFP reporter cells were stimulated with
10 ng/ml IFN-λ. At the indicated time points we detected the fraction of IFIT1-deGFP+
cells (green color) and Mx1-deGFP+ cells (yellow color) by flow cytometry. (C, D) Dose-
dependent IFN response of IFIT1 and Mx1 reporter cells. A549 IFIT1-deGFP and Mx1-
deGFP reporter cells were stimulated with various concentrations of IFN-λ (x-axis) for 24 h.
The mean fluorescence intensity (MFI) (C; dashed gray line indicates the detection limit)
and the fraction of deGFP positive cells (D) was determined for IFIT1-deGFP reporter
cells (green color) and Mx1-deGFP reporter cells (yellow color) by flow cytometry. The
dose-response data regarding IFIT1 represents the mean and standard deviation of three
independent experiments. All other values correspond to the mean and standard deviation
of two independent measurements. (Experiments by B. Schmid and R. Bartenschlager)
3.1.3. The heterogeneous IFN response in single cells fosters the
coexistence of viral spread and antiviral protection
As we are particularly interested in analyzing the immediate interactions between
DENV infection and the antiviral IFN system, we utilized the generated DENV
reporter construct together with the fluorescent reporter cells for live-cell dual-color
imaging (cf. section 3.1.1).
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Figure 3.9.: Single-cell heterogeneity of DENV replication and IFN induction. (A-C) A549
IRF-3-eGFP reporter cells were infected with DENV-faR-wt at a MOI of 150 and monitored
every hour via time-lapse microscopy. Quantification of expression onset of DENV-faR-
wt and first nuclear translocation of IRF-3-eGFP was evaluated by manually tracking of
single-cell dynamics using the MTrackJ plug-in of the ImageJ software package. Shown are
tracking data without daughter cell informations. (A) Representative fluorescence pictures
at indicated time post infection (p.i.) visualize the expression of latent transcription factor
IRF-3 (cyan cytoplasm), DENV-faR-wt replication (red nucleus) and translocated IRF-3
(cyan nucleus). (B) Quantification of the expression onset of 143 DENV-faR-wt+ cells in
the time period between [12 h p.i.; 69 h p.i.]. (C) Detection of the first nuclear translocation
of 51 IRF-3-eGFP+ cells in the time frame between [18 h p.i.; 72 h p.i.]. (Experiments by
B. Schmid and R. Bartenschlager; manual tracking by J. Fo¨rster)
First, we studied the induction of IFN after DENV infection through analyzing the
virus-induced nuclear translocation of the transcription factor IRF-3. After high-
dose infection of the IRF-3-eGFP reporter cells with DENV-faR-wt, we monitored
viral replication along with IRF-3-eGFP expression by time-lapse microscopy (Fig-
ure 3.9A, viral replication colored in red and IRF-3-eGFP expression in cyan color).
Initially, we observed the expression of the latent transcription factor IRF-3 in the
cytoplasm of the cells. After a certain delay post infection, the number of virus repli-
cating cells increased over time and nuclear translocation of IRF-3 was detectable in
some infected cells. To quantify the expression onset of the viral faR reporter gene
and the first nuclear translocation of IRF-3-eGFP, our intern Jonas Fo¨rster manually
tracked single cells by using the MTrackJ plug-in of the ImageJ software package.
The tracking data of individual cells showed a broad distribution of DENV-faR-wt
expression onset as well as highly varying initial nuclear translocation of IRF-3 (Fig-
ure 3.9B and C). The onset of viral replication started ∼ 12 h p.i., whereby IRF-3
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Figure 3.10.: Coexistence of viral spread and antiviral IFIT1 expression. (A-C) A549
IFIT1-deGFP reporter cells were infected with DENV-faR-wt at a MOI of 0.2 and mon-
itored every half hour via time-lapse microscopy. Quantification of expression onset was
evaluated by manually tracking of single-cell dynamics using the MTrackJ plug-in of the
ImageJ software package. Shown are tracking data without daughter cell informations. (A)
Representative fluorescence pictures at indicated time post infection (p.i.) demonstrate the
expression of DENV-faR-wt (red nucleus) and IFIT1-deGFP (green cytoplasm). (B) Quan-
tification of the expression onset of 91 DENV-faR-wt+ cells in the time period between[22.0 h p.i.; 68.0 h p.i.]. (C) Detection of 119 IFIT1-deGFP+ cells in the time frame be-
tween [24.5 h p.i.; 71.5 h p.i.]. (Experiments by B. Schmid and R. Bartenschlager; manual
tracking by J. Fo¨rster)
initially translocated into the nucleus ∼ 18 h after infection. While cells became
DENV-faR-wt positive between 12 h and approximately 3 days post infection , we
tracked IFN induction in 34% of the virus replicating cells. These live-cell imaging
data demonstrate a high heterogeneity of viral replication and IFN induction after
DENV infection at single-cell level.
In addition to the virus-induced transcription factor activation, we examined the
dynamics of DENV replication and spread together with the IFN response in real
time. For this purpose we performed live-cell microscopy experiments of IFIT1-
deGFP reporter cells (Figure 3.10A) or Mx1-deGFP reporter cells (Figure 3.11A)
post infection with DENV-faR-wt at a low MOI to enable viral spread through
secondary infection events. The time delay until the initial DENV-faR-wt expression
appeared was quite similar in both cell lines with 22 h p.i. for IFIT1-deGFP and
24 h p.i. for Mx1-deGFP reporter cells, respectively (cf. Figure 3.10B and Figure
3.11B). The expression onset of DENV-faR-wt was broadly distributed in both ISG
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Figure 3.11.: Coexistence of viral spread and antiviral Mx1 expression. (A-C) A549 Mx1-
deGFP reporter cells were infected with DENV-faR-wt at a MOI of 0.1 and monitored
every hour via time-lapse microscopy. Quantification of expression onset was evaluated by
manually tracking of single-cell dynamics using the MTrackJ plug-in of the ImageJ software
package. Shown are tracking data without daughter cell informations. (A) Representa-
tive fluorescence pictures at indicated time post infection (p.i.) visualize the expression of
DENV-faR-wt (red nucleus) and Mx1-deGFP (yellow cytoplasm). (B) Quantification of the
expression onset of 79 DENV-faR-wt+ cells in the time period between [24 h p.i.; 63 h p.i.].
(C) Detection of 83 Mx1-deGFP+ cells in the time frame between [31 h p.i.; 72 h p.i.]. (Ex-
periments by B. Schmid and R. Bartenschlager; manual tracking by J. Fo¨rster)
reporter cell lines. Given that the extrapolated time delay for the first appearance
of secreted infectious DENV is approximately 14 h p.i. (cf. blue curve in Figure 3.7)
and that replication is detectable ∼ 22−24 h after infection by the faR reporter, the
large number of cells becoming DENV-faR-wt positive between 1.5 and 3 days is
probably caused by viral spread and secondary infection events.
During the propagation process of DENV, many cells achieve protection against
viral infection by induction of antiviral ISGs. The first onset of ISG-reporter ex-
pression was delayed relative to the appearance of DENV-faR-wt positive cells by
2.5 h for IFIT1-deGFP and 7 h in the case of Mx1-deGFP. The short time period
between the initial DENV-faR-wt and IFIT1-deGFP expression possibly reflects the
required time to activate IFIT1 directly by IRF-3 in an IFN-independent manner
(cf. Figure 3.2B) (Grandvaux et al. 2002, Diamond and Farzan 2013, Chen et al.
2013). However, only rarely we observed IFIT1-deGFP - DENV-faR-wt double-
positive cells, arguing that in our system IFIT1 expression is induced primarily in
response to secreted IFN, rather than due to virus-induced signaling. In contrast
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Figure 3.12.: Cell-to-cell heterogeneity of the IFN response. (A) A549 IFIT1-deGFP re-
porter cells were treated with increasing amounts of IFN-α (x-axis) for 24 h. After the
stimulation period we determined the fraction of IFIT1-deGFP+ cells (y-axis) by flow cy-
tometry. (B) A549 IFIT1-deGFP reporter cells stimulated with 10 or 100 IU/ml IFN-α for
24 h from (A) were sorted in IFIT1-deGFP− and IFIT1-deGFP+ cells (x-axis). Separated
cell groups were seeded and 24 h later re-stimulated with IFN-α concentrations specified in
the legend. After a re-stimulation period of 24 h we measured the fraction of IFIT1-deGFP+
cells (y-axis) by flow cytometry. (Experiments by B. Schmid and R. Bartenschlager)
to IFIT1, the induction of Mx1 requires the activation of the JAK-STAT signaling
pathway by extracellular IFN (Bandyopadhyay et al. 1995). Indeed, the number
of Mx1-deGFP - DENV-faR-wt double-positive cells was negligible. In particular,
the fact that DENV-faR expressing cells did not induce Mx1-deGFP is consistent
with an efficient block of JAK-STAT signaling in DENV-infected cells (cf. Figure
3.6). Although DENV is able to prevent antiviral protection in infected cells and
efficiently spreads, the highly heterogeneous onset of IFIT1-deGFP and Mx1-deGFP
expression (cf. Figure 3.10C and Figure 3.11C) demonstrate that antiviral protection
of na¨ıve cells by IFN coexists with viral spread in unprotected cells.
Additionally, we checked whether the heterogeneous IFN response in single cells is
not caused by an insufficiency of cells to respond towards secreted IFN. First, we
measured the fraction of IFIT1-deGFP positive cells upon stimulation with differ-
ent concentrations of IFN-α using flow cytometry (Figure 3.12A). The determined
IFN-responding fraction increased continuously with IFN-α dose to nearly 95%. Af-
terwards, we sorted IFIT1-deGFP reporter cells treated with either 10 or 100 IU/ml
IFN-α into deGFP-expressing and non-expressing fractions. Sorted cell fractions
were seeded and re-stimulated with the same IFN-α concentrations as in the first
treatment (Figure 3.12B). Almost all cells that had responded in the first stimulation
experiment expressed IFIT1-deGFP after the second treatment. This high degree of
responsiveness is possibly a result of larger amounts of signal-transduction molecules
like STAT1/2 as well as IRF-9 and/or the further induction of these proteins during
the first IFN treatment (Maiwald et al. 2010). However, cells that did not respond
to primary IFN-α stimulation showed practically the same dose response as na¨ıve
cells during primary IFN-α treatment. These results indicate that responsiveness to
extracellular IFN is a stochastic process in individual cells, which does not depend
on the ability of cells to respond towards extracellular IFN.
Overall, the single-cell analysis demonstrates a strong cell-to-cell heterogeneity of
viral replication, IFN induction and IFN response. The similar time courses of
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IFIT1-deGFP and Mx1-deGFP induction indicate that secreted IFN is the prime
inducer of the antiviral response in our system. Cells expressing either ISG reporter
remained DENV-faR-wt negative, showing that IFN produced by DENV-infected
cells protected na¨ıve cells against virus infection. Thus, the live-cell imaging data
demonstrate that viral spread and protection of cells through IFN response occur in
parallel - and compete - after DENV infection.
3.1.4. Examination of viral fitness by comparing DENV-wt with a
DENV mutant lacking 2’-O-methyltransferase activity
Our studies of the interactions between DENV and the IFN system revealed that
efficient viral spread and IFN-induced antiviral immune defense occur simultane-
ously in an infected cell population (cf. section 3.1.2 and 3.1.3). To analyze which
antiviral factors have the greatest influence on viral fitness, we compare DENV-wt
with the DENV-E217A mutant, which is unable to modify the DENV RNA genome
by 2’-O-methylation (Egloff et al. 2002, Ray et al. 2006, Dong et al. 2014).
Virus mutants, which lack 2’-O methylation of the viral genome, induce stronger
immune responses, are severely attenuated in vivo, and thus might serve as vaccine
candidates (Li et al. 2013b, Zu¨st et al. 2013). It was suggested that 2’-O-methylation
is a mechanism to evade detection of the virus by the intracellular receptor MDA5
(Zu¨st et al. 2011), which in turn impedes the induction of IFN. Another rationale
for the attenuated DENV-E217A mutant infection comes from the observation that
IFIT1 sequesters 2’-O-unmethylated capped RNA and hence inhibits the transla-
tion of viral RNA (Pichlmair et al. 2011, Habjan et al. 2013). Given that IFIT1
can be expressed in an IFN-independent manner (Grandvaux et al. 2002, Diamond
and Farzan 2013, Chen et al. 2013) and in response to IFN (cf. Figure 3.2B), the
attenuation of the DENV-E217A mutant could result from an IFN-independent and
an IFN-dependent antiviral response.
To examine the dynamics of the DENV-E217A mutant in living cells, our cooper-
ation partners generated a replication competent DENV-faR-E217A fluorescent re-
porter (Schmid 2014). The DENV-faR-E217A mutant was created from the DENV-
faR-wt reporter construct through substituting the glutamic acid residue (E) by an
alanine residue (A) at the amino acid position 217 of the NS5 protein (Figure 3.13)
(Egloff et al. 2002, Zu¨st et al. 2013).
The infection of the IFN-competent IFIT1-deGFP and Mx1-deGFP reporter cells
with DENV-faR-wt or DENV-faR-E217A is a suitable reporter system to investi-
gate the differences between wild-type and E217A mutant infections. To directly
compare the dynamics of DENV-wt with DENV-E217A mutant, we performed in
parallel time-resolved flow cytometry measurements of the ISG reporter cells after
infection with DENV-faR-wt or DENV-faR-E217A (Figure 3.14A and B for IFIT1-
deGFP reporter cells; similar results for Mx1-deGFP reporter cells, Schmid 2014).
Both ISG reporter cell lines were infected with a low viral titer to allow viral spread
through secondary infection events. The dynamic flow-cytometric analysis for all
experimental combinations was independently repeated and yielded comparable re-
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Figure 3.13.: Scheme of the established DENV-faR-E217A mutant reporter virus. Based
on the DENV-faR-wt reporter construct (cf. Figure 3.2A) a DENV-faR-E217A mutant was
generated through substituting the glutamic acid residue (E) by an alanine residue (A) at
the amino acid position 217 of the NS5 protein (dark red color). (Graph provided by B.
Schmid)
sults (cf. data in Figure 3.21 for IFIT1-deGFP reporter cells). After infection with
DENV-faR-wt we detected the first virus replicating cells 36 h p.i. followed by a
continuous rise of DENV-faR-wt positive cells over time. Approximately 12 h after
the onset of DENV-faR-wt expression cells began to express IFIT1-deGFP and the
fraction of responding cells increased in the time frame between 48 and 84 h post
infection. In contrast to DENV-faR-wt infection, the DENV-faR-E217A infected
cells became IFIT1-deGFP positive much earlier at ∼ 24 h p.i. and the fraction of
IFIT1-deGFP expressing cells rose strongly until the end of the experiment. The ini-
tial DENV-faR-E217A positive cells were visible 36 h p.i. and only a minor increase
of DENV-faR-E217A replicating cells could be monitored within the observation pe-
riod. In agreement with the single-cell analysis by time-lapse microscopy (cf. section
3.1.3 page 67), the fraction of IFIT1-deGFP - DENV-faR double-positive cells was
very low. Altogether, the immediate comparison of DENV-wt with DENV-E217A
demonstrates that the E217A mutant induces an attenuated infection as well as an
earlier and enhanced IFN response.
In addition, we used the cell culture supernatants of the kinetic experiments to
quantify the production of IFN by enzyme-linked immunosorbent assay (ELISA).
We found that the A549 reporter cells predominantly express IFN-λ (Figure 3.15),
while the secretion of IFN-β was comparatively lower and IFN-α was not detectable
(Schmid 2014). After infection with DENV-faR-wt extracellular IFN-λ was verifi-
able together with virus replication from 36 h p.i. onwards (cf. Figure 3.14A). In
the DENV-faR-E217A infected cell culture we detected IFN-λ already at 24 h af-
ter infection, while virus replication of the DENV-faR-E217A mutant was initially
determined later at 36 h post infection (cf. Figure 3.14B). The IFN-λ production
and IFIT1-deGFP expression appeared simultaneously 24 h post DENV-faR-E217A
infection (cf. Figure 3.14B), while in the DENV-faR-wt experiment the onset of
IFIT1-deGFP expression occurred 12 hours after the initial release of IFN-λ (cf.
Figure 3.14A). As very low levels of produced IFN lie probably below the detection
limit of the ELISA, we have no experimental information about the exact onset
time of IFN production. But comparing the shape of the IFN-λ release kinetics
after DENV-faR-wt or DENV-faR-E217A infection, we assume an earlier secretion
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Figure 3.14.: In contrast to DENV-wt, the DENV-E217A mutant causes faster IFN re-
sponse and barely spreads. (A, B) A549 IFIT1-deGFP reporter cells were infected with
DENV-faR-wt (A) or DENV-faR-E217A mutant (B) at a MOI of 0.1. At the indicated time
points post infection (p.i.), cells were fixed and 100 µl of the cell suspension was subjected
to flow cytometry. The dot plots illustrate the jointly measured DENV-faR (x-axis) and
IFIT1-deGFP (y-axis) fluorescence intensities of individual cells. Shown is one of two inde-
pendent experiments after infection with DENV-wt or DENV-E217A mutant. (Experiments
by B. Schmid and R. Bartenschlager)
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Figure 3.15.: The DENV-E217A mutant induces faster IFN production compared to
DENV-wt. Cell supernatant of A549 IFIT1-deGFP reporter cells infected with DENV-
faR-wt (black color) or DENV-faR-E217A mutant (dark red color) at a MOI of 0.1 from the
respective experiment shown in Figure 3.14 were analyzed for IFN-λ expression by ELISA.
(Experiments by B. Schmid and R. Bartenschlager)
of IFN-λ through DENV-faR-E217A infected cells.
In summary, compared to DENV-wt, the vaccine candidate DENV-E217A mutant
elicits faster IFN production resulting in an earlier onset of the IFN response and
barely spreads in IFN-competent cells.
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3.2. Population-based delay differential equation model
of viral spread and IFN-induced antiviral defense
Our research on the competition between spreading DENV and IFN-induced an-
tiviral protection is driven by the question, which components of the IFN system
have the greatest influence on viral fitness. The comparison between DENV-wt
and attenuated DENV-E217A mutant infections (cf. section 3.1.4), is a perfectly
suited experimental tool to detect key factors contributing to the improved antivi-
ral defense against DENV-E217A mutant. To analyze the underlying differences
between DENV-wt and DENV-E217A mutant infections by means of mathematical
modeling, we first need to select the appropriate type of model to describe the data.
The results of our stochastic model of the IFN response against primary viral in-
fection demonstrate that the heterogeneous single-cell behavior can be translated
into predictable cell population dynamics (cf. section 2.2.3 and 2.4). Further-
more, a rapid spread of DENV and IFN over many cell diameters on the relevant
time scale of hours is proven by the high diffusion coefficients of DENV and IFN
(DDENV = 2.6 × 104µm2/h, Chang et al. 2008 and DIFN = 1.1 × 105µm2/h, Hu et al.
2011), and spatial gradients are therefore negligible. For these reasons, we decide
to use a population-based modeling approach with uniform distribution of secreted
IFN and viral spread. The time-resolved data after DENV-wt or DENV-E217A
mutant infection (cf. Figure 3.14 and 3.15) suggest that the timing of viral spread as
well as IFN release play an important role in the competition between virus and the
IFN system. Accordingly, we establish a delay differential equation (DDE) model of
viral spread and IFN-induced antiviral defense in a cell population.
In population dynamics, DDE models might be classified between ordinary differ-
ential equation (ODE) models and so called structured population models given
by first-order hyperbolic partial differential equations (PDEs) (Baker et al. 1999,
Bocharov and Rihan 2000). The latter class of models describes the dynamics of
age-structured or, more widely, state-structured populations (Charlesworth 1980,
Metz and Diekmann 1986, Barbarossa 2013) where the population is characterized
by a distribution depending on both time and a property of the individuals like
age, mass or any other feature (cf. Bocharov and Hadeler 2000, Getto et al. 2008,
Gwiazda et al. 2014, for instance). While state-structured population models deal
with at least two independent dynamic variables, DDE models only consider tem-
poral dynamics (cf. Bazhan and Belova 1999, Lee et al. 2009, Pawelek et al. 2012,
Tan et al. 2012, for example).
In general, DDEs are defined by equations of the form
y˙ = f(t, y(t),W(ω1(t), y(t)),W(ω2(t), y(t)), . . . ,W(ωn(t), y(t))), (3.1)
with t ∈ R, n ∈N, weighting functions ωi(t) for i = 1, . . . , n and
W(ωi(t), y(t)) = t∫−∞ ωi(t − s)y(s)ds. (3.2)
A DDE with discrete delays arises if the weighting factors ωi(t) correspond to delta
distributions, also called delta functions, δ(z) with z = t − τi (Murray 2002).
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One possible definition of the delta distribution δ(z) is given by
δ(z) = ⎧⎪⎪⎪⎪⎨⎪⎪⎪⎪⎩
0 , for z ≠ 0;
z+∫
z− δ(s)ds = 1 , ∀  > 0 (3.3)
and results in the following characteristic property:
∞∫−∞ δ(s − z)f(s)ds = f(z), (3.4)
for a continuous function f on R. By applying the property (3.4) as well as setting
ωi(t) = δ(t − τi), equation (3.2) changes to
W(δ(t − τi), y(t)) = t∫−∞ δ(t − τi − s)y(s)ds = y(t − τi). (3.5)
A discrete DDE is defined by the combination of the equation (3.1) and (3.5). If τi
in (3.5) is constant, time-dependent or depending on y(t), then the discrete DDE
describes a differential equation with constant delay, time-dependent delay or state-
dependent delay, respectively (Barbarossa 2013).
Using mathematical modeling, we would like to analyze the timing of virus replica-
tion, virus production and IFN secretion. The measured single-step growth curve of
these processes after high dose infection with DENV-faR-wt (cf. Figure 3.7) corre-
sponds, from a mathematical point of view, to the integral of the probability density
function of the onset time of these events in single cells. As an approximation of
these onset time distributions, we decided to create a DDE model with constant
time delays for virus replication, virus production and IFN secretion. To consider a
differential equation system with constant delays is a good compromise of tractabil-
ity and detail. In section 3.3 we will show that this model can be parameterized
by experimental data and therefore provides a starting point for a full mechanistic
understanding of viral propagation and IFN-induced antiviral defense.
In our DDE model with constant delays (Figure 3.16 and DDE system (3.11)) we
consider at the initial time t0 a number of na¨ıve cells S0 which are susceptible to
virus infection, as well as an initial extracellular viral load V0. Susceptible cells S
can become infected by extracellular virus V with infection rate rV (cf. blue arrow
in Figure 3.16). Depending on the time elapsed since viruses have entered the host
cells, infected cells I can acquire up to three different features in parallel:
– After a time delay τR > 0, infected but not yet virus replicating cells IR turn
into virus replicating cells IR. The time delay of virus replication τR is related
to the mean expression onset of virus replication in individual cells monitored
after infection with DENV-faR-wt (cf. Figure 3.9 - 3.11 and 3.14A) or DENV-
faR-E217A mutant (cf. Figure 3.14B).
– After a time delay τV > 0, infected but not yet virus releasing cells IV become
virus producing cells IV and release new generated infectious virus particles
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Figure 3.16.: Scheme of the mathematical model which describes how na¨ıve and thus sus-
ceptible cells can become either infected by extracellular virus or protected by the antiviral
effect of secreted IFN. Susceptible cells (gray oval) can become infected by extracellular
virus with the infection rate rV (blue arrow). Virus replication (⤿) arises in infected cells
(black oval) at time τR after viral entry (red color) and results in virus production with
the virus production rate vV from time τV > τR onwards. Moreover, infected cells start to
express IFN with the secretion rate vF at time τF after viral infestation. Recognition of
secreted IFN turn susceptible cells into protected cells (yellow oval) with the protection rate
rF (solid green arrow). In addition, IFN can indirectly induce antiviral genes in infected
cells (dashed green inhibition link). Extracellular virus and IFN are removed (∅) by cellular
uptake as well as extracellular degradation with the rate constant of virus degradation dV
and the rate constant of IFN degradation dF. While propagation is inhibited in infected
cells, susceptible and protected cells proliferate (↺) with the rates pS and pP, respectively.
with the virus production rate vV. The time delay of virus production τV repre-
sents the average time required to replicate, translate viral proteins, assemble
and release new virus particles (cf. blue curve in Figure 3.7).
– After a time delay τF > 0, infected but not yet IFN expressing cells IF turn
into IFN secreting cells IF and produce IFN F with the IFN secretion rate
vF. The time delay of IFN secretion τF corresponds to the mean onset of IFN
expression. It includes the necessary time of viral recognition, downstream
signal transduction as well as IFN transcription, translation and secretion (cf.
dark green curve in Figure 3.7 and Figure 3.15).
Since the time delay τV also comprises the duration of virus replication, the condition
τV > τR must be fulfilled, while we do not require any temporal link between τF and
both other time delays. Whether the production of new virus particles takes longer
than IFN secretion or vice versa will be determined by the parameter estimation in
section 3.3.
According to the experimental study, IFN has two antiviral effects (cf. Figure 3.5):
– Pre-stimulation with IFN demonstrated that extracellular IFN can protect
na¨ıve cells against productive DENV infection. To incorporate this paracrine
IFN response in our model, we take into account an IFN-induced switch from
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susceptible cells to protected cells P with the protection rate rF (solid green
arrow in Figure 3.16).
– Stimulation of infected cells with IFN in an early phase after viral entry can
activate antiviral defense mechanisms, which reduce virus replication and con-
sequently virus production. To keep the model initially simple, so that its
parameters can be identified from experimental data, we neglect a direct au-
tocrine impact of IFN in the first instance (dashed green inhibition link in
Figure 3.16). After the model parameterization (cf. section 3.3), we will ex-
amine the effect of secreted IFN on infected cells explicitly with an extended
version of the model (cf. section 3.4 and 3.5).
In order to include the removal of extracellular virus and IFN by cellular uptake
and, to a lesser extent, by extracellular degradation, we assume a decrease of virus
and IFN with the rate constant of virus degradation dV and the rate constant of
IFN degradation dF, respectively.
Furthermore, we observed that infected cells proliferate less and die faster than
non-infected cells. To compensate this propagation difference and, additionally, to
keep the number of model parameters low, we suppose an inhibited proliferation in
infected cells, whereby susceptible and protected cells proliferate with the rates pS
and pP, respectively.
To establish the DDE system of our model, particular attention must be paid to the
formulation of the three features of the infected cells comprising virus replication,
virus production and IFN expression, which begin at time τR, τV and τF, respectively.
As the time delays τm for m ∈ {R, V, F} are free parameters and only bound to the
condition τV > τR, the properties of the infected cells can arise at different times,
overlap each other and take place in parallel. Therefore we consider each feature of
the infected cells separately and calculate the number of inactive infected cells Im(t)
and active infected cells Im(t) for m ∈ {R, V, F} depending on time t ∈ R. For this
purpose we first require the total number of infected cells I at time t
I(t) = Im(t) + Im(t) ∀m ∈ {R, V, F} (3.6)
and the corresponding differential equation
I˙(t) page 74=
Fig. 3.16
rVV (t)S(t). (3.7)
The number of inactive infected cells Im at time t consists of all cells which become
infected in the time period [t − τm, t], since after τm inactive cells Im progress to
active cells Im. Thus, Im is given by
Im(t) (3.7)= t∫
t−τm rVV (s)S(s)ds. (3.8)
To obtain the differential equation I˙m, we differentiate both sides of (3.8) with
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respect to time t and apply the fundamental theorem of calculus:
I˙m(t) = d
dt
t∫
t−τm rVV (s)S(s)ds= rVV (t)S(t) − rVV (t − τm)S(t − τm). (3.9)
Using the preceding equations, the differential equation I˙m results from
I˙m(t) (3.6)= d
dt
(I(t) − Im(t))= I˙(t) − I˙m(t)(3.7, 3.9)= rVV (t − τm)S(t − τm). (3.10)
Taking all considerations together, our model is described by the following DDE
system:
S˙(t) = −rVV (t)S(t) − rFF (t)S(t) + pSS(t)
I˙R(t) = rVV (t)S(t) − rVV (t − τR)S(t − τR)
I˙R(t) = rVV (t − τR)S(t − τR)
I˙V(t) = rVV (t)S(t) − rVV (t − τV)S(t − τV)
I˙V(t) = rVV (t − τV)S(t − τV)
I˙F(t) = rVV (t)S(t) − rVV (t − τF)S(t − τF)
I˙F(t) = rVV (t − τF)S(t − τF)
P˙ (t) = rFF (t)S(t) + pPP (t)
F˙ (t) = vFIF(t) − dFF (t)
V˙ (t) = vVIV(t) − dVV (t).
(3.11)
The initial value problem corresponding to our model is defined by the DDE system
(3.11) for time t ∈ [t0, tend] together with initial conditions, which we specify next.
As we will use our model to simulate experiments in which na¨ıve cells have been
infected with a viral load V0 at the starting time t0 = 0, only two initial values of our
DDE system are unequal to zero, namely the number of susceptible cells S(0) = S0
as well as the extracellular viral load V (0) = V0.
In addition, we need to provide a history function for each variable in (3.11) that has
a delay argument and therefore refers to the past [t0−τm, t0] for m ∈ {R, V, F}. For
DDE models with multiple discrete delays, the history functions have to be defined
on the time interval [t0−τmax, t0], where τmax represents the maximum of the positive
time delays (Bellen and Zennaro 2003). Since in the experimental setup the initial
infection took place at time t0 = 0, we must set V (t) = 0 for t < 0. This implies,
however, that the choice of the history function for the number of susceptible cells
S is irrelevant for the solution of the DDE system (3.11), since the delayed variable
S(t− τm) with τm > 0 is always multiplied by V (t− τm) and V (t− τm) = 0 for t < τm.
For simplicity, we take S(t) = 0 for t < 0.
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To reflect the experimental situation, we cannot avoid that the initial condition of
the DDE system (3.11) with respect to the extracellular viral load V is discontinuous
due to
lim
t→0,t<0V (t) = 0 ≠ V0 = limt→0,t>0V (t). (3.12)
Such a discontinuity in the initial time t0 propagates along the integration interval
and causes subsequent discontinuity points in the first and higher order time deriva-
tives, whereby, however, the solution of the DDE system becomes smoother with
increasing integration time (Bellen and Zennaro 2003).
Bellen and Zennaro analyzed the propagation of initial discontinuities in a general
ny-dimensional DDE system with nτ constant time delays τi, i = 1, . . . , nτ , defined
by
y˙(t) = f(t, y(t), y(t − τ1), y(t − τ2), . . . , y(t − τnτ )), t0 ≤ t ≤ tend,
y(t0) = y0,
y(t) = h(t), t0 − τmax ≤ t ≤ t0, (3.13)
with the state variable y(t) ∈ Rny , the right-hand-side function f ∈ Rny , the initial
state y0 ∈ Rny , the history function h(t) ∈ Rny and positive time delays τi > 0 under
the conditions that
(C1) f is continuous with respect to t,
(C2) f is Lipschitz continuous with respect to y(t) and with respect to y(t−τi) and
(C3) h(t) is Lipschitz continuous.
Our 10-dimensional DDE model (3.11) with three strictly positive constant time
delays belongs to the class of DDE systems given by the initial value problem (3.13)
and fulfills the conditions (C1)–(C3): (C1) The right-hand-side function of (3.11)
does not depend on the variable t explicitly and thus continuity with respect to t
is trivial. (C2) The required Lipschitz continuity of the right-hand-side function f
follows from the continuous differentiability of the right-hand-side function of (3.11)
with respect to y(t) and with respect to y(t−τi) on an appropriately chosen compact
subset of R ×Rny × (Rny)nτ . (C3) The Lipschitz continuity of the history function
is ensured as we consider the constant zero function as history functions for those
variables in our system (3.11) that have a delay argument.
Under these conditions, Bellen and Zennaro demonstrated that in the general DDE
system (3.13) a discontinuity in the initial time t0 causes the discontinuity points
ξi,j = t0 + j τi ∀j ∈N and i = 1, . . . , nτ . (3.14)
For our DDE system (3.11), this means that the discontinuities in the initial time
t0 = 0 leads to a continuous solution for t > 0, but with discontinuities in (higher
order) derivatives at the time points t = j τm ∀j ∈N and m ∈ {R, V, F}.
In spite of the occurrence of discontinuous derivatives, the existence of a unique
solution of the DDE system (3.13), and in particular of our DDE system (3.11), can
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be proven with the method of steps (Bellen and Zennaro 2003, Smith 2011, Lenz
et al. 2014, Lenz 2014). This method is based on the principle of partitioning the
integration interval [t0, tend] into subintervals ranging from one discontinuity point
to the next. In each subinterval, the DDE system reduces to an ODE system by
substituting the delayed terms by known quantities: the history function or the
solution at earlier times, respectively. Since this ODE system fulfills the conditions
(C1)–(C3) (cf. page 78), the Theorem of Picard and Lindelo¨f (e.g. Hartman 2002)
can be applied, which provides existence and uniqueness of the solution on the
subintervals. Thus, by successive integration on the subintervals, a unique solution
of the DDE system (3.13) is obtained on the finite time interval [t0, tend].
As our DDE model (3.11) considers the kinetics of an infected cell population along
with the dynamics of extracellular virus and IFN, we must ensure that the solution
of our DDE system stays non-negative for positive initial data. For this purpose, we
apply a positivity theorem given in the book by Smith (Smith 2011). Smith gives
this result for the case of one constant delay using method of steps and employing a
theorem about non-negative solutions of ODE initial value problems. This positivity
theorem can be extended straightforwardly to DDE systems with multiple constant
delays:
The solution y(t) of a DDE system (3.13) with positive constant time delays τi > 0,
i = 1, . . . , nτ and a right-hand-side function f ∶ R ×Rny≥0 × (Rny≥0)nτ Ð→ Rny satisfies
y(t) ≥ 0∀t ∈ [t0, tend], if the following conditions hold:
(P1) f is continuous,
(P2) f is continuously differentiable with respect to y(t),
(P3) h(t) is continuous,
(P4) h(t) ≥ 0 and
(P5) ∀k = 1, . . . , ny,∀t,∀y(t) ∈ Rny≥0 ,∀y(t − τi) ∈ Rny≥0 for i = 1, . . . , nτ ∶
yk(t) = 0 ⇒ fk(t, y(t), y(t − τ1), y(t − τ2), . . . , y(t − τnτ )) ≥ 0.
In the case of our DDE system (3.11), the requirements (P1) and (P2) are met
as the right-hand-side function does not depend on the variable t explicitly and
is continuously differentiable with respect to y(t) and with respect to y(t − τi).
Since we use the constant zero history function for S and V , the conditions (P3)
and (P4) are also fulfilled. To verify (P5), we will first take a closer look at each
equation of a subsystem of the DDE model (3.11) concerning the state variable
y˜ = (S, IR, IV, IF, P,F, V ). The reduced system obtained by restricting (3.11) to the
state variable y˜ is still a closed DDE system, since it is independent of the neglected
variables Im describing the number of inactive infected cells. Examining it, we verify
that for t ∈ [t0, tend], y˜(t) ∈ R7≥0, y˜(t− τm) ∈ R7≥0∀m ∈ {R, V, F} and strictly positive
constant rates it holds:
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If S(t) = 0 ⇒ S˙(t) = 0.
If Im(t) = 0 ⇒ I˙m(t) = rVV (t − τm)S(t − τm) ≥ 0.
If P (t) = 0 ⇒ P˙ (t) = rFF (t)S(t) ≥ 0.
If F (t) = 0 ⇒ F˙ (t) = vFIF(t) ≥ 0.
If V (t) = 0 ⇒ V˙ (t) = vVIV(t) ≥ 0.
Therefore, the subsystem with the state variable y˜ satisfies the conditions (P1)–
(P5) of the positivity theorem and has a unique non-negative solution. In particu-
lar, we obtain a non-negative solution for the number of susceptible cells S(t) ≥ 0
and the extracellular viral load V (t) ≥ 0∀t ∈ [t0, tend] as required for a mean-
ingful solution to the biological problem. By utilizing these non-negative solu-
tions we can verify that the original DDE system (3.11) with the state variable
y = (S, IR, IR, IV, IV, IF, IF, P,F, V ) ∈ R10 fulfills the requirement (P5). For this
purpose, it remains to show that Im for m ∈ {R, V, F} satisfies (P5). Accord-
ing to equation (3.8), Im for m ∈ {R, V, F} are integrals over the function I˙(t) =
rVV (t)S(t) ≥ 0∀t ∈ [t0, tend] as shown above, and are therefore uniquely defined,
continuous and non-negative.
Taken together, the initial value problem of our DDE model (3.11) has a unique
positive solution on any finite time interval.
For the simulation of the DDE system (3.11) we utilize Matlab as a programming
environment. Using a binary Matlab executable (mex) subroutine, we set up an
interface between Matlab and the freely available RADAR5 solver written in ANSI
Fortran-90 (Guglielmi and Hairer 2005). The RADAR5 framework comprises an
algorithm to calculate numerically the solution of stiff delay differential equations
based on an adapted 3-stage Radau IIA collocation method (Hairer and Wanner
1999, Guglielmi and Hairer 2001, Guglielmi and Hairer 2008). This algorithm cor-
responds to a certain implicit Runge-Kutta method of order 5 in which the Runge-
Kutta equations are solved by means of a suitable Newton process (Guglielmi 2005).
The Newton iterations require two Jacobian matrices, on the one hand, the standard
Jacobian matrix J and, on the other hand, the Jacobian matrix with respect to the
delayed variables Jτ . These Jacobian matrices are either computed internally or can
be provided by the user. In order to increase the accuracy of the numerical solution,
we implement the time dependent Jacobian matrices J (t) and Jτ(t) of our DDE
system (3.11) within the RADAR5 code. An explicit presentation of both Jacobian
matrices is given in appendix A.1.
In addition to the RADAR5 solver we also tested Matlab’s dde23 solver for delay dif-
ferential equations with constant delays (Shampine and Thompson 2001, Shampine
and Thompson 2009). Although the implementation in Matlab is more conve-
nient and modifications of the model can be achieved with less effort than within
the RADAR5 framework, the significantly faster calculation in Fortran makes the
RADAR5 solver more suitable for the purpose of parameter estimation, which will
be detailed next.
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3.3. Parameterization of the delay differential equation
model
As we are primarily interested in examining the underlying mechanisms of the dif-
ferences between DENV-wt and attenuated DENV-E217A mutant infections (cf.
section 3.1.4), we first parameterize our model (3.11) using DENV-wt infection mea-
surements exclusively (see section 3.3.1). Based on this DENV-wt specific parameter
set, we fit the DENV-E217A mutant related data by allowing only four reasonable
key parameters to be different (see section 3.3.2).
This approach will enable us to discover two parameters which differ strongly be-
tween DENV-wt and DENV-mutant infections: The virus production rate is ∼ 8-fold
lower and the delay of IFN secretion is ∼ 24 h shorter after DENV-E217A mutant
infection compared to DENV-wt. Importantly, IFN release sets in prior to virus
production after DENV-E217A mutant infection, whereby the timing of these two
events are almost identical in the case of DENV-wt.
3.3.1. Estimation of model parameters by using DENV-wt
measurements
In order to analyze the mechanistic differences between DENV-wt and attenuated
DENV-E217A mutant infections, we first parameterize our model (3.11) by consider-
ing only DENV-wt infection data and, subsequently, utilize these estimates to deter-
mine DENV-E217A mutant specific parameter changes. For parameter estimation
we focus on the well-suited time-resolved flow cytometry data set along with ELISA
quantification of IFN-λ after infection of the ISG reporter cells with DENV-faR-wt
or DENV-faR-E217A (cf. Figure 3.14 and 3.15). This data set was obtained by
measuring a specified proportion of the cell suspensions and thus provides quantita-
tive as well as directly comparable differences between DENV-wt and DENV-E217A
mutant infections in terms of absolute cell numbers in a certain volume.
At the beginning of the experiments, the ISG reporter cells were infected at a MOI
of 0.1. Based on the definition of MOI given by
MOI = V0
S0
, (3.15)
and the initial number of na¨ıve cells S0 ∼ 15000 in the relevant experiments, we set
the initial extracellular viral load V0
(3.15)= 0.1×15000 = 1500 arbitrary units/ml. This
specification implies that the viral load related infection rate rV can be determined
up to a scaling factor.
In addition, we take advantage of an independent virus stability experiment to obtain
an estimate of the virus degradation rate constant dV (Figure 3.17). The DENV-
faR-wt stability analysis was performed by incubating IFN-incompetent baby ham-
ster kidney cells (BHK-21) with a high number of DENV-faR-wt particles i.e., the
BHK-21 cells were infecting and the cell culture medium was not changed. The
extracellular amount of virus was identified by TCID50 assay over time. Since the
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Figure 3.17.: Estimation of the rate constant of virus degradation dV. The parameter
determination of the rate constant of virus degradation dV is based on a virus stability ex-
periment, in which na¨ıve BHK-21 cells were incubated with 1.6×106 DENV-faR-wt particles
and virus titers (black dots) were quantified by TCID50 assay at the indicated time points
post infection (p.i.). The data are fitted with an exponential decay equation (blue curve) by
applying a trust-region-reflective least-squares algorithm with 104 different random initial
values. The best fit results in dV = 0.4/h together with an initial virus concentration of
1.6 × 106 TCID50/ml. (Experiments by B. Schmid and R. Bartenschlager)
production of new infectious virus particles in host cells takes approximately 14 h
(cf. blue curve in Figure 3.7), the measured extracellular amount of virus decreased
continuously between 0 and 12 h after incubation. According to the shape of the
observed virus kinetic, we suppose an exponential decay of extracellular virus V and
consider as objective function
V(t) = V0 e−dVt (3.16)
for t ∈ R with the initial condition V(0) = V0. To fit the parameters of the objective
function (3.16) to the virus stability data, we utilize the trust-region-reflective least-
squares algorithm of Matlab’s optimization toolbox (Coleman and Zhang 2003) and
choose for the corresponding chi-squares statistic (2.35) a constant error. After
applying the optimization method with 104 different random initial values, the best
fit yields dV = 0.4/h and provides a satisfying match with the data (cf. Figure 3.17,
blue curve).
Moreover, we found that fitting of the IFN secretion rate vF and the rate constant of
IFN degradation dF at once would lead to a correlation of both parameters. Thus,
we set dF = 0.15/h to the previously determined rate constant of IFN degradation
of the stochastic model (cf. Table 2.2 in section 2.2.3).
To determine the remaining model parameters, we use the time-resolved data set
consisting of two independent flow cytometry measurements along with ELISA quan-
tifications (cf. Figure 3.14 and 3.15) by comparing the following observed kinetics
with the related model readouts (ROs) (Figure 3.18):
(RO1) The total number of cells A serves as a control and is described in our model
by
A(t) = S(t) + Im(t) + Im(t) + P (t), (3.17)
at time t ∈ R and m ∈ {R, V, F}.
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(RO2) The number of experimentally identified IFIT1-deGFP – DENV-faR double-
negative cells are represented by S̃(t) defined as
S̃(t) = S(t) + IR(t). (3.18)
S̃(t) comprises both susceptible cells S and already infected but not yet virus
replicating cells IR, which implies that the DENV-faR fluorescent protein is
not yet visible in the host cell.
(RO3) The observed DENV-faR positive cells corresponds to the calculated number
of virus replicating cells IR(t).
(RO4) The detected ISG expressing IFIT1-deGFP+ – DENV-faR− cells are modeled
by the protected cells P (t).
(RO5) Since IFN-λ is the most prominent type of IFN in our cell system (Schmid
2014), we equate the measured level of secreted IFN-λ with the simulated
amount of released IFN F (t).
To exploit both independently performed experiments, the model dynamics listed
in (RO2)–(RO5) are simultaneously fitted to the related time course data of exper-
iments 1 and 2 by allowing only the initial number of susceptible cells S0 to vary
between experiments, while all other parameters are identical.
As optimization method we use the trust-region-reflective least-squares algorithm
of Matlab’s optimization toolbox (Coleman and Zhang 2003) by calling the Fortran
program of our DDE system with a binary mex subroutine. Since we compare several
components of the model with their respective data, the chi-squares statistic χ2 of
the model parameters θk, k = 1, . . . ,Np, is given by
χ2(θ1, ..., θNp) = Nc∑
j=1
Nt∑
i=1 (dj(ti) − yj(ti ∣ θ1, . . . , θNp)σj(ti) )
2
, (3.19)
where Np stands for the number of model parameters and Nc denotes the num-
ber of model components yj(ti ∣ θ1, . . . , θNp) that describe the associated data set(ti, dj(ti)) with the measurement error σj(ti) for i = 1, . . . ,Nt and j = 1, . . . ,Nc at
Nt observation times. To account for the fact that the data used for fitting were
obtained via different measurement techniques and comprise small as well as large
values, we assume for the measurement errors a 10% deviation band relative to the
measured kinetic data: σj(ti) = 0.1 dj(ti). To find a reliable best fit parameter set
of our optimization problem
min{θk ∣k=1,...,Np} (χ2(θ1, . . . , θNp)), (3.20)
the least-squares minimization has to be repeated for a large number of different
random initial values. Although it turns out that the simulation of the DDE model
(3.11) using the RADAR5 solver written in Fortran is considerably less time con-
suming as our stochastic model based on Gillespie’s algorithm (cf. 2.2 - 2.3), the
integration of the DDE system (3.11) is still slower than solving comparably large
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Figure 3.18.: Best fit of the mathematical model to two independent experiments concern-
ing DENV-faR-wt infection. For parameter estimation we compare simulated (solid lines)
with observed (circles) cell dynamics of (1) all (as control), (2) susceptible IFIT1-deGFP –
DENV-faR-wt double-negative, (3) virus replicating DENV-faR-wt positive as well as (4)
protected IFIT1-deGFP+ – DENV-faR-wt− cells along with (5) IFN-λ release after infection
of A549 IFIT1-deGFP reporter cells with DENV-faR-wt at a MOI of 0.1. The data set is
based on two independent flow cytometry measurements (cf. Figure 3.14A), while IFN-λ
was quantified in experiment 2 by ELISA (cf. Figure 3.15, colored in black). Absolute cell
numbers can be considered as a volume (vol.) of 100 µl was consistently analyzed. We fit
the model simultaneously to both experiments by only allowing the initial number of sus-
ceptible cells to be specific to each measurement, whereby all other parameters are the same
for both experiments. The best fit is obtained by using a trust-region-reflective least-squares
algorithm with at least 104 different random initial values. (Experiments by B. Schmid and
R. Bartenschlager)
ODE systems. To speed up calculation, we utilize Matlab’s parallel computing tool-
box to run several optimization processes simultaneously on a computer cluster.
Since this cluster can execute 240 individual sessions in parallel, we are able to
repeat the optimization procedure for more than 104 different random initial val-
ues. The resulting best fit correctly reproduces the observed kinetic data of both
experiments (Figure 3.18).
In order to assess the uncertainties of the best fit parameter values, we calculate
likelihood-based confidence intervals for the estimated parameters by applying the
profile likelihood method (Venzon and Moolgavkar 1988). Likelihood-based confi-
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dence regions dependent on a threshold in the likelihoods Qχ2(1 − α,DF), which
represents the (1 − α) quantile of the χ2-distribution with DF degrees of freedom.
As we aim to compute the confidence bound of each individual parameter, the degree
of freedom in this case is equal to 1. The (1−α) confidence interval (CI) of a single
parameter θl, l ∈ {1, . . . ,Np}, encloses a set of parameter values ν and is defined as
CI θl(1−α) = {ν ∣ ∆χ2θl(ν) ≤ Qχ2(1 − α,1)}, (3.21)
with
∆χ2θl(ν) = min{θk ∣k=1,...,Np;k≠l} (χ2(θ1, . . . , θl−1, ν, θl+1, . . . , θNp))− min{θk ∣k=1,...,Np} (χ2(θ1, . . . , θNp)) . (3.22)
To compute
min(χ2θlfix) ∶= min{θk ∣k=1,...,Np;k≠l} (χ2(θ1, . . . , θl−1, ν, θl+1, . . . , θNp)) (3.23)
from equation (3.22), we fix the parameter θl, l ∈ {1, . . . ,Np} systematically to dif-
ferent values ν around the estimated optimum and solve the minimization problem
with respect of the remaining parameters {θk ∣ k = 1, . . . ,Np;k ≠ l}. Afterwards, the
term ∆χ2θl(ν) (cf. (3.22)) is obtained by subtracting the fitted χ2-value minimized
over all parameters (3.20) from the calculated min(χ2θlfix)-value. The most com-
mon confidence regions CI95% and CI68% follow from equation (3.21) by taking into
account the corresponding quantiles of the χ2-distribution Qχ2(95%,1) = 3.8 and
Qχ2(68%,1) = 1, respectively. By plotting ∆χ2θl(ν) and detecting those values ν for
which ∆χ2θl remain below the respective quantile-based thresholds, the confidence
intervals can be determined directly from the graph of the profile likelihood.
The application of the profile likelihood method for our model regarding the param-
eters that were estimated based on the kinetic DENV-wt data set shown in Figure
3.18, reveals that all these parameters are identifiable within narrow confidence
bounds (Figure 3.19 and Table 3.2). Since the model is constrained by experimen-
tal DENV-wt data, we can utilize it to make quantitative predictions about the
competition between spreading DENV and IFN-induced antiviral protection.
To validate the parameterization, we examine whether key parameter values are
consistent with the results of independent measurements. Since we suspect that
timing is an important factor in the antiviral immune defense, our focus lies on the
estimates of the three time delays.
The determined delay of virus replication τR of 24 h (cf. Figure 3.19, first pro-
file likelihood in the upper row and Table 3.2) is mainly influenced by fitting the
virus replicating cells IR(t) to the DENV-faR-wt positive IFIT1 reporter cells af-
ter low dose infection (cf. (RO3) on page 83 and Figure 3.18(3)). Thus, τR should
comply with the mean expression onset of virus replication in individual IFIT1-
deGFP reporter cells after infection with DENV-faR-wt at a low MOI, which was
independently monitored by live-cell imaging (cf. Figure 3.10B). In this time-lapse
microscopy experiment DENV-faR-wt+ reporter cells became visible in the time
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Figure 3.19.: Profile likelihoods demonstrate that the model parameters are identified by
DENV-wt data. The profile likelihood method is applied to determine the 95% confidence
interval (CI) of all model parameters, which are estimated using the kinetic DENV-wt data
set shown in Figure 3.18 (cf. Table 3.2). The plots illustrate the change of the χ2-function
(∆χ2, y-axis) of the indicated parameter (x-axis) calculated according to equation (3.22).
Abbreviations: arbitrary units (a.u.), experiment (exp.), hours (h), milliliter (ml), picogram
(pg), volume (vol.; 100 µl).
period between [22.0 h p.i.; 68.0 h p.i.] with a mean onset of 32.2 h post infection.
Hence, the time delay τR corresponds to the initial rather than the average onset of
virus replication in real time at single-cell level.
For testing the estimated delay of virus production τV = 31.4 h (cf. Figure 3.19,
second profile likelihood in the upper row and Table 3.2), we relate this time delay
to the halftime of DENV particle release after high dose infection quantified at high
temporal resolution by TCID50 assay (cf. blue curve in Figure 3.7). A direct compar-
ison demonstrates that the predicted time delay τV accurately reflects the measured
halftime of ∼ 32 h (Figure 3.20A). Moreover, the single-step growth curves in the
upper panel of Figure 3.7 enable us to extrapolate the first appearance of replicated
viral RNA and released DENV in a heavily infected cell population. Although these
approximated values of ∼ 8 h and ∼ 14 h for the onset of virus replication and DENV
production, respectively, are much shorter than the respective model estimates, the
time difference of ∼ 6 h between the two events agrees with the predicted lag of
τV − τR = 31.4 − 24 = 7.4 h. The consistency between the predicted and detected
mean latency of virus production post infection as well as after onset of virus repli-
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Model parameter Value [95% CI]
Virus dynamics
Initial viral load V0 1500 a.u./ml
Delay of virus replication τR 24.0[23.9;24.1] h
Delay of virus production τV 31.4[30.6;32.2] h
Virus production rate vV 0.54[0.45;0.67] a.u./h/cell
Infection rate rV 1.7×10−5[1.5×10−5;2.0×10−5] ml/a.u./h
Virus degradation rate dV 0.4/h
IFN dynamics
Delay of IFN secretion τF 31.9[31.4;32.5] h
IFN secretion rate vF 0.014[0.012;0.016] pg/h/cell
Protection rate rF 1.5×10−5[1.3×10−5;1.8×10−5] ml/pg/h
IFN degradation rate dF 0.15/h
Cell numbers
Initial susceptible cells (exp. 1) S0 12540 [10760;14460] cells/ml
Initial susceptible cells (exp. 2) S0 11720 [10210;13330] cells/ml
Proliferation rate susceptible cells pS 0.041[0.038;0.044] 1/h
Proliferation rate protected cells pP 0.083[0.078;0.087] 1/h
Table 3.2.: Model parameter estimates of the population-based DDE model. According to
the biological meaning of the model parameters (cf. section 3.2), we estimate the parameter
values as depicted in section 3.3.1 by considering only experiments regarding DENV-wt
infection. Given are the best fit values and the 95% confidence intervals (calculated with
the profile likelihood method) after fitting the model to the time-resolved data set shown
in Figure 3.18 using a fixed initial viral load along with separately determined values for
virus and IFN degradation rates. All model simulations concerning DENV-wt refer to this
parameter set. Abbreviations: arbitrary units (a.u.), confidence interval (CI), experiment
(exp.), hours (h), milliliter (ml), picogram (pg).
cation is especially noteworthy, since the DDE system as a whole was fitted without
using data of extracellular virus dynamics (cf. Figure 3.18).
Furthermore, the single-step growth curve of secreted IFN-λ after infection with
DENV-faR-wt at a high MOI (cf. dark green curve in Figure 3.7) can serve as a
control experiment for the determined delay of IFN secretion τF = 31.9 h (cf. Figure
3.19, first profile likelihood in the second row and Table 3.2). Comparing τF with the
measured halftime of IFN-λ release of ∼ 26.5 h, we found that the model prediction
provides a reasonably close approximation (Figure 3.20B).
As already mentioned in section 3.2, the single-step growth curves in Figure 3.7
illustrate the temporal distribution of heterogeneous single-cell behavior, which we
approximated by constant time delays. However, the fact that the fixed time de-
lays of the parameterized model match independently observed delays, confirms the
ability of our model to make quantitative predictions of cell population dynamics.
In addition to the time delays, we also examine the parameterized IFN response in
the model using a previously described IFN stimulation experiment, in which A549
IFIT1-deGFP reporter cells were treated with IFN-λ (cf. green curve in Figure 3.8B).
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Figure 3.20.: The estimated parameter values of virus production time, IFN secretion de-
lay and IFN response agree with independently measured key data. (A, B) IFN-competent
A549 cells were infected with DENV-faR-wt at a MOI of 10 and analyzed at the indicated
time points post infection. (A) Extracellular virus (blue color) was detected by TCID50
assay. Highlighted are the observed halftime of ∼ 32 h (dashed black line) and the esti-
mated delay of virus production τV = 31.4 h (red line with shaded 95% confidence interval[30.6 h; 32.2 h]; data replotted from Figure 3.7 on linear scale). (B) Extracellular IFN-λ
(dark green color) was quantified by ELISA. Marked are the observed halftime of ∼ 26.5 h
(dashed black line) and the estimated delay of IFN secretion τF = 31.9 h (red line with
shaded 95% confidence region [31.4 h; 32.5 h]; data replotted from Figure 3.7). (C) A549
IFIT1-deGFP reporter cells were stimulated with 10 ng/ml IFN-λ and subjected to flow
cytometry at the displayed times after treatment. Plotted are the experimentally observed
rise in IFIT1-deGFP+ cells (yellow dots) and the predicted increase in protected cells (red
line with shaded 95% confidence bound) simulated with the submodel (3.24) by assuming an
initial stimulation with IFN (data replotted from Figure 3.8B). (Experiments by B. Schmid
and R. Bartenschlager)
To imitate the initial conditions of this experiment, we consider a number of suscep-
tible cells S0 along with the applied extracellular IFN concentration F0 = 10 ng/ml.
When simulating the IFN response, we assume that the recognition of extracellular
IFN F turn susceptible cells S into protected cells P with the protection rate rF.
The removal of IFN by cellular uptake and, to a lesser extent, by extracellular degra-
dation is taken into account through the IFN degradation rate dF. The dynamics of
this small submodel at time t ∈ R is defined by the following ODE system:
S˙(t) = −rFF (t)S(t) S(0) = S0
P˙ (t) = rFF (t)S(t) P (0) = 0
F˙ (t) = −dFF (t) F (0) = F0. (3.24)
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We fix S0, rF and dF to the fitted values given in Table 3.2. The ODE system
(3.24) was then solved using a standard ODE solver of Matlab based on explicit
Runge-Kutta method (Bogacki and Shampine 1989, Shampine and Reichelt 1997).
The direct comparison shows a good agreement between the predicted fraction of
protected cells and the observed IFN-responding cells (Figure 3.20C). This test
indicates that the parameterized model describes the IFN response correctly and,
additionally, underscores the accuracy of the estimated protection rate rF.
Taken together, the validity of the model is corroborated by the parameterization
within narrow confidence intervals from DENV-wt data and, additionally, by the
consistency with key results obtained in independent experiments that were not
utilized for model fitting.
3.3.2. Detection of DENV mutant specific model parameters by
utilizing the knowledge from DENV-wt fitting
In order to analyze the differences between DENV-wt and attenuated DENV-E217A
mutant infections on a quantitative level, we utilize the population-based model pa-
rameterized exclusively with DENV-wt data (cf. section 3.3.1) to identify DENV-
E217A mutant specific parameters, which are able to describe the observed pop-
ulation dynamics after DENV-faR-E217A mutant infection (cf. Figure 3.14B and
3.15).
Motivated by findings from the literature, we argue that four parameters might vary
between DENV-wt and DENV-E217A mutant infections. Since studies demonstrate
that IFIT1 inhibits translation of mutant RNA (Pichlmair et al. 2011, Habjan et al.
2013), the generation of new infectious virus particles could take longer or occur at
a lower rate after infection with DENV-E217A mutant. Moreover, as other reports
show that 2’-O-unmethylated RNA is detected more readily by intracellular pattern
recognition receptors (Zu¨st et al. 2011), infected cells might also produce IFN faster
or to a larger extent.
For the parameter optimization regarding DENV-E217A mutant infection, we take
advantage of the established DENV-wt parameter set (cf. Table 3.2) and estimate
only the four just mentioned potentially DENV-E217A mutant specific parameters
(MP) in line with the respective constraints:
(MP1) Delay of mutant virus production τVmut > τR
(MP2) Mutant virus production rate vVmut ≤ vV
(MP3) Delay of IFN secretion after mutant virus infection τFmut
(MP4) IFN secretion rate after mutant virus infection vFmut ≥ vF.
In the same way as in the DENV-wt case, we determine the DENV-E217A mutant
specific parameters (MP1)–(MP4), by fitting the model dynamics listed in (RO2)–
(RO5) (cf. section 3.3.1 page 82) simultaneously to the related time-resolved data
set consisting of two independent flow cytometry measurements along with ELISA
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Figure 3.21.: Best fit of the mathematical model to two independent experiments concern-
ing DENV-faR-E217A mutant infection by utilizing the DENV-wt parameter estimates.
Initially, the model simulations concerning DENV-wt (dashed lines) are fitted to the respec-
tive time-resolved DENV-wt data (circles). The resulting DENV-wt parameter estimates
(cf. section 3.3.1 and Table 3.2) are used to optimize the DENV-E217A mutant specific
parameters (MP1)–(MP4) (cf. page 89) by fitting the model dynamics regarding DENV-
E217A mutant (solid lines) simultaneously to the related DENV-E217A mutant kinetics
(squares) of both independent experiments. For parameter optimization we compare sim-
ulated with observed cell dynamics of (1) all (as control), (2) susceptible IFIT1-deGFP –
DENV-faR double-negative, (3) virus replicating DENV-faR positive as well as (4) pro-
tected IFIT1-deGFP+ – DENV-faR− cells along with (5) IFN-λ release after infection of
A549 IFIT1-deGFP reporter cells with DENV-faR at a MOI of 0.1. The best fit is obtained
by applying a trust-region-reflective least-squares algorithm with at least 5 × 103 different
random initial values. The data set is based on two independently performed flow cytometry
measurements (cf. Figure 3.14), while IFN-λ was quantified in experiment 2 by ELISA (cf.
Figure 3.15). Absolute cell numbers can be considered as a volume (vol.) of 100 µl was
consistently analyzed. (Experiments by B. Schmid and R. Bartenschlager)
quantifications post DENV-faR-E217A mutant infection (Figure 3.21(2)–(5)).
We repeated the optimization procedure for more than 5 × 103 different random
initial values in the same way as for the data concerning DENV-wt. The obtained
best fit provides a good match with the observed kinetics after DENV-faR-E217A
mutant infection of both experiments (Figure 3.21).
Again, applying the profile likelihood method, we calculate the 95% confidence in-
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Figure 3.22.: The difference between DENV-wt and attenuated DENV-E217A mutant
infection is mainly based on an accelerated IFN induction and decreased virus production
triggered by the E217A mutant. The direct comparison of the estimated best fit values
(vertical black lines) and the corresponding 95% confidence intervals (bands; calculated
with the profile likelihood method) of the four model parameters (right y-axis), which have
been allowed to differ between DENV-wt and DENV-E217A mutant infection (left y-axis)
demonstrates that only the delay of IFN secretion τF and the virus production rate vV differ
considerably (framed in dark red color).
tervals of the estimated DENV-E217A mutant specific parameters (MP1)–(MP4)
according to (3.21). The resulting narrow confidence bounds confirm the identifia-
bility of all four parameters. More importantly, the comparison of the confidence
regions reveals that only two of the four DENV-E217A mutant specific parameters
differ strongly from their DENV-wt values: The delay of IFN secretion is ∼ 24 h
shorter and the virus production rate is ∼ 8-fold lower after DENV-E217A mutant
infection in contrast to DENV-wt (Table 3.3 and Figure 3.22). While the estimated
delays for virus production and IFN secretion are almost identical after DENV-
wt infection, IFN release takes place well before virus production in DENV-E217A
mutant infected cells.
Both identified DENV-E217A mutant specific parameters could contribute to the
observed attenuated spread of the E217A mutant, but their relative importance is
still open. Indeed, the IFN production delay τF and the virus production rate vV
might not be independent parameters as virus replication could be inhibited by
autocrine IFN in a time-dependent manner (cf. Figure 3.5). To account for this
effect, we extend the mathematical model in the following section 3.4. Using this
extended version of the model, we will analyze the antiviral effect of τF and vV in
detail in section 3.5.
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Model parameter Value [95% CI]
Virus dynamics
Delay of virus production (DENV-wt) τV 31.4[30.6;32.2] h
Delay of virus production (E217A mutant) τVmut 28.3[26.8;29.7] h
Virus production rate (DENV-wt) vV 0.540[0.45;0.670] a.u./h/cell
Virus production rate (E217A mutant) vVmut 0.067[0.06;0.074] a.u./h/cell
IFN dynamics
Delay of IFN secretion (DENV-wt) τF 31.9[31.4;32.5] h
Delay of IFN secretion (E217A mutant) τFmut 8.2[ 7.5; 9.1] h
IFN secretion rate (DENV-wt) vF 0.014[0.012;0.016] pg/h/cell
IFN secretion rate (E217A mutant) vFmut 0.014[0.014;0.015] pg/h/cell
Table 3.3.: Optimized model parameters of the population-based DDE model which differ
between DENV-wt and DENV-E217A mutant infection. After the model parameterization
by considering only DENV-wt related experiments (cf. section 3.3.1 and Table 3.2), data
concerning DENV-E217A mutant infection are fitted by allowing only four parameters to
differ between DENV-wt and DENV-E217A mutant (cf. section 3.3.2). Given are the best
fit values and the 95% confidence intervals (calculated with the profile likelihood method)
of these four infection specific parameters after fitting the model to the time-resolved data
set shown in Figure 3.21. Abbreviations: arbitrary units (a.u.), confidence interval (CI),
DENV-E217A mutant (mut), hours (h), picogram (pg).
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3.4. Extension of the population-based model to
elucidate the autocrine and paracrine effects of
IFN
The prediction of the data-driven quantitative model that a decreased virus produc-
tion and accelerated IFN induction make the difference between DENV-wt and the
attenuated DENV-E217A mutant (cf. Figure 3.22), raises the questions how much
impact either factor individually has on the outcome of infection, or even if the
two factors are possibly related to each other. The latter question is prompted by
our observation that stimulation of infected cells with IFN in an early phase after
infection causes a reduction of virus replication and consequently virus production
(cf. Figure 3.5). However, this autocrine effect of IFN must be temporally limited,
since stimulation with IFN has no further influence after a certain time period post
infection.
To analyze explicitly the impact of IFN on infected cells, we expand our established
model (3.11) by assuming that recognition of IFN with the rate rP, in the time
window of IFN responsiveness τP after viral entry, inhibits the production of new
infectious virus particles (Figure 3.23, solid green inhibition link). Technically, we
calculate the probability of infected cells to sense secreted IFN in the time period
τP after viral entry by applying a technique from the field of the survival analysis
(Cox and Oakes 1984, Dobson 2001, Rodr´ıguez 2007).
For this purpose we first consider a non-negative, continuous random variable T ,
which represents the waiting time until an infected cell recognizes IFN. The cumu-
lative distribution function (CDF) of T is defined by
CDF T(t˜) = P(T ≤ t˜) (3.25)
T continuous
and non-negative= t˜∫
0
fT(x)dx, (3.26)
where fT is the density function of T . The CDF T describes the probability P to
recognize IFN within the time span t˜ ∈ R≥0.
Accordingly, the complement of CDF TZT(t˜) = 1 −CDF T(t˜) (3.27)(3.25)= P(T > t˜) (3.28)
(3.26)= ∞∫˜
t
fT(x)dx,
with the initial condition ZT(0) = 1, (3.29)
is the probability that IFN was not sensed within the time period t˜. ZT is known
as the “survival function” and has the derivativeZ ′T(t˜) = −fT(t˜). (3.30)
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In addition, we need the so-called hazard function, which is the time-dependent
probability rate of recognizing IFN in an infinitesimally small time interval [t˜; t˜+dt˜]
under the condition that there was no stimulation through IFN up to time t˜. The
hazard function is generally defined by
h(t˜) = lim
dt˜→0(P(t˜ ≤ T < t˜ + dt˜ ∣ T ≥ t˜)dt˜ )
= lim
dt˜→0(P(t˜ ≤ T < t˜ + dt˜ ∩ T ≥ t˜)dt˜ ) 1P(T ≥ t˜)
T continuous=(3.28) limdt˜→0(P(t˜ ≤ T < t˜ + dt˜dt˜ ) 1ZT(t˜)
T continuous=(3.25) limdt˜→0(CDF T(t˜ + dt˜) −CDF T(t˜)dt˜ ) 1ZT(t˜)= CDF ′T(t˜)ZT(t˜)(3.26)= fT(t˜)ZT(t˜)(3.30)= −Z ′T(t˜)ZT(t˜) . (3.31)
In order to obtain a formula of ZT depending on the hazard function we reformulate
equation (3.31) by integrating both sides:
h(t˜) = −Z ′T(t˜)ZT(t˜)⇐⇒ h(t˜) = − d
dt˜
ln(ZT(t˜))
⇐⇒ t˜∫
0
h(x)dx = − (ln(ZT(t˜)) − ln(ZT(0)))
(3.29)⇐⇒ − t˜∫
0
h(x)dx = ln(ZT(t˜))
⇐⇒ ZT(t˜) = exp⎛⎜⎝−
t˜∫
0
h(x)dx⎞⎟⎠ . (3.32)
In our case, the probability rate of recognizing IFN is given by
h(t) = rPF (t), (3.33)
where rP denotes the rate of IFN-induced inhibition of virus production and F (t)
is the time-dependent amount of extracellular IFN (cf. Figure 3.23, solid green in-
hibition link).
The distinction whether or not an infected cell is stimulated by IFN within the time
window τP after the time point of infection tI ≥ 0 (Figure 3.24) is relevant at the
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Figure 3.23.: Scheme of the full population-based model, which describes the competition
between spreading virus and the antiviral immune response induced in a paracrine and tem-
porally limited autocrine manner by secreted IFN. Susceptible cells (gray oval) can become
infected by extracellular virus with the infection rate rV (blue arrow). Virus replication
(⤿) arises in infected cells (black oval) at time τR after viral entry (red color) and results in
virus production with the virus production rate vP from time τV > τR onwards. Moreover,
infected cells start to express IFN with the secretion rate vF at time τF post viral infesta-
tion. Recognition of secreted IFN turn susceptible cells into protected cells (yellow oval)
with the protection rate rF (solid green arrow). In addition, sensing of IFN with the rate
rP in the time window τP after viral entry inhibits virus production in infected cells (solid
green inhibition link). Extracellular virus and IFN are removed (∅) by cellular uptake as
well as extracellular degradation with the rate constant of virus degradation dV and the rate
constant of IFN degradation dF. While propagation is inhibited in infected cells, susceptible
and protected cells proliferate (↺) with the rates pS and pP, respectively.
time
t = tI + τV⇐⇒ t − τV = tI. (3.34)
Therefore, we compute the probability that IFN is not recognized up to the time
tI + τP (3.34)= t − τV + τP (3.35)
under the condition that there was no stimulation through IFN before the time point
of viral entry. The condition is necessary, since sensing of IFN before infection leads
to antiviral protection in our model. The probability of an infected cell to produce
virus without antiviral IFN action is thus calculated as
P(T > tI + τP ∣ T > tI) (3.35)=(3.34) P(T > t − τV + τP ∣ T > t − τV)
= P(T > t − τV + τP ∩ T > t − τV)P(T > t − τV)= P(T > t − τV + τP)P(T > t − τV)
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Figure 3.24.: Scheme of the modeled antiviral effect of IFN on already infected cells. To
incorporate in our model an antiviral impact of IFN on infected cells, we assume after the
time point of infection tI of susceptible cells (gray oval) an IFN responsive time window
τP. Inactive infected cells (black oval), which receive no IFN stimulus in the time interval[tI; tI+τP] become at tI+τV virus producing cells (dark blue oval) and release new infectious
viral particles with the rate constant vP (upper sequence). In contrast, virus production is
inhibited in inactive infected cells, which recognize IFN in the time frame [tI; tI + τP] (light
blue oval; lower sequence).
(3.28)= ZT(t − τV + τP)ZT(t − τV)
(3.32)= exp⎛⎜⎝−
t−τV+τP∫
0
h(x)dx⎞⎟⎠ exp
⎛⎜⎝
t−τV∫
0
h(x)dx⎞⎟⎠
(3.33)= exp⎛⎜⎝−
t−τV+τP∫
0
rPF (x)dx⎞⎟⎠ exp
⎛⎜⎝
t−τV∫
0
rPF (x)dx⎞⎟⎠
= exp⎛⎜⎝−rP
t−(τV−τP)∫
t−τV F (x)dx
⎞⎟⎠= exp (rP [F (t − τV) −F (t − (τV − τP))]) , (3.36)
where F denotes the antiderivative of F .
The probability (3.36) enables us to discriminate between infected cells IVP, which
receive no IFN stimulus and thus produce virus with the rate constant vP after τV,
and infected, non-virus producing cells IVP, which recognize IFN within the time
window τP (cf. Figure 3.24). Accordingly, we include IVP, IVP and F in our DDE
model (3.11) and obtain the following DDE system with four time delays:
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S˙(t) = −rVV (t)S(t) − rFF (t)S(t) + pSS(t)
I˙R(t) = rVV (t)S(t) − rVV (t − τR)S(t − τR)
I˙R(t) = rVV (t − τR)S(t − τR)
I˙V(t) = rVV (t)S(t) − rVV (t − τV)S(t − τV)
I˙VP(t) = exp (rP [F1(t) −F2(t)]) rVV (t − τV)S(t − τV)
I˙VP(t) = (1 − exp (rP [F1(t) −F2(t)])) rVV (t − τV)S(t − τV)
I˙F(t) = rVV (t)S(t) − rVV (t − τF)S(t − τF)
I˙F(t) = rVV (t − τF)S(t − τF)
P˙ (t) = rFF (t)S(t) + pPP (t)
F˙ (t) = vFIF(t) − dFF (t)
F˙1(t) = F (t − τV)
F˙2(t) = F (t − (τV − τP))
V˙ (t) = vPIVP(t) − dVV (t).
(3.37)
The initial value problem corresponding to the extended model is defined by the DDE
system (3.37) for time t ∈ [t0, tend] together with initial conditions, which we specify
in the following. In analogy to the DDE system (3.11), only the initial number
of susceptible cells S(0) = S0 and the initial extracellular viral load V (0) = V0 are
non-zero at the starting time t0 = 0. For those variables in (3.37) that have a delay
argument, we use as history functions the constant zero function, that is, S(t) = 0,
V (t) = 0 as well as F (t) = 0 for all t < 0.
In a manner analogous to the investigation of the original DDE system (3.11),
we can show that the initial value problem of the full DDE model (3.37) has a
unique positive solution. To see this note that the condition (P5) of the posi-
tivity theorem (cf. page 79) can be verified by demonstrating (P5) for a closed
subsystem of the extended DDE model (3.37) concerning the state variable y˜ =(S, IR, IVP, IVP, IF, P,F,F1,F2, V ). In particular, the right-hand-side function of
I˙VP fulfills (P5), as the exponential function is positive. To verify (P5) with respect
to IVP, we recall that the term exp (rP [F1(t) −F2(t)]) ∈ (0,1], as it represents
the probability of an infected cell to produce virus without antiviral IFN action (cf.
equation (3.36)).
To simulate the full DDE model (3.37), we utilize Matlab as a programming environ-
ment and solve the DDE system numerically by calling the RADAR5 solver written
in ANSI Fortran-90 (Guglielmi and Hairer 2005) with a binary mex subroutine. For
an increased accuracy of the numerical solution, we implement the time-dependent
standard Jacobian matrix Jfull(t) and the Jacobian matrix with respect to the de-
layed variables Jfull,τ(t) within the RADAR5 code. Both Jacobian matrices are
given in appendix A.2.
The results of the IFN-stimulation experiment depicted in Figure 3.5 indicate an
IFN responsive time window τP of approximately 6 h post infection with DENV-wt
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Figure 3.25.: The full model reproduces the observed dynamics of both DENV-wt and
DENV-E217A mutant infections. The full model (3.37) can describe the data concerning
DENV-wt (dashed lines and circles, respectively) and DENV-E217A mutant (solid lines and
squares, respectively) infections, which were previously used to parameterize the original
model (3.11). We compare simulated with observed cell dynamics of (1) all (as control),
(2) susceptible IFIT1-deGFP – DENV-faR double-negative, (3) virus replicating DENV-faR
positive as well as (4) protected IFIT1-deGFP+ – DENV-faR− cells along with (5) IFN-λ
release after infection of A549 IFIT1-deGFP reporter cells with DENV-faR at a MOI of
0.1. The data set is based on two independently performed flow cytometry measurements
(cf. Figure 3.14), while IFN-λ was quantified in experiment 2 by ELISA (cf. Figure 3.15).
Absolute cell numbers can be considered as a volume (vol.) of 100 µl was consistently
analyzed. The full model (3.37) is simulated with the additional parameter values given in
Table 3.4 and the DENV-wt parameter estimates listed in Table 3.2 as well as the established
DENV-E217A mutant specific parameter set shown in Table 3.3. (Experiments by B. Schmid
and R. Bartenschlager)
at a MOI of 10. The infection with such a high viral dose causes a synchronized
infection of the cell population. Since the delay of virus replication after a non-
synchronized infection is expected to be delayed, we simulate low dose infections
with a time window of IFN responsiveness of τP = 8 h. Additionally, we fix the
rate of IFN-induced inhibition of virus production rP = 104 rF, as we suspect that
restriction of virus replication is achieved faster than antiviral protection.
According to findings from the literature, IFIT1 is one of those ISGs that can be
induced directly after viral recognition in an IFN-independent manner (Grandvaux
et al. 2002, Diamond and Farzan 2013, Chen et al. 2013). An early IFN-independent
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Model parameter Value
Virus dynamics
Virus production rate (DENV-wt) vP 0.54 a.u./h/cell
Virus production rate (E217A mutant) vPmut 0.27 a.u./h/cell
IFN dynamics
Time window of IFN responsiveness τP 8 h
Rate of IFN-induced inhibition of virus production rP 0.15 ml/pg/h
Table 3.4.: Additional parameters of the full population-based model. The extended model
(3.37) is simulated with the given additional parameter values and the DENV-wt parameter
estimates listed in Table 3.2 as well as the established DENV-E217A mutant specific param-
eter set shown in Table 3.3. Abbreviations: arbitrary units (a.u.), DENV-E217A mutant
(mut), hours (h), milliliter (ml), picogram (pg).
IFIT1 induction could thus also be contributing to the predicted decreased virus
production in IFIT1 reporter cells after DENV-E217A mutant infection. Since we
have no available data on the extent to which virus production of the DENV-
E217A mutant is influenced by IFN-independent mechanisms in our system, we
assume that virus producing cells release new infectious virus particles with the rate
vPmut = 0.5 vV after infection with the DENV-E217A mutant. Accordingly, the virus
production rate of the E217A mutant represents half of the virus production rate
vP = vV after infection with DENV-wt.
The simulation of the model (3.37) with the mentioned modifications listed in Table
3.4 shows that the simulated dynamics match the observed kinetics of both DENV-
wt and DENV-E217A mutant infections equally well as the original model (3.11)
(Figure 3.25).
In summary, the full model allows us to study the competition between spread-
ing DENV and the antiviral immune response induced in an autocrine as well as
paracrine manner by secreted IFN. Therefore we will utilize the model (3.37) in the
following section 3.5 to analyze the relative importance of decreased virus produc-
tion and accelerated IFN expression triggered by DENV-E217A mutant, taking into
account the antiviral effect of IFN on infected and/or susceptible cells.
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3.5. Quantitative modeling predicts effective limitation
of viral spread by rapid autocrine IFN action on
infected cells
The population-based model implies that there are two distinct waves of virus repli-
cation after DENV-wt infection (cf. Figure 3.18(3)). While the first wave corre-
sponds to replication in cells that were initially infected, the second wave, starting
at ∼ 60 h post infection, is most likely due to reinfection by spreading DENV-wt
released from primary infected cells. In contrast to DENV-wt, virus replication
resulting from secondary infection events of propagating DENV-E217A mutant is
considerably weaker (cf. Figure 3.21).
The quantitative model explains the attenuated spread of the DENV-E217A mutant
by two effects. First, virus production is reduced, and second, IFN induction is faster
after infection with DENV-E217A mutant in comparison to DENV-wt (cf. Figure
3.22). To examine the individual impact of these two factors on viral spread, we
simulate the outcome of DENV-wt infections for varying mutant specific parameter
values (Figure 3.27) by considering the following three model variations (M1)–(M3)
(Figure 3.26):
(M1) The full model (3.37), which enables the simulation of the interaction between
spreading DENV and the antiviral immune defense induced in an autocrine
and paracrine way by released IFN (cf. Figure 3.26A and Figure 3.27 left
column).
(M2) A variation of the model to consider only the antiviral effect of autocrine
IFN acting on DENV-infected cells. This model is simulated by setting the
protection rate rF to zero in (3.37) (cf. Figure 3.26B and Figure 3.27 middle
column).
(M3) The original model (3.11), which only regards the antiviral effect of paracrine
IFN protecting susceptible cells against DENV infection (cf. Figure 3.26C and
Figure 3.27 right column).
After simulating these combinations, we compare the relative change of the popula-
tion structure consisting of susceptible, virus replicating and protected cells as well
as the different amount of IFN and virus (cf. rows in Figure 3.27). For easier com-
parison, the color scales are normalized so that the result of the full model simulated
with the determined DENV-wt parameter values (cf. Table 3.2 and 3.4) have value
zero (cf. Figure 3.27, green color).
The simulations of the full model (M1) with varying mutant specific parameter values
show that both the delay of IFN secretion τF and the virus production rate vP can
independently control the fraction of susceptible as well as virus replicating cells
and, consequently, the spread of IFN and virus. Moreover, the relative change of
the protected cells implies the existence of a time limit for the delay of IFN secretion
of ∼ 24 h. For longer latencies of IFN expression, protection is ineffective and the
population is separated in susceptible as well as infected cells, depending of the virus
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Virus 
IFN 
I S  P 
Virus 
IFN 
I S  
Virus 
IFN 
I S  P 
(M1) Full model (M2) Only autocrine
IFN effect
(M3) Only paracrine
IFN effect
A B C
Figure 3.26.: Schemes of the three model variations (M1)–(M3). (A) The full model (M1)
considers the autocrine and paracrine effect of IFN in an infected cell population: Susceptible
cells S (gray oval) can become infected by extracellular virus (blue arrow). Virus replication
in infected cells I (black oval) results in virus production and expression of IFN. Recognition
of secreted IFN turn susceptible cells into protected cells P (yellow oval) (solid green arrow).
In addition, sensing of IFN in an early phase after viral entry inhibits virus production in
infected cells (solid green inhibition link). Extracellular virus and IFN are removed (∅)
by cellular uptake as well as extracellular degradation. While propagation is inhibited in
infected cells, susceptible and protected cells proliferate (↺). (B) In comparison to the full
model, the model variant (M2) only considers the autocrine effect of IFN on infected cells.
(C) Compared to the full model, the model variant (M3) only regards the antiviral effect of
paracrine IFN protecting susceptible cells against viral infection.
production rate. Importantly, the IFN-independent reduction of virus production
rate attenuates viral spread, but this attenuation is strongly enhanced by the rapid
secretion of IFN. The control of the mutant specific parameters τF and vP over the
amounts of susceptible cells, virus replicating cells, secreted IFN and extracellular
virus still remains intact in the model variant (M2), where a solely autocrine effect
of IFN is allowed. It is particularly notable that the simulations of the model (M2)
concerning the number of virus replicating cells and the amount of produced virus
look practically identical to the full model. The main difference is in the number
of protected cells, but interestingly this has no strong effect on viral spread. In
contrast to the models (M1) and (M2), the influence of IFN on viral spread largely
disappears if IFN has only a paracrine effect. Moreover, the amount of extracellular
virus in model (M3) illustrates a very high virus production, which by far exceeds
that in the models with autocrine effect of IFN.
According to this analysis, the spread of the DENV-E217A mutant is mainly re-
stricted through an autocrine effect of IFN on infected cells which causes a decreased
virus production. Remarkably, the models predict that an increased paracrine effect
due to accelerated IFN secretion would have very little effect on viral spread.
The measured population structures after infection with DENV-faR-wt or DENV-
faR-E217A mutant illustrate the persistence of a large fraction of susceptible cells
throughout the entire 4-day time course (Figure 3.28). The number of na¨ıve cells
remained even larger in the DENV-E217A mutant infected cell population, although
IFN is induced faster after DENV-E217A mutant infection. This observation con-
firms the modeling prediction that viral spread is primarily limited by decreased
virus production rather than by the effect of IFN to protect as many cells as possi-
ble.
101
3. Viral spread is mainly controlled by the autocrine effect of rapidly produced IFN
Delay of IFN secretion τF (h) 
(M1) Full model (M3)  Only paracrine 
IFN effect 
(M2) Only autocrine 
IFN effect 
DENV 
E217A 
mutant 
Relative 
change 
at 96 h p.i. 
 
> 1 
4 
2 
0 
 0.5 
4 
2 
0 
2 
1 
0 
-0.5 
-1 
0 
 0.2 
 0          
-0.2 
-0.4 
-0.6 
-0.8 
6 12 18 24 30 36 6 12 18 24 30 36 6 12 18 24 30 36 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
0.6 
0.5 
0.4 
0.3 
0.2 
0.1 
Susceptible (S) 
(cells/vol.) 
Virus replicating 
 (IR) (cells/vol.) 
Protected (P) 
(cells/vol.) 
IFN (F) 
(pg/vol.) 
Virus (V) 
(a.u./vol.) 
V
iru
s p
ro
du
ct
io
n 
ra
te
 v
P (
a.
u.
/h
/c
el
l) 
Figure 3.27.: Quantitative modeling predicts strong restriction of viral spread by a rapid
autocrine effect of IFN on infected cells. DENV-wt infections are simulated with varying
parameter values for the delay of IFN secretion τF (x-axis) and virus production rate vP
(y-axis) by using the three model variations (M1)–(M3) (cf. page 100 and Figure 3.26).
Shown is the relative change of susceptible S, virus replicating IR and protected P cells
as well as extracellular IFN F and virus V at 96 h post infection (arranged in rows). The
relative values are obtained by scaling to the results of the full model simulated with the
determined DENV-wt parameter values (white circles), so that these reference results have
always value zero (green color). Values below or above the respective reference value are
plotted in cool or warm colors, respectively. For the purpose of comparison, the results of
the full model simulated with the DENV-E217A mutant parameter estimates are denoted
through the white squares. Abbreviations: arbitrary units (a.u.), picogram (pg), volume
(vol.; 100 µl).
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Figure 3.28.: A large proportion of the cell population remains susceptible after infection
with DENV-wt or DENV-E217A mutant. (A, B) A549 IFIT1-deGFP reporter cells were
infected with DENV-faR-wt (A) or DENV-faR-E217A mutant (B) at a MOI of 0.1. At
the indicated time points post infection, cells were fixed and 100 µl of the cell suspension
was subjected to flow cytometry. The area plots represent the distribution of the observed
population structure consisting of susceptible IFIT1-deGFP – DENV-faR double-negative
(gray color), virus replicating DENV-faR positive (red color) and protected IFIT1-deGFP+
– DENV-faR− cells (yellow color). Shown is the first of two independent experiments after
infection with DENV-wt or DENV-E217A mutant replotted from Figure 3.21. (Experiments
by B. Schmid and R. Bartenschlager)
To further examine the ability of autocrine action of IFN to reduce virus produc-
tion, we electroporated IFN-competent A549 cells and IFN-incompetent BHK-21
cells with DENV-faR-wt or DENV-faR-E217A mutant RNA (Figure 3.29). By us-
ing electroporation of the respective viral RNA genome, we hit almost all cells, which
enables us to investigate predominantly autocrine IFN effects. In the IFN-competent
A549 cell culture, we detected a strong decrease of infectious particle release after
electroporation with DENV-faR-E217A mutant in contrast to DENV-faR-wt. A
relative small difference between the two types of virus reporter constructs could
be found in the electroporated IFN-incompetent BHK-21 cells, which indicates that
the DENV-faR-E217A mutant has no general defect in RNA replication. A possi-
ble reason for the slightly reduced DENV-faR-E217A mutant virus production in
BHK-21 cells compared to DENV-wt might be due to IFN-independent expression
of IFIT1 (Grandvaux et al. 2002, Diamond and Farzan 2013, Chen et al. 2013)
that in turn inhibits 2’-O-unmethylated RNA translation (Pichlmair et al. 2011,
Habjan et al. 2013). The moderate decline of virus production in BHK-21 cells
between the two time points could result from an increased cell death of BHK-21
cells. Notably, the lacking strong attenuation of DENV-E217A mutant production
in an IFN-incompetent cell line corroborates the modeling prediction that a rapid
autocrine effect of IFN on infected cells strongly limits viral spread.
Taken together, our study of the competition between spreading DENV and the
antiviral IFN response by means of mathematical modeling and experimental val-
idation demonstrates that the fitness of the DENV-E217A mutant is reduced due
to an early IFN effect on already infected cells, which in turn curbs virus produc-
tion. Since we also consider an IFN-independent inhibition of virus production in
the full model (cf. section 3.4 page 99) and our analysis reveals a control of viral
spread by both the virus production rate (cf. Figure 3.27, relative change of virus
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Figure 3.29.: The virus production of the DENV-E217A mutant is reduced through the
action of autocrine IFN. (A, B) IFN-competent A549 cells (A) and IFN-incompetent BHK-21
cells (B) were electroporated with the RNA genome of DENV-faR-wt (black color) or DENV-
faR-E217A mutant (dark red color). Infectious virus release was determined by TCID50
assay at 48 h and 72 h post electroporation. Arrows and numbers refer to fold difference of
virus titers monitored on average in the supernatant of the cell cultures. (Experiments by
B. Schmid and R. Bartenschlager)
replicating cells in vertical direction) and the delay of IFN secretion (cf. Figure
3.27, relative change of virus replicating cells in horizontal direction), the reduction
in virus production appears to have an IFN-independent component as well as an
IFN-dependent component. Importantly, the accelerated secretion of IFN enables a
rapid and strong autocrine effect of IFN, which counteracts virus production most
likely before DENV prevents an efficient IFN response by inhibition of STAT1 or
degradation of STAT2 (cf. Figure 3.1 and 3.6). Our results therefore indicate that
the outcome of infection is primarily determined by the relative kinetics of DENV
replication and autocrine IFN action on infected cells (Schmid, Rinas et al. submit-
ted).
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This thesis consists of two main parts: First, we analyzed the antiviral IFN system
after primary infection at single-cell level with a data-based stochastic model (cf.
chapter 2). Second, we studied the competition between viral spread and IFN-
induced antiviral protection in a cell population by using a parameterized delay
differential equation model (cf. chapter 3). In the following we will discuss our
findings separately for each model system and subsequently in overall terms.
4.1. Stochastic modeling predicts paracrine propagation
of the IFN response mediated by individual
sentinels
Live-cell imaging data demonstrate multi-layered stochasticity. By live-
cell imaging, we have examined the dynamics of the antiviral IFN system in single
cells after primary infection (cf. section 2.1). We illustrated that signal transduction
and IFN gene induction contribute quantitatively to heterogeneous expression of
the IFN-β gene, and that cell-intrinsic stochasticity prevails in both processes. In
addition to heterogeneous IFN induction, we detected a bimodal, all-or-nothing ex-
pression of antiviral target genes, in which virus can replicate in the non-responding
subpopulation and the responding subpopulation is protected against viral replica-
tion. Thus, cell-to-cell variability is a pervasive feature of the IFN network.
Heterogeneous IFN induction is largely determined by cell-intrinsic noise.
The origin of cell-to-cell variability in IFN expression became the subject of con-
troversial debate. Both host cell-intrinsic causes (Hu et al. 2007, Apostolou and
Thanos 2008, Hu et al. 2011) and the ability of viruses to antagonize the IFN sys-
tem (Chen et al. 2010, Killip et al. 2011) have been considered to be responsible for
heterogeneous IFN induction. In section 2.1.2 we addressed the question, whether
the stochasticity in IFN expression depends on the infecting virus. We demonstrated
that the cell-to-cell heterogeneity in IFN-β induction after infection with NDV is
not caused by varying infection times, the level of viral replication or the absence
of IFN-inducing viral RNA. On that basis, we conclude that the stochastic IFN-β
expression is predominantly of cellular origin in our experimental system. However,
viruses have developed multiple mechanisms to interfere with the expression of IFN
(Haller et al. 2006, Versteeg and Garc´ıa-Sastre 2010). Thus, it is possible that antag-
onizing effects triggered by other types of viruses could contribute to heterogeneous
IFN induction.
Using live-cell imaging, we could demonstrate that the heterogeneity in IFN expres-
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sion is largely due to cell-intrinsic stochasticity. Imaging IFN expression in sister
cells after viral infection or transfection with the viral-surrogate poly I:C indicates
that cell-intrinsic mechanisms generate high variability in antiviral signaling as well
as IFN-β gene expression (cf. Figure 2.5). Therefore, host cell intrinsic noise plays
an important role in heterogeneous IFN induction.
The decision to express IFN is primarily taken upstream of transcription
factor activation. By live-cell microscopy, we analyzed the sources of cell-intrinsic
stochasticity in IFN expression and quantified their relative contributions (cf. Figure
2.4 and Figure 2.5). Our findings revealed that both signal transduction activating
the key transcription factors of IFN and IFN-β gene expression have strong stochas-
tic components. Previous reports described stochastic gene regulation as the main
source of heterogeneous IFN-β expression (Hu et al. 2007, Apostolou and Thanos
2008). We rather observed that the majority of cells (91% after high dose infection)
that activated transcription factor IRF-7 also expressed IFN shortly after. There-
fore, we conclude that, the decision to express IFN-β is primarily taken upstream
of transcription factor activation. Heterogeneity at the level of signal transduction
could result from limiting amounts of RIG-I pathway components like RIG-I, MAVS,
IRF-3 or IRF-7 (cf. Figure 1.2) as proposed by other studies (Zhao et al. 2012). De-
pending on the expression levels of pathway components, the relative contribution of
transcription factor activation and IFN-β gene induction to cell-to-cell heterogeneity
could be cell-type specific.
Data-based stochastic modeling transforms heterogeneous single-cell be-
havior into predictable cell population dynamics. To link intracellular het-
erogeneous single-cell decisions with the IFN-induced antiviral protection of the cell
population, we established a multi-scale stochastic model. This stochastic model
combines the heterogeneous IFN signaling in individual cells with the cell-to-cell
communication through released IFN. Based on experimental data we determined
the model parameters and found that stochastic switching in individual cells trans-
lates into predictable dynamics of IFN-secreting and IFN-responding cell fractions
at the population level.
Parameter determination reveals cooperative RIG-I signaling. From the
parameter estimation of our stochastic model, we were able to draw two mechanisti-
cally relevant conclusions characterizing IFN induction. Concerning viral signaling,
we found that the activation of RIG-I-mediated signaling by virus is cooperative (cf.
section 2.3.1). This result is supported by the fact that RIG-I cooperatively multi-
merizes along viral dsRNA (Binder et al. 2011). In this earlier work it was concluded
that the strength of the viral signal in terms of initiation efficiency and viral dsRNA
length is transmitted through the RIG-I pathway to induce an adjusted antiviral
response. After detection of viral infection in a cell, RIG-I activates MAVS (cf.
Figure 1.2), which leads to the formation of a MAVS-associated signaling complex
(Onoguchi et al. 2010, West et al. 2011). The formation of large macromolecular
complexes is linked to slow stochastic processes (Luijsterburg et al. 2010) that could
influence both frequency and temporal heterogeneity of IFN-β expression.
IFN gene induction needs to be modeled as a slow multi-step process.
Similar to RIG-I activation, IFN-β gene induction requires the step-wise assembly
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A
Individual sentinels 
B
Quorum sensing 
No response 
Figure 4.1.: Stochastic modeling predicts that IFN expressing cells act as individual sen-
tinels of viral infection to protect a large fraction of na¨ıve cells. (A) Stochastic modeling
and validation experiments (cf. section 2.4) indicate that an individual IFN-β expressing cell
(green cell) can trigger an antiviral immune response (red cells) in a large number of of na¨ıve
cells (gray cells). (B) Quorum sensing is a communication mechanism according to which a
single signal-producing cell (green cell) is unable to induce a response in inactive cells (gray
cells) (upper scheme). A response in terms of target gene expression (red cells) only occurs
if a critical number of signal-producing cells exceed an extracellular signal threshold (lower
scheme).
of a multi-protein complex known as the IFN-β enhanceosome (Hu et al. 2007, Ford
and Thanos 2010). The proposed step-wise assembly of the IFN-β enhanceosome
agrees well with our fitting result, namely that the observed distribution of IFN-
β expression onset in single cells must be described as a slow multi-step process
(cf. section 2.3.2). In addition to the assembly of large protein structures, varying
expression levels of signaling molecules, transcription factors etc. may further con-
tribute to the detected cell-to-cell heterogeneity (Feinerman et al. 2008, Tay et al.
2010).
Stochastic modeling predicts paracrine amplification of the IFN response.
Despite strong cell-to-cell variability in IFN induction and response, the correspond-
ing behavior of the cell population is remarkably predictable. The stochastic model
demonstrates that simulated stochastic single-cell decisions were able to reproduce
the observed reliable, non-stochastic population dynamics (cf. Figure 2.11). Impor-
tantly, mathematical modeling and experimental validation show that this reliable
population level response is mediated by paracrine propagation of the IFN signal,
which compensates the strong heterogeneity in IFN induction. In this way, indi-
vidual IFN-secreting cells can act as sentinels of viral infection to protect a large
number of na¨ıve cells (Figure 4.1A). This protective warning system allows a fast
antiviral response initiated by few early sentinels with up to 40 times as many IFN
responding cells than IFN-secreting cells (cf. Figure 2.15B). Since the IFN system
functions as a first line of defense against viral infections, a rapid action is generally
required to limit viral propagation.
Our prediction that paracrine propagation of the IFN signal can translate stochastic
single-cell decisions into reliable antiviral protection of the cell population (Rand,
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Rinas et al. 2012) has been confirmed by a subsequent study (Shalek et al. 2014). In
this recent paper, individual bacteria-stimulated cells were isolated in sealed cham-
bers to prevent cell-to-cell communication. The expression of core antiviral genes
in isolated cells was substantially decreased compared to the control experiment
where cell-to-cell communication was unhindered, while cell-to-cell variability was
detectable in both cases. This result confirms our finding that paracrine signaling
enhances antiviral response.
Sentinel mechanism versus quorum sensing. The predicted sentinel mecha-
nism of paracrine signal propagation can be contrasted with another mode of cell-to-
cell communication known as quorum sensing. In quorum sensing, a critical number
of signal-producing cells is necessary to exceed an extracellular signal threshold,
which is then sufficient to induce a target gene program in inactive cells (Figure
4.1B). Quorum sensing was found to be a communication behavior of certain T cells
during an immune response (Burroughs et al. 2006, Busse et al. 2010, Feinerman
et al. 2010, Butler et al. 2013). In comparison with the individual sentinel system,
quorum sensing may result in a delayed reaction against pathogens. However, such
a cooperative activation can act as a control system to prevent autoimmunity, which
is a misdirected immune response of an organism against its own cells and tissues
(Burroughs et al. 2006). Autoimmune diseases are the third most common cause of
morbidity as well as mortality in industrialized countries (Kivity et al. 2009). Infec-
tious agents like viruses can trigger autoimmune disorders and many studies assume
that a dysregulated IFN system plays a role in the development of autoimmune
diseases (Hall and Rosen 2010, Ivashkiv and Donlin 2014).
Interpretation of heterogeneous IFN expression. How exactly heterogeneous
IFN expression should be interpreted is not fully clear. Stochastic IFN induction
could arise from mechanistic limitations of the host cells (as has been suggested for
other cytokines; Mariani et al. 2010) that are compensated by paracrine response
amplification. Alternatively, cell-to-cell variability may have functional benefits. In
particular, the widely distributed onset times of IFN expression in single cells could
sustain signaling if the IFN production period per cell is restricted, for example,
due to temporally limited presence of transcription factors in the cell nucleus, viral
countermeasures or cell death.
Summary remarks. Taken together, our findings demonstrate that the key steps
of the antiviral IFN signaling pathway are stochastic events in individual cells, which
can be described by a stochastic mathematical model. Based on single-cell data after
primary infection, mathematical modeling and validation experiments indicate that
the paracrine amplification of the IFN signal can mediate reliable antiviral protection
at the cell-population level. The prediction of paracrine cell-to-cell communication
as an efficient mechanism for averaging single-cell heterogeneity will likely be relevant
also for other systems.
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4.2. Population-based modeling predicts strong
reduction of viral spread by the autocrine effect of
rapidly produced IFN
Studying the immediate interactions between viral spread and IFN-in-
duced antiviral defense. Above, using our stochastic model and a virus capable of
primary infections only, we showed that paracrine propagation of the IFN signal is an
efficient mechanism to transmit stochastic single-cell decisions into reliable antiviral
protection of the cell population. Driven by the question which components of the
IFN system are essential for limiting viral spread due to secondary infections, we
investigated the dynamics of the antiviral IFN network after infection with spreading
DENV (cf. chapter 3).
The outcome of virus infections, either rapid containment or spreading, depends
closely on the relative kinetics of viral propagation and the activation of the antiviral
IFN system. Some earlier reports showed that IFN-induced ISG expression protects
cultured cells against subsequent DENV infection (Diamond et al. 2000, Brass et al.
2009, Li et al. 2013a). However, the kinetics of the antiviral IFN response in relation
to virus replication and spread have not been quantified in a single system based on
live-cell imaging data.
The observed characteristics of the competition between spreading DENV
and the antiviral IFN response. To study the underlying dynamics of viral repli-
cation and spread versus IFN-induced antiviral defense at the single-cell level, we
used a fully viable DENV reporter construct and host cells with authentic fluores-
cence reporters for IFN-stimulated antiviral genes. We found that IFN has two
antiviral effects. First, stimulation with IFN before infection efficiently protects
na¨ıve cells against productive DENV infection and, second, stimulation of infected
cells with IFN in an early phase after infection reduces viral replication and con-
sequently viral spread (cf. Figure 3.5). In accordance with the results regarding
primary infection with NDV in chapter 2, we observed strong cell-to-cell hetero-
geneity in IFN induction and in IFN response (cf. section 3.1.3). The heterogeneous
expression of antiviral genes leads to a coexistence of antiviral protection of na¨ıve
cells by IFN and viral spread in non-protected cells. To identify which antiviral
components are able to control viral spread, we compare DENV-wt with the vaccine
candidate DENV-E217A mutant. This mutant fails to counteract the IFN system
by 2’-O-methylation of the viral RNA. In contrast to DENV-wt, we detected that
the DENV-E217A mutant elicits faster IFN expression and barely spreads at all (cf.
Figure 3.14 and 3.15).
Parameter optimization of the DDE model identifies DENV-E217A mu-
tant specific parameters. In order to analyze the underlying differences between
DENV-wt and DENV-E217A mutant infections, we established a differential equa-
tion model with constant time delays for viral replication, virus production and IFN
secretion (cf. Figure 3.16). Our delay differential equation (DDE) model of viral
spread and IFN-induced protection was initially parameterized using a consistent set
of experimental data based on DENV-wt infection of IFN-competent human cells.
109
4. Discussion
By utilizing the DENV-wt related parameter set and time-course data concerning
DENV-E217A mutant infection, we identified E217A mutant specific parameters.
The profile likelihood analysis revealed that only two mutant specific parameters
differed strongly from the corresponding DENV-wt values: The virus production
rate vV is ∼ 8-fold lower, and the delay of IFN secretion τF is ∼ 24 h shorter after
DENV-E217A mutant infection, compared to DENV-wt. Importantly, IFN secre-
tion takes place prior to virus production after DENV-E217A mutant infection,
whereas the production of IFN and virus occurs almost simultaneously in the case
of DENV-wt.
Data-driven modeling predicts limitation of DENV spread by rapid au-
tocrine IFN action. As a faster expression of IFN results in more rapid IFN
response and an accelerated autocrine effect of IFN on infected cells can inhibit
virus replication in a time-dependent manner (cf. Figure 3.5), the two mutant spe-
cific parameters τF and vV could be related, with shorter τF causing lower vV. We
therefore extended our model to elucidate the autocrine and paracrine effects of
IFN. By means of mathematical modeling and validation experiments, we arrived at
the prediction that rapid autocrine IFN action curbing virus production in infected
cells is essential for the attenuation of the DENV-E217A mutant, whereas faster
paracrine IFN action on na¨ıve cells has only a low impact on the spread of DENV.
The result that paracrine IFN response contributes only marginally to the limitation
of spreading DENV is quite surprising, as a small fraction of DENV-E217A mutant
infected cells does protect a larger number of na¨ıve cells by paracrine IFN action (cf.
Figure 3.28B). But at the same time, a large number of cells remained susceptible
throughout the entire 4-day observation period illustrating that lack of available host
cells is not a limiting factor for viral spread in our system. These data indicate that
fast-acting autocrine IFN signaling is able to contain viral spread quickly, while an
accelerated paracrine IFN response could serve as an additional protective measure,
which is, however, limited due to high cell-to-cell heterogeneity.
Our model prediction that the autocrine action of IFN on infected cells is decisive
in controlling the spread of DENV is supported by a seminal mathematical model
of hepatitis C virus (HCV) kinetics (Neumann et al. 1998). This earlier model
describes the dynamics of uninfected target cells, infected cells and extracellular
HCV, informed by time course data of patients after treatment with IFN. While
considering the antiviral effect of IFN only indirectly with an effectiveness rate, this
standard model of HCV kinetic demonstrated that the major effect of IFN treatment
is to inhibit HCV production or release rather than blocking new infections.
Reported reasons for the attenuation of viruses with 2’-O-unmethylated
RNA. The attenuated spread of viruses lacking 2’-O-methyltransferase activity of
the viral genome has been widely discussed in the literature. It was proposed that
in wild-type the 2’-O-methylation of the viral genome prevents the recognition of
the virus by the RNA sensor MDA5 and thus inhibits IFN induction (Zu¨st et al.
2011). Furthermore, it was demonstrated that viruses with 2’-O-methylation largely
evade antiviral IFN response mediated by IFIT1 (Daffis et al. 2010, Zu¨st et al.
2011, Kimura et al. 2013, Szretter et al. 2012). A restriction of viral replication
through IFIT1 can be explained through the sequestration of 2’-O-unmethylated
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RNA by IFIT1, thereby impeding translation of viral RNA (Pichlmair et al. 2011,
Habjan et al. 2013). IFIT1 is an ISG, which can be induced directly after viral
sensing by IRF-3 independent from IFN (Grandvaux et al. 2002, Diamond and
Farzan 2013, Chen et al. 2013). Additionally, IFIT1 can also be induced in response
to secreted IFN (cf. Figure 3.2B and Figure 3.12). Therefore, the attenuation of the
DENV-E217A mutant might result from an IFN-independent and an IFN-dependent
antiviral response.
Accelerated IFN secretion is a critical determinant for the attenuation
of the DENV-E217A mutant. The slight decline of DENV-E217A mutant virus
production in IFN-incompetent BHK-21 cells compared to DENV-wt (cf. Figure
3.29B) could indeed arise from an IFN-independent decrease of the virus production
rate. However, in IFN-competent A549 cells we detected a much larger difference be-
tween DENV-wt and E217A mutant virus production compared to IFN-incompetent
BHK-21 cells (cf. Figure 3.29). In our full DDE model we also take into account
that the virus replication of the DENV-E217A mutant can be restricted in an IFN-
independent manner. Since we have no available data on the extent to which virus
production of the E217A mutant is influenced by IFN-independent mechanisms in
the A549 reporter cell line, we assumed that the DENV-E217A mutant produces half
as much virus as DENV-wt. With this assumption the model matched the kinetics
of both DENV-wt and E217A mutant replication and IFN response as before the
extension of the model (cf. Figure 3.25 and Figure 3.21). The model analysis of the
relative importance of decreased virus production and accelerated IFN expression
(cf. Figure 3.27) revealed that the IFN-independent reduction of virus production
rate attenuates viral spread (cf. Figure 3.27, relative change of virus replicating cells
in vertical direction), but this attenuation was strongly enhanced for shorter delays
of IFN secretion (cf. Figure 3.27, relative change of virus replicating cells in hori-
zontal direction). Therefore, the timing of IFN induction is an important factor of
viral spread and critically determines the attenuation of the E217A mutant.
Further insight on the antiviral effects of IFN-independent mechanisms would be
gained by accurately quantifying the IFN-independent reduction on the virus pro-
duction rate. The contribution of IFN-independent antiviral signaling on the virus
production rate could be detected experimentally by infecting A549 cells, in which
the IFN-α and IFN-λ receptors are knocked down, for instance through a small-
interfering RNA (siRNA) approach. The determination of the virus production in
such knockout cells after infection with DENV-wt and DENV-E217A mutant might
be used to fit the IFN-independent decrease of the virus production rate of the
DENV-E217A mutant.
Effective autocrine IFN action on infected cells during the initial stage of
viral replication. According to the results of the parameter estimation, DENV-
E217A mutant infected cells secrete IFN ∼ 8 h after infection and thus much earlier
than DENV-wt infected cells, which express IFN ∼ 32 h post infection (cf. Figure
3.22). A rapid IFN signal can activate the JAK-STAT signaling pathway, most likely
before DENV is able to counteract an efficient IFN response in infected cells. For
example, DENV-induced degradation of STAT2 (cf. Figure 3.6) requires a sufficient
expression level of viral proteins (Acosta et al. 2014). Therefore, DENV-E217A mu-
tant infected cells receive an autocrine IFN stimulus during the initial phase of viral
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replication, in which infected cells may still be IFN responsive, and IFN-mediated
expression of ISGs can then lead to a strong reduction of the virus production rate.
In contrast, DENV-wt infected cells express IFN in later stages of viral replication
when high amounts of non-structural viral proteins are present and probably al-
ready disturb the JAK-STAT signaling pathway. An autocrine IFN signal at such a
late phase of viral replication would not be able to inhibit virus production in these
already IFN unresponsive DENV-wt infected cells. This could explain the observed
stronger increase in the number of virus replicating cells due to secondary infection
events starting ∼ 60 h post infection after DENV-wt compared to E217A mutant
infection (cf. Figure 3.21(3)).
The parameter estimates reveal a temporal advantage of IFN secretion
over E217A mutant spread. In the case of DENV-E217A mutant infections,
our model predicts a temporal advantage of IFN secretion which takes place ∼ 20 h
prior to virus production. During this time window, IFN signaling can initiate an
antiviral gene program in susceptible cells before new infectious virus particles are
released. Additionally, extracellular IFN produced as a result of the initial infection
is immediately available in the early stages of all secondary infection events and will
lead to an efficient decrease of the virus production rate in susceptible cells, which
become newly infected by viral spread. In such case, a further wave of virus pro-
duction would be minimal. In contrast to the DENV-E217A mutant, the estimated
delays of IFN secretion and virus production after infection with DENV-wt are al-
most identical and last ∼ 31 − 32 h. Therefore, the antiviral IFN response has to
compete against spreading DENV-wt without a temporal advantage of IFN expres-
sion, and the primary DENV-wt infected cells may already be IFN unresponsive. If
this is the case, IFN produced by primary infected cells may influence only those
infected cells that are subject to secondary DENV-wt infections during viral spread.
Summarizing remarks. In summary, our study of the interactions between spread-
ing DENV and the antiviral IFN defense reveals an early “window of opportunity”
during which the IFN response can curb viral replication by acting on already in-
fected cells. Thus, our results demonstrate that the relative dynamics of virus repli-
cation and the antiviral impact of autocrine IFN primarily determine the outcome
of DENV infections.
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4.3. Using mathematical modeling to gain insight into
virus-host competitions
Integrating data and mechanisms from the molecular to the cell-popu-
lation level by means of mathematical modeling. In this work we estab-
lished two complementary mathematical models to examine the dynamics of the
IFN response against viral infections. While the first model focuses on stochastic
single-cell decisions, the second one classifies the cell population in different subpop-
ulations according to their infection state. Finding the right balance between the
detailed simulation of the observed molecular as well as population-based virus-host
dynamics (Figure 4.2) and the computational feasibility of mathematical models is
a challenging task.
Our stochastic model links the virus-induced IFN signaling in individual cells with
the extracellular cell-to-cell communication via secreted IFN in a cell population af-
ter primary infection with NDV (cf. Figure 2.9). The stochastic state transitions of
the single cells with respect to virus replication, IFN induction and IFN response are
generated using Gillespie’s stochastic simulation algorithm and only the intercellu-
lar communication via released IFN is calculated deterministically. The simulation
of such an almost entirely stochastic model with a large number of heterogeneous
individuals on timescales of several hours is very time consuming and practically ex-
cludes straightforward parameter optimization approaches (Gillespie 2007, Cao and
Samuels 2009, Banks et al. 2011). Thus, it is necessary to reduce model complexity
in some way.
We here took the approach of a differential equation model with constant time delays
for viral replication, virus production, IFN secretion and autocrine IFN responsive-
ness to analyze the dynamics of viral spread and IFN-induced antiviral protection
at the population level (cf. Figure 4.2B and Figure 3.23). This model type describes
multi-step processes with a single delay equal for all individual cells. While our
stochastic model is constructed to directly reflect the observed heterogeneous events
in individual cells, the DDE model also accounts for the stochastic onset of the
IFN response in individual cells due to the slow protection rate (cf. Figure 3.21(4)
and Figure 3.20C). This population-based estimate of a slow protection will appear
stochastic at the single-cell level. In order to incorporate more directly the observed
single-cell heterogeneity of viral replication, viral release and IFN expression (cf.
Figure 3.7) into the DDE model, one could replace constant delays by temporally
distributed delays (MacDonald 1989, Rateitschak and Wolkenhauer 2007). Since the
results of our stochastic model demonstrate that cell-to-cell variability can be trans-
lated into predictable cell population dynamics, the use of temporally distributed
delays would probably only lead to smoother simulated kinetics of the number of
virus replicating cells and the extracellular concentration of IFN (cf. Figure 3.21(3)
and (5)).
Data-driven modeling provides insight into the competition between
spreading DENV and IFN-induced antiviral protection. Our study of
the antiviral IFN response after infection with non-spreading NDV and spreading
DENV-E217A mutant revealed a strong paracrine propagation of the IFN signal
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according to which one IFN-secreting cell protects a large number of na¨ıve cells by
IFN-induced expression of antiviral genes (cf. Figure 2.15B and Figure 3.28B). This
protective warning system was severely impaired after infection with DENV-wt (cf.
Figure 3.28A). In addition, the determination of predominantly autocrine IFN ac-
tion using electroporation revealed that the ability of DENV-wt to modify its RNA
genome by 2’-O-methylation also disturbs the autocrine IFN response (cf. Figure
3.29). Although both modes of action of IFN are more powerful after infection with
the DENV-E217A mutant than post DENV-wt infection, we demonstrated by math-
ematical modeling that a rapid autocrine action of IFN on infected cells is essential
for the attenuation of the E217A mutant (cf. Figure 3.27). In contrast, accelerated
protection of na¨ıve cells by paracrine IFN action has only a minor impact on the
spread of DENV (cf. Figure 3.27 right column).
Our experimental data and modeling results indicate that the timing of IFN sensing
by DENV-infected cells is crucial for an efficient autocrine effect in our system. The
stimulation of infected cells with IFN in an early phase after DENV-wt infection
resulted in a reduction of virus replication and consequently virus production (cf.
Figure 3.5). However, the time window during which treatment with IFN post in-
fection had an impact on virus replication was limited. On the basis of our model
simulations, an IFN signal at the earliest possible stage of viral replication strongly
enhanced the attenuation of viral spread (cf. Figure 3.27, varying parameter val-
ues for the delay of IFN secretion τF in horizontal direction). Therefore it seems
that DENV is most prone to antiviral response in the very initial stages of viral
replication, where therapeutic interventions against DENV should prove to be most
effective.
The interference strategies of viruses could influence the dynamics of the
antiviral IFN system. The narrow “window of opportunity”, during which IFN
treatment has an antiviral effect on DENV-infected cells, could be explained by
the ability of DENV to disturb the JAK-STAT signaling pathway (cf. Figure 3.1).
An IFN signal during the initial phase of DENV replication might induce an IFN
response before a sufficiently high amount of non-structural viral proteins has been
generated to inhibit STAT1 (Mun˜oz-Jorda´n et al. 2003, Mun˜oz-Jorda´n et al. 2005)
or degrade STAT2 (cf. Figure 3.6). On the one hand, such an IFN-responsive time
window could be longer after infection of a cell with a different type of virus, which
does not counteract the IFN response such as HIV or hepatitis A virus (Versteeg
and Garc´ıa-Sastre 2010). But on the other hand, the IFN-responsive time slot might
also be shorter if a cell become infected with a virus, which is able to antagonize the
IFN response right after infection. An example for this is the Rift Valley fever virus,
which expresses the nonstructural protein NSs immediately after infection (Ikegami
et al. 2005) and, subsequently, the NSs protein is able to antagonize both IFN
induction and ISG expression (Haller et al. 2006, Ikegami and Makino 2011). In a
case where viral infection inhibits ISG expression in the host before viral replication
can be restricted, protection of na¨ıve cells by paracrine sensing of IFN could be
crucial to limit viral spread. We thus expect that various interference strategies
of pathogenic viruses inhibiting IFN induction and/or IFN response (Versteeg and
Garc´ıa-Sastre 2010) will have different effects on the dynamics of the IFN system.
Options for further work. To examine more precisely how an early autocrine IFN
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Figure 4.2.: Scheme of the molecular and population-based virus-host interactions of the
antiviral IFN response. (A) Virus-host interactions at the single-cell level. After infection
of a cell, viruses use the host machinery for their replication (↺). The recognition of
viruses by specific receptors induces a signaling cascade, which activates the transcription
factors (TFs) of IFN. The nuclear translocation of the transcription factors leads to the
expression of IFN and antiviral ISGs (green cytoplasm). The ISGs can prevent further viral
entry and inhibit viral replication in the infected cell. Moreover, secreted IFN stimulates
the JAK/STAT signaling pathway, which in turn results in the expression of further ISGs
(yellow cytoplasm). (B) Virus-host interactions at the population level. After the initial viral
infection of a cell population, viruses require a certain amount of time for their replication
(red nucleus) and the production of new infectious virus particles. The release of newly
generated virus causes further infections of host cells by viral spread. Parallel to the viral
propagation, the cellular recognition of viral pathogens evokes the secretion of IFN (green
cytoplasm) after a certain delay post infection. Sensing of IFN leads to the expression of
antiviral genes which block viral activity in infected cells and trigger an antiviral protective
state in na¨ıve cells (yellow cytoplasm).
effect interferes with the production of DENV, it would be advisable to incorporate
intracellular steps of DENV replication into the DDE model. Moreover, a possi-
ble alternative modeling approach for such an extension might be an infection-age
structured PDE model (Hethcote 2000, Nelson et al. 2004, Getto et al. 2008, Guedj
et al. 2013). This type of model offers more flexibility by allowing to describe viral
115
4. Discussion
replication, virus production and antiviral response depending on the time a cell
has been infected. While age-structured PDE models are valuable tools to analyze
the interactions between intracellular and extracellular processes, PDE models are,
in general, more computationally demanding than DDE models (Kim et al. 2009).
Time-resolved data of viral RNA as well as virus production kinetics after infection
with DENV-wt and DENV-E217A mutant could provide the experimental basis for
such models. A deeper mechanistic understanding of the stages of the DENV repli-
cation cycle, which are most sensitive to the antiviral IFN response and/or most
amenable to antiviral treatment could guide the design of novel antiviral therapies
to combat DENV infections.
In both models, spatial effects of viral spread and cell responses have not been con-
sidered explicitly as on the relevant time scale for virus replication and host gene
expression, all cells in the culture are likely to see spatially averaged virus and IFN
concentrations (Chang et al. 2008, Hu et al. 2011). This might change in dense
tissues (Funk et al. 2005, Graw et al. 2014) or focal infections (Haseltine et al. 2008,
Labadie and Marciniak-Czochra 2011, Bertolusso and Kimmel 2012) where viral
spread and IFN diffusion could cause, at least initially, more localized infections
and IFN responses. It would be interesting to investigate how DENV spreads in
a non-well-mixed system, and whether spatial heterogeneity can be observed. A
reaction-diffusion model based on spatio-temporal data might be used to analyze
whether a rapid autocrine effect of IFN is still the key determinant for the attenua-
tion of the E217A mutant in a spatially distributed system. The parameterization of
such a PDE model could be facilitated by utilizing the estimates of the cell-intrinsic
parameters of our DDE model as a starting point to determine the remaining spa-
tially dependent parameters from the spatio-temporal data.
Final remarks. In conclusion, our work emphasizes that mathematical modeling
plays an important role in integrating data and mechanisms from the molecular to
the cell-population level. The research on understanding which molecular mecha-
nisms of the antiviral IFN response are able to control the spread of a certain virus
can help to develop novel antiviral therapies and vaccines.
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A.1. Jacobian matrices of the delay differential
equation model
The population-based delay differential equation model (3.11) is numerically solved
by using the RADAR5 solver written in ANSI Fortran-90 (Guglielmi and Hairer
2005). To ensure a high accuracy of the solution, we implement within the RADAR5
code the following sparse standard Jacobian matrix J (t) and the Jacobian matrix
with respect to the delayed variables Jτ(t) for time t ∈ R:
J (t) =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
−rVV (t) − rFF (t) + pS 0 0 0 0 0 0 0 −rFS(t) −rVS(t)
rVV (t) 0 0 0 0 0 0 0 0 rVS(t)
0 0 0 0 0 0 0 0 0 0
rVV (t) 0 0 0 0 0 0 0 0 rVS(t)
0 0 0 0 0 0 0 0 0 0
rVV (t) 0 0 0 0 0 0 0 0 rVS(t)
0 0 0 0 0 0 0 0 0 0
rFF (t) 0 0 0 0 0 0 pP rFS(t) 0
0 0 0 0 0 0 vF 0 −dF 0
0 0 0 0 vV 0 0 0 0 −dV
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
Jτ(t) =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0 0 0 0 0−rVV (t − τR) 0 0 0 0 0 0 0 0 −rVS(t − τR)
rVV (t − τR) 0 0 0 0 0 0 0 0 rVS(t − τR)−rVV (t − τV) 0 0 0 0 0 0 0 0 −rVS(t − τV)
rVV (t − τV) 0 0 0 0 0 0 0 0 rVS(t − τV)−rVV (t − τF) 0 0 0 0 0 0 0 0 −rVS(t − τF)
rVV (t − τF) 0 0 0 0 0 0 0 0 rVS(t − τF)
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
.
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A.2. Jacobian matrices of the full delay differential
equation model
A numerical solution of the full population-based delay differential equation model
(3.37) is obtained by utilizing the RADAR5 solver written in ANSI Fortran-90
(Guglielmi and Hairer 2005). For an increased accuracy of the solution, we provide
within the RADAR5 code the following sparse standard Jacobian matrix Jfull(t) and
the Jacobian matrix with respect to the delayed variables Jfull,τ(t) for time t ∈ R:
Jfull (t) =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
j1 0 0 0 0 0 0 0 0 −rFS(t) 0 0 −rVS(t)
rVV (t) 0 0 0 0 0 0 0 0 0 0 0 rVS(t)
0 0 0 0 0 0 0 0 0 0 0 0 0
rVV (t) 0 0 0 0 0 0 0 0 0 0 0 rVS(t)
0 0 0 0 0 0 0 0 0 0 jF −jF 0
0 0 0 0 0 0 0 0 0 0 −jF jF 0
rVV (t) 0 0 0 0 0 0 0 0 0 0 0 rVS(t)
0 0 0 0 0 0 0 0 0 0 0 0 0
rFF (t) 0 0 0 0 0 0 0 pP rFS(t) 0 0 0
0 0 0 0 0 0 0 vF 0 −dF 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 vP 0 0 0 0 0 0 0 −dV
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
Jfull,τ(t) =
⎛⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎜⎝
0 0 0 0 0 0 0 0 0 0 0 0 0−rVV (t − τR) 0 0 0 0 0 0 0 0 0 0 0 −rVS(t − τR)
rVV (t − τR) 0 0 0 0 0 0 0 0 0 0 0 rVS(t − τR)−rVV (t − τV) 0 0 0 0 0 0 0 0 0 0 0 −rVS(t − τV)
jτ,(5,1) 0 0 0 0 0 0 0 0 0 0 0 jτ,(5,13)
jτ,(6,1) 0 0 0 0 0 0 0 0 0 0 0 jτ,(6,13)−rVV (t − τF) 0 0 0 0 0 0 0 0 0 0 0 −rVS(t − τF)
rVV (t − τF) 0 0 0 0 0 0 0 0 0 0 0 rVS(t − τF)
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 1 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0 0
⎞⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎟⎠
with
j1 = −rVV (t) − rFF (t) + pS
jF = rP exp (rP [F1(t) −F2(t)]) rVV (t − τV)S(t − τV)
jτ,(5,1) = exp (rP [F1(t) −F2(t)]) rVV (t − τV)
jτ,(5,13) = exp (rP [F1(t) −F2(t)]) rVS(t − τV)
jτ,(6,1) = (1 − exp (rP [F1(t) −F2(t)])) rVV (t − τV)
jτ,(6,13) = (1 − exp (rP [F1(t) −F2(t)])) rVS(t − τV).
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Abbreviations and symbols
1A characteristic function of the set A, p. 43=̂ corresponds to
∅ degradation
f˙(t) = d
dt
f(t) derivative of the function f(t) with respect to time t
∈ element of
∶= equal by definition
A ∩B intersection of the sets A and B
↺ replication
∀ universal quantifier; for all
α alpha
A549 carcinomic human alveolar epithelial cell line, p. 56
AIDS acquired immunodeficiency syndrome, p. 13
a.u. arbitrary units, p. 86
β beta
BAC bacterial artificial chromosome, p. 21, 56
BHK-21 baby hamster kidney cell line, p. 81
C capsid protein of DENV, p. 7, 55
CDF cumulative distribution function, p. 43, 93
CFP cyan fluorescent protein, p. 21
χ2 chi-squares statistic, p. 43, 49, 83
CI confidence interval, p. 85
CS1 circularization sequence 1, p. 57
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Abbreviations and symbols
CV coefficient of variation, p. 22
δ(x) delta distribution also known as delta function, p. 73
∆Tgen time difference between sister cells regarding IFN-β-tGFP expression, p. 26
∆T sig time difference between sister cells regarding IRF-7 signaling, p. 26
DAPI 4’,6-diamidino-2-phenylindole fluorescent stain, p. 61
DDE delay differential equation, p. 3, 73
deGFP destabilized version of enhanced green fluorescent protein, p. 56
DENV Dengue virus, p. 6, 6, 53
DF degree of freedom, p. 44, 85
DKFZ German Cancer Research Center, p. 143
DNA deoxyribonucleic acid, p. 5
ds double-stranded, p. 5, 57
E envelope protein of DENV, p. 7, 55
 epsilon
E217A mutant DENV mutant, which differ from the DENV-wt due to a single
substitution of the glutamic acid residue (E) by an alanine residue (A) at the
amino acid position 217 of the NS5 protein, p. 11, 16, 54, 69
eGFP enhanced green fluorescent protein, p. 56
ELISA enzyme-linked immunosorbent assay, p. 63, 70
exp. experiment, p. 86
FACS fluorescence-activated cell sorting, p. 30
faR far red fluorescent protein, p. 55
γ gamma
γ(m,z) gamma distribution with the positive parameters m and z, p. 46
Γ Gamma
Γ(m) gamma function with the positive parameter m, p. 46
g gram
GAPDH glyceraldehyde 3-phosphate dehydrogenase, p. 63
GFP green fluorescent protein, p. 21
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Abbreviations and symbols
h hours
H Heaviside step function, p. 36
HAART highly active antiretroviral therapy, p. 13
HAU haemagglutinating unit, p. 22
HCV hepatitis C virus, p. 13, 110
HIV human immunodeficiency virus, p. 13
HN hemagglutinin-neuraminidase, p. 6, 23
HZI Helmholtz Centre for Infection Research, p. 19
IFIT1 interferon-induced protein with tetratricopeptide repeats 1 also known as
ISG56, p. 56
IFIT3 interferon-induced protein with tetratricopeptide repeats 3, p. 64
IFN interferons, p. 1, 9, 19
i.i.d. independent and identically distributed, p. 46
IRF interferon regulatory factor, p. 9, 21
ISG interferon stimulated gene, p. 9, 19
ISG56 interferon stimulated gene 56, also known as IFIT1, p. 56
ISGF3 IFN-stimulated gene factor 3, p. 9
IU international units, p. 61
JAK janus activated kinase, p. 9
κ kappa
kDa kilodalton, p. 62
λ lambda
L likelihood function, p. 46
L log-likelihood function, p. 46
ln natural logarithm
log logarithm
µg microgram
µl microliter
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Abbreviations and symbols
µm micrometer
MAVS mitochondrial antiviral-signaling protein, p. 9
mCherry monomeric cherry (red fluorescent protein), p. 21
MDA5 melanoma differentiation-associated protein 5, p. 9, 55
mex subroutine Matlab executable subroutine, p. 4, 80
MFI mean fluorescence intensity, p. 24, 62
min minutes
ml milliliter
MOI multiplicity of infection, p. 24
MP potentially DENV-E217A mutant specific model parameter, p. 89
mRNA messenger RNA, p. 5
Mx MX dynamin-like GTPase, p. 56
N set of natural numbers {1,2,3, ...}
N0 set of non-negative integer numbers {0,1,2,3, ...}
NDV Newcastle disease virus, p. 6, 22
NF-κB nuclear factor kappa B, p. 9, 21
ng nanogram
NIH3T3 mouse embryonic fibroblast cell line, p. 22
NLS nuclear localization signal, p. 55
NS non-structural protein of DENV, p. 7, 55
ODE ordinary differential equation, p. 73
P(A) probability of A, p. 93
P(A ∣B) conditional probability of A under the condition B, p. 32
p50 protein involved in nuclear factor kappa B heterodimer formation, p. 9
p65 protein involved in nuclear factor kappa B heterodimer formation, p. 9, 21
PAMP pathogen-associated molecular pattern, p. 8
PCS sequence encoding for the 2A cleavage factor of the Thosea asigna virus, p.
57
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Abbreviations and symbols
PDE partial differential equation, p. 73
pg picogram
p.i. post infection, p. 23
poly I:C polyinosinic-polycytidylic acid, p. 22
prM premembrane protein of DENV, p. 7, 55
PRR pattern-recognition receptor, p. 8
qPCR quantitative polymerase chain reaction, p. 30
qRT-PCR quantitative real time reverse polymerase chain reaction, p. 63
r correlation coefficient, p. 26
r2 coefficient of determination, p. 26
R set of real numbers
R≥0 set of nonnegative real numbers
RIG-I retinoic acid-inducible gene I, p. 9, 19
RLR RIG-I-like receptor, p. 9
RNA ribonucleic acid, p. 5
RO readout, p. 38, 82
RPS9 40S ribosomal protein S9, p. 30
RSAD2 radical S-adenosyl methionine domain containing 2, p. 30
siRNA small-interfering RNA, p. 111
ss single-stranded, p. 5, 22, 55
SSA stochastic simulation algorithm, p. 32
STAT signal transducer and activator of transcription, p. 9
STING stimulator of interferon genes also known as MITA, p. 9, 53
TagRFP red fluorescent protein tag, p. 28
TCID50 tissue culture infectious dose 50, p. 58
TCP trans-complementation particle, p. 58
Tdiv time of cell division, p. 26
TF transcription factor, p. 9
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Tgen time delay between nuclear translocation of NF-κB/IRF-7 and onset of IFN-β
expression, p. 26
T gen mean value of T gen, p. 26
Tgen simulated time delay between nuclear translocation of NF-κB/IRF-7 and onset
of IFN-β expression, p. 39
tGFP turbo green fluorescent protein, p. 21
TLR Toll-like receptor, p. 9, 55
TMV tobacco mosaic virus, p. 5
T sig signaling delay from viral infection to nuclear translocation of the transcription
factors NF-κB and IRF-7, p. 26
T sig mean value of T sig, p. 26Tsig simulated signaling delay from viral infection to nuclear translocation of the
transcription factors NF-κB and IRF-7, p. 39
TYK tyrosine kinase, p. 9
U unit, p. 28
USP18 ubiquitin specific peptidase 18, p. 30
UTR untranslated region, p. 57, 70
vol. volume, p. 84
WHO World Health Organization, p. 12
wt wild-type, p. 16, 53
YFP yellow fluorescent protein, p. 21
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